The present invention relates to surgical instruments designed to treat tissue, including but not limited to surgical instruments that are configured to cut and fasten tissue. The surgical instruments may include electrosurgical instruments powered by generators to effect tissue dissecting, cutting, and/or coagulation during surgical procedures. The surgical instruments may include instruments that are configured to cut and staple tissue using surgical staples and/or fasteners. The surgical instruments may be configured for use in open surgical procedures, but have applications in other types of surgery, such as laparoscopic, endoscopic, and robotic-assisted procedures and may include end effectors that are articulatable relative to a shaft portion of the instrument to facilitate precise positioning within a patient.
In various embodiments, an electrosurgical system comprising an end effector and a control circuit is disclosed. The end effector comprises a first jaw and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The control circuit is configured to cause an application of two different energy modalities to the tissue simultaneously and separately during a tissue treatment cycle comprising a tissue coagulation stage and a tissue transection stage.
In various embodiments, an electrosurgical instrument comprising an end effector is disclosed. The end effector comprises a first jaw and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The end effector is configured to cause an application of three different energy modalities to the tissue during a tissue treatment cycle comprising a tissue coagulation stage and a tissue transection stage.
In various embodiments, an electrosurgical system comprising a first generator configured output a bipolar energy, a second generator configured to output a monopolar energy, a surgical instrument electrically coupled to the first generator and the second generator, and a control circuit is disclosed. The surgical instrument comprises an end effector. The end effector comprises a first jaw and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The control circuit comprises a processor and a storage medium comprising program instructions that, when executed by the processor, causes the processor to cause the first generator and the second generator to apply a predetermined power scheme to the end effector. The power scheme comprises a simultaneous application and a separate application of the bipolar energy and the monopolar energy to the tissue in a tissue treatment cycle.
The novel features of the various aspects are set forth with particularity in the appended claims. The described aspects, however, both as to organization and methods of operation, may be best understood by reference to the following description, taken in conjunction with the accompanying drawings in which:
Applicant of the present application owns the following U.S. Patent Applications that are filed on May 28, 2020, and which are each herein incorporated by reference in their respective entireties:
Applicant of the present application owns the following U.S. Provisional Patent applications that were filed on Dec. 30, 2019, the disclosure of each of which is herein incorporated by reference in its entirety:
Applicant of the present application owns the following U.S. Patent applications, the disclosure of each of which is herein incorporated by reference in its entirety:
Before explaining various aspects of an electrosurgical system in detail, it should be noted that the illustrative examples are not limited in application or use to the details of construction and arrangement of parts illustrated in the accompanying drawings and description. The illustrative examples may be implemented or incorporated in other aspects, variations, and modifications, and may be practiced or carried out in various ways. Further, unless otherwise indicated, the terms and expressions employed herein have been chosen for the purpose of describing the illustrative examples for the convenience of the reader and are not for the purpose of limitation thereof. Also, it will be appreciated that one or more of the following-described aspects, expressions of aspects, and/or examples, can be combined with any one or more of the other following-described aspects, expressions of aspects, and/or examples.
Various aspects are directed to electrosurgical systems that include electrosurgical instruments powered by generators to effect tissue dissecting, cutting, and/or coagulation during surgical procedures. The electrosurgical instruments may be configured for use in open surgical procedures, but has applications in other types of surgery, such as laparoscopic, endoscopic, and robotic-assisted procedures.
As described below in greater detail, an electrosurgical instrument generally includes a shaft having a distally-mounted end effector (e.g., one or more electrodes). The end effector can be positioned against the tissue such that electrical current is introduced into the tissue. Electrosurgical instruments can be configured for bipolar or monopolar operation. During bipolar operation, current is introduced into and returned from the tissue by active and return electrodes, respectively, of the end effector. During monopolar operation, current is introduced into the tissue by an active electrode of the end effector and returned through a return electrode (e.g., a grounding pad) separately located on a patient's body. Heat generated by the current flowing through the tissue may form hemostatic seals within the tissue and/or between tissues and thus may be particularly useful for sealing blood vessels, for example.
A first voltage sensing circuit 912 is coupled across the terminals labeled ENERGY1 and the RETURN path to measure the output voltage therebetween. A second voltage sensing circuit 924 is coupled across the terminals labeled ENERGY2 and the RETURN path to measure the output voltage therebetween. A current sensing circuit 914 is disposed in series with the RETURN leg of the secondary side of the power transformer 908 as shown to measure the output current for either energy modality. If different return paths are provided for each energy modality, then a separate current sensing circuit should be provided in each return leg. The outputs of the first and second voltage sensing circuits 912, 924 are provided to respective isolation transformers 928, 922 and the output of the current sensing circuit 914 is provided to another isolation transformer 916. The outputs of the isolation transformers 916, 928, 922 on the primary side of the power transformer 908 (non-patient isolated side) are provided to a one or more ADC circuit 926. The digitized output of the ADC circuit 926 is provided to the processor 902 for further processing and computation. The output voltages and output current feedback information can be employed to adjust the output voltage and current provided to the surgical instrument and to compute output impedance, among other parameters. Input/output communications between the processor 902 and patient isolated circuits is provided through an interface circuit 920. Sensors also may be in electrical communication with the processor 902 by way of the interface circuit 920.
In one aspect, the impedance may be determined by the processor 902 by dividing the output of either the first voltage sensing circuit 912 coupled across the terminals labeled ENERGY1/RETURN or the second voltage sensing circuit 924 coupled across the terminals labeled ENERGY2/RETURN by the output of the current sensing circuit 914 disposed in series with the RETURN leg of the secondary side of the power transformer 908. The outputs of the first and second voltage sensing circuits 912, 924 are provided to separate isolations transformers 928, 922 and the output of the current sensing circuit 914 is provided to another isolation transformer 916. The digitized voltage and current sensing measurements from the ADC circuit 926 are provided the processor 902 for computing impedance. As an example, the first energy modality ENERGY1 may be RF monopolar energy and the second energy modality ENERGY2 may be RF bipolar energy. Nevertheless, in addition to bipolar and monopolar RF energy modalities, other energy modalities include ultrasonic energy, irreversible and/or reversible electroporation and/or microwave energy, among others. Also, although the example illustrated in
As shown in
Additional details are disclosed in U.S. Patent Application Publication No. 2017/0086914, titled TECHNIQUES FOR OPERATING GENERATOR FOR DIGITALLY GENERATING ELECTRICAL SIGNAL WAVEFORMS AND SURGICAL INSTRUMENTS, which published on Mar. 30, 2017, which is herein incorporated by reference in its entirety.
The generator 1100 is configured to drive multiple surgical instruments 1104, 1106, 1108. The first surgical instrument is an ultrasonic surgical instrument 1104 and comprises a handpiece 1105 (HP), an ultrasonic transducer 1120, a shaft 1126, and an end effector 1122. The end effector 1122 comprises an ultrasonic blade 1128 acoustically coupled to the ultrasonic transducer 1120 and a clamp arm 1140. The handpiece 1105 comprises a trigger 1143 to operate the clamp arm 1140 and a combination of the toggle buttons 1137, 1134b, 1134c to energize and drive the ultrasonic blade 1128 or other function. The toggle buttons 1137, 1134b, 1134c can be configured to energize the ultrasonic transducer 1120 with the generator 1100.
The generator 1100 also is configured to drive a second surgical instrument 1106. The second surgical instrument 1106 is an RF electrosurgical instrument and comprises a handpiece 1107 (HP), a shaft 1127, and an end effector 1124. The end effector 1124 comprises electrodes in clamp arms 1145, 1142b and return through an electrical conductor portion of the shaft 1127. The electrodes are coupled to and energized by a bipolar energy source within the generator 1100. The handpiece 1107 comprises a trigger 1145 to operate the clamp arms 1145, 1142b and an energy button 1135 to actuate an energy switch to energize the electrodes in the end effector 1124. The second surgical instrument 1106 can also be used with a return pad to deliver monopolar energy to tissue.
The generator 1100 also is configured to drive a multifunction surgical instrument 1108. The multifunction surgical instrument 1108 comprises a handpiece 1109 (HP), a shaft 1129, and an end effector 1125. The end effector 1125 comprises an ultrasonic blade 1149 and a clamp arm 1146. The ultrasonic blade 1149 is acoustically coupled to the ultrasonic transducer 1120. The handpiece 1109 comprises a trigger 1147 to operate the clamp arm 1146 and a combination of the toggle buttons 11310, 1137b, 1137c to energize and drive the ultrasonic blade 1149 or other function. The toggle buttons 11310, 1137b, 1137c can be configured to energize the ultrasonic transducer 1120 with the generator 1100 and energize the ultrasonic blade 1149 with a bipolar energy source also contained within the generator 1100. Monopolar energy can be delivered to the tissue in combination with, or separately from, the bipolar energy.
The generator 1100 is configurable for use with a variety of surgical instruments. According to various forms, the generator 1100 may be configurable for use with different surgical instruments of different types including, for example, the ultrasonic surgical instrument 1104, the RF electrosurgical instrument 1106, and the multifunction surgical instrument 1108 that integrates RF and ultrasonic energies delivered simultaneously from the generator 1100. Although in the form of
In certain instances, the closure motor assembly 610 includes a closure motor. The closure 603 may be operably coupled to a closure motor drive assembly 612 which can be configured to transmit closure motions, generated by the motor to the end effector, in particular to displace a closure member to close to transition the end effector to the closed configuration. The closure motions may cause the end effector to transition from an open configuration to a closed configuration to capture tissue, for example. The end effector may be transitioned to an open position by reversing the direction of the motor.
In certain instances, the articulation motor assembly 620 includes an articulation motor that be operably coupled to an articulation drive assembly 622 which can be configured to transmit articulation motions, generated by the motor to the end effector. In certain instances, the articulation motions may cause the end effector to articulate relative to the shaft, for example.
One or more of the motors of the surgical instrument 600 may comprise a torque sensor to measure the output torque on the shaft of the motor. The force on an end effector may be sensed in any conventional manner, such as by force sensors on the outer sides of the jaws or by a torque sensor for the motor actuating the jaws.
In various instances, the motor assemblies 610, 620 include one or more motor drivers that may comprise one or more H-Bridge FETs. The motor drivers may modulate the power transmitted from a power source 630 to a motor based on input from a microcontroller 640 (the “controller”), for example, of a control circuit 601. In certain instances, the microcontroller 640 can be employed to determine the current drawn by the motor, for example.
In certain instances, the microcontroller 640 may include a microprocessor 642 (the “processor”) and one or more non-transitory computer-readable mediums or memory units 644 (the “memory”). In certain instances, the memory 644 may store various program instructions, which when executed may cause the processor 642 to perform a plurality of functions and/or calculations described herein. In certain instances, one or more of the memory units 644 may be coupled to the processor 642, for example. In various aspects, the microcontroller 640 may communicate over a wired or wireless channel, or combinations thereof.
In certain instances, the power source 630 can be employed to supply power to the microcontroller 640, for example. In certain instances, the power source 630 may comprise a battery (or “battery pack” or “power pack”), such as a lithium-ion battery, for example. In certain instances, the battery pack may be configured to be releasably mounted to a handle for supplying power to the surgical instrument 600. A number of battery cells connected in series may be used as the power source 630. In certain instances, the power source 630 may be replaceable and/or rechargeable, for example.
In various instances, the processor 642 may control a motor driver to control the position, direction of rotation, and/or velocity of a motor of the assemblies 610, 620. In certain instances, the processor 642 can signal the motor driver to stop and/or disable the motor. It should be understood that the term “processor” as used herein includes any suitable microprocessor, microcontroller, or other basic computing device that incorporates the functions of a computer's central processing unit (CPU) on an integrated circuit or, at most, a few integrated circuits. The processor 642 is a multipurpose, programmable device that accepts digital data as input, processes it according to instructions stored in its memory, and provides results as output. It is an example of sequential digital logic, as it has internal memory. Processors operate on numbers and symbols represented in the binary numeral system.
In one instance, the processor 642 may be any single-core or multicore processor such as those known under the trade name ARM Cortex by Texas Instruments. In certain instances, the microcontroller 620 may be an LM 4F230H5QR, available from Texas Instruments, for example. In at least one example, the Texas Instruments LM4F230H5QR is an ARM Cortex-M4F Processor Core comprising an on-chip memory of 256 KB single-cycle flash memory, or other non-volatile memory, up to 40 MHz, a prefetch buffer to improve performance above 40 MHz, a 32 KB single-cycle SRAM, an internal ROM loaded with StellarisWare® software, a 2 KB EEPROM, one or more PWM modules, one or more QEI analogs, one or more 12-bit ADCs with 12 analog input channels, among other features that are readily available for the product datasheet. Other microcontrollers may be readily substituted for use with the surgical instrument 600. Accordingly, the present disclosure should not be limited in this context.
In certain instances, the memory 644 may include program instructions for controlling each of the motors of the surgical instrument 600. For example, the memory 644 may include program instructions for controlling the closure motor and the articulation motor. Such program instructions may cause the processor 642 to control the closure and articulation functions in accordance with inputs from algorithms or control programs of the surgical instrument 600.
In certain instances, one or more mechanisms and/or sensors such as, for example, sensors 645 can be employed to alert the processor 642 to the program instructions that should be used in a particular setting. For example, the sensors 645 may alert the processor 642 to use the program instructions associated with closing and articulating the end effector. In certain instances, the sensors 645 may comprise position sensors which can be employed to sense the position of a closure actuator, for example. Accordingly, the processor 642 may use the program instructions associated with closing the end effector to activate the motor of the closure drive assembly 620 if the processor 642 receives a signal from the sensors 630 indicative of actuation of the closure actuator.
In some examples, the motors may be brushless DC electric motors, and the respective motor drive signals may comprise a PWM signal provided to one or more stator windings of the motors. Also, in some examples, the motor drivers may be omitted and the control circuit 601 may generate the motor drive signals directly.
It is common practice during various laparoscopic surgical procedures to insert a surgical end effector portion of a surgical instrument through a trocar that has been installed in the abdominal wall of a patient to access a surgical site located inside the patient's abdomen. In its simplest form, a trocar is a pen-shaped instrument with a sharp triangular point at one end that is typically used inside a hollow tube, known as a cannula or sleeve, to create an opening into the body through which surgical end effectors may be introduced. Such arrangement forms an access port into the body cavity through which surgical end effectors may be inserted. The inner diameter of the trocar's cannula necessarily limits the size of the end effector and drive-supporting shaft of the surgical instrument that may be inserted through the trocar.
Regardless of the specific type of surgical procedure being performed, once the surgical end effector has been inserted into the patient through the trocar cannula, it is often necessary to move the surgical end effector relative to the shaft assembly that is positioned within the trocar cannula in order to properly position the surgical end effector relative to the tissue or organ to be treated. This movement or positioning of the surgical end effector relative to the portion of the shaft that remains within the trocar cannula is often referred to as “articulation” of the surgical end effector. A variety of articulation joints have been developed to attach a surgical end effector to an associated shaft in order to facilitate such articulation of the surgical end effector. As one might expect, in many surgical procedures, it is desirable to employ a surgical end effector that has as large a range of articulation as possible.
Due to the size constraints imposed by the size of the trocar cannula, the articulation joint components must be sized so as to be freely insertable through the trocar cannula. These size constraints also limit the size and composition of various drive members and components that operably interface with the motors and/or other control systems that are supported in a housing that may be handheld or comprise a portion of a larger automated system. In many instances, these drive members must operably pass through the articulation joint to be operably coupled to or operably interface with the surgical end effector. For example, one such drive member is commonly employed to apply articulation control motions to the surgical end effector. During use, the articulation drive member may be unactuated to position the surgical end effector in an unarticulated position to facilitate insertion of the surgical end effector through the trocar and then be actuated to articulate the surgical end effector to a desired position once the surgical end effector has entered the patient.
Thus, the aforementioned size constraints form many challenges to developing an articulation system that can effectuate a desired range of articulation, yet accommodate a variety of different drive systems that are necessary to operate various features of the surgical end effector. Further, once the surgical end effector has been positioned in a desired articulated position, the articulation system and articulation joint must be able to retain the surgical end effector in that position during the actuation of the end effector and completion of the surgical procedure. Such articulation joint arrangements must also be able to withstand external forces that are experienced by the end effector during use.
Various modes of one or more surgical devices are often used throughout a particular surgical procedure. Communication pathways extending between the surgical devices and a centralized surgical hub can promote efficiency and increase success of the surgical procedure, for example. In various instances, each surgical device within a surgical system comprises a display, wherein the display communicates a presence and/or an operating status of other surgical devices within the surgical system. The surgical hub can use the information received through the communication pathways to assess compatibility of the surgical devices for use with one another, assess compatibility of the surgical devices for use during a particular surgical procedure, and/or optimize operating parameters of the surgical devices. As described in greater detail herein, the operating parameters of the one or more surgical devices can be optimized based on patient demographics, a particular surgical procedure, and/or detected environmental conditions such as tissue thickness, for example.
Referring to
In addition to the electrodes 1252, 1272, 1274, a patient return pad is employed with the application of monopolar energy. Furthermore, the bipolar and monopolar energies are delivered using electrically isolated generators. During use, the patient return pad can detect unexpected power crossover by monitoring power transmission to the return pad via one or more suitable sensors on the return pad. The unexpected power crossover can occur where the bipolar and monopolar energy modalities are used simultaneously. In at least one example, the bipolar mode uses a higher current (e.g. 2-3 amp) than the monopolar mode (e.g. 1 amp). In at least one example, the return pad includes a control circuit and at least one sensor (e.g. current sensor) coupled thereto. In use, the control circuit can receive an input indicative of an unexpected power crossover based on measurements of the at least one sensor. In response, the control circuit may employ a feedback system to issue an alert and/or pause application of one or both of the bipolar and monopolar energy modalities to tissue.
Further to the above, the jaws 1250, 1270 of the end effector 1200 comprise angular profiles where a plurality of angles are defined between discrete portions of each of the jaws 1250, 1270. For example, a first angle is defined by portions 1250a, 1250b (
In one example, the first angles and the second angles are the same, or at least substantially the same. In another example, the first angles and the second angles are different. In another example, the first angle and the second angle comprise values selected from a range of about 120° to about 175°. In yet another example, the first angle and the second angle comprise values selected from a range of about 130° to about 170°.
Furthermore, the portions 1250a, 1270a, which are proximal portions, are larger than the portions 1250b, 1270b, which are intermediate portions. Similarly, the intermediate portions 1250b, 1270b are larger than the portions 1250c, 1270c. In other examples, the distal portions can be larger than the intermediate and/or proximal portions. In other examples, the intermediate portions are larger than the proximal and/or distal portions.
Further to the above, the electrodes 1252, 1272, 1274 of the jaws 1250, 1270 comprise angular profiles that are similar to the angular profiles of the jaws 1250, 1270. In the example of
When in the closed configuration, the jaws 1250, 1270 cooperate to define a tip electrode 1260 formed of electrode portions 1261, 1262 at the distal ends of the jaws 1250, 1270, respectively. The tip electrode 1260 can be energized to deliver monopolar energy to tissue in contact therewith. Both of the electrode portions 1261, 1262 can be activated simultaneously to deliver the monopolar energy, as illustrated in
The angular profiles of the jaws 1250, 1270 cause the tip electrode 1260 to be on one side of a plane extending laterally between the proximal portion 1252c and the proximal portion 1272c in the closed configuration. The angular profiles may also cause the intersections between portions 1252b, 1252c, portions, 1272b, 1272c, and portions 1274b, 1274c to be on the same side of the plane as the tip electrode 1260.
In at least one example, the jaws 1250, 1270 include conductive skeletons 1253, 1273, which can be comprised, or at least partially comprised, of a conductive material such as, for example, Titanium. The skeletons 1253, 1273 can be comprised of other conductive materials such as, for example, Aluminum. In at least one example, the skeletons 1253, 1273 are prepared by injection molding. In various examples, the skeletons 1253, 1273 are selectively coated/covered with an insulative material to prevent thermal conduction and electrical conduction in all but predefined thin energizable zones forming the electrodes 1252, 1272, 1274, 1260. The skeletons 1253, 1273 act as electrodes with electron focusing where the jaws 1250, 1270 have built-in isolation from one jaw to the other. The insulative material can be an insulative polymer such as, for example, PolyTetraFluoroEthylene (e.g. Teflon®). The energizable zones that are defined by the electrodes 1252, 1272 are on the inside of the jaws 1250, 1270, and are operable independently in a bipolar mode to deliver energy to tissue grasped between the jaws 1250, 1270. Meanwhile, the energizable zones that are defined by the electrode tip 1260 and the electrode 1274 are on the outside of the jaws 1250, 1270, and are operable to deliver energy to tissue adjacent an external surface of the end effector 1200 in a monopolar mode. Both of the jaws 1250, 1270 can be energized to deliver the energy in the monopolar mode.
In various aspects, the coating 1264 is a high temperature PolyTetraFluoroEthylene (e.g. Teflon®) coating that is selectively applied to a conductive skeleton yielding selective exposed metallic internal portions that define a three-dimensional geometric electron modulation (GEM) for a focused dissection and coagulation. In at least one example, the coating 1264 comprises a thickness of about 0.003 inches, about 0.0035 inches, or about 0.0025 inches. In various examples, the thickness of the coating 1264 can be any value selected from a range of about 0.002 inches to about 0.004 inches, a range of about 0.0025 inches to about 0.0035 inches, or a range of about 0.0027 inches to about 0.0033 inches. Other thicknesses for the coating 1263 that are capable of three-dimensional geometric electron modulation (GEM) are contemplated by the present disclosure.
The electrodes 1252, 1272, which cooperate to transmit bipolar energy through the tissue, are offset to prevent circuit shorting. As energy flows between the offset electrodes 1252, 1272, the tissue-grasped therebetween is heated generating a seal at the area between electrodes 1252, 1272. Meanwhile, regions of the jaws 1250, 1270 surrounding the electrodes 1252, 1272 provide non-conductive tissue contact surfaces owing to an insulative coating 1264 selectively deposited onto the jaws 1250, 1270 on such regions but not the electrodes 1252, 1272. Accordingly, the electrodes 1252, 1272 are defined by regions of the metallic jaws 1250, 1270, which remain exposed following application of the insulative coating 1264 to the jaws 1250, 1270. While the jaws 1250, 1270 are generally formed of electrically conductive material in this example, the non-conductive regions are defined by the electrically insulative coating 1264.
In at least one example, a lateral gap is defined between the offset electrodes 1252, 1272 in a closed configuration without tissue therebetween. In at least one example, the lateral gap is defined between the offset electrodes 1252, 1272 in the closed configuration by any distance selected from a range of about 0.01 inch to about 0.025 inch, a range of about 0.015 inch to about 0.020 inch, or a range of about 0.016 inch to about 0.019 inch. In at least one example, the lateral gap is defined by a distance of about 0.017 inch.
In the example illustrated in
The angular and narrowing profiles of the jaws 1250, 1270 gives the end effector 1200 a bent finger-like shape or an angular hook shape in the closed configuration. This shape permits accurate delivery of energy to a small portion of the tissue using the tip electrode 1260 (
Furthermore, as illustrated in
The electrodes 1252′, 1272′ are different from the electrodes 1252″, 1272″ in that they define stepped, or uneven, tissue contacting surfaces 1257, 1277. Electrically conductive skeletons 1253′, 1273′ of the jaws 1250′, 1270′ include bulging, or protruding, portions that form the conductive tissue contacting surfaces of the electrodes 1252′, 1272′. The coating 1264 partially wraps around the bulging, or protruding portions, that form the electrodes 1252′, 1272′, only leaving exposed the conductive tissue contacting surfaces of the electrodes 1252′, 1272′. Accordingly, in the example illustrated in
Furthermore, in a closed configuration without tissue therebetween, the offset electrodes 1252′, 1272′ overlap defining a gap between opposing insulative outer surfaces of the jaws 1250′, 1270′. Accordingly, this configuration provides electrode surfaces that are both vertically offset from each other and laterally offset from each other when jaws 1250′, 1270′ are closed. In one example, the gap is about 0.01 inch to about 0.025 inch. In addition, while overlapping, the electrodes 1252′, 1272′ are spaced apart by a lateral gap. To prevent circuit shorting, the lateral gap is less than or equal to a predetermined threshold. In one example, the predetermined threshold is selected from a range of 0.006 inch to 0.008 inch. In one example, the predetermined threshold is about 0.006 inch.
Referring again to
Additionally, the segments 1274a, 1274b, 1274c define an angular profile extending along the peripheral side 1275 of the jaw 1270. The segments 1274a, 1274b, 1274c are defined by uncoated linear portions protruding from an angular body of the skeleton 1273 on the peripheral side 1275. The segments 1274a, 1274b, 1274c comprise outer surfaces that are flush with an outer surface of the coating 1264 defined on the peripheral side 1275. In various examples, a horizontal plane extends through the segments 1274a, 1274b, 1274c. The angular profile of the electrode 1274 is defined in the horizontal plane such that the electrode 1274 does not extend more than 45 degrees off a curvature centerline to prevent unintended lateral thermal damage while using the electrode 1274 to dissect or separate tissue.
In use, jaws of an end effector of an electrosurgical instrument are subjected to a thermal load that can interfere with the performance of their electrode(s). To minimize the thermal load interference without negatively affecting the electrode(s) tissue treatment capabilities, the jaw 6270 includes an electrically conductive skeleton 6273 that has a thermally insulative portion and a thermally conductive portion integral with the thermally insulative portion. The thermally conductive portion defines a heat sink and the thermally insulative portion resists heat transfer. In certain examples, the thermally insulative portion includes inner gaps, voids, or pockets that effectively isolate the thermal mass of the outer surfaces of the jaw 6270 that are directly in contact with the tissue without compromising the electrical conductivity of the jaw 6270.
In the illustrated example, the thermally conductive portion defines a conductive outer layer 6269 that surrounds, or at least partially surrounds, an inner conductive core. In at least one example, the inner conductive core comprises gap-setting members, which can be in the form of pillars, columns, and/or walls extending between opposite sides of the outer layer 6269 with gaps, voids, or pockets extending between the gap setting members.
In at least one example, the gap-setting members form honeycomb-like lattice structures 6267 to provide directional force capabilities as the jaws (i.e. the jaw 6270 and another jaw of the end effector) are transitioned into a closed configuration to grasp tissue therebetween (similar to the jaws 1250, 1270 of
Alternatively, or additionally, the conductive inner core of jaw 6270 may include micro pockets of air, which could be more homogeneously distributed and shaped with no predefined organization relative to exterior shape of the jaw to create a more homogeneous stress-strain distribution within the jaw. In various aspects, the electrically conductive skeleton 6273 can be prepared by three-dimensional printing, and may include three dimensionally printed interior pockets that produce electrically conductive but proportionally thermally insulated cores.
Referring still to
Furthermore, the outer layer 6273 defines gripping features 6277 that extend on opposite sides of the electrode 6272, and are at least partially covered by the coating 1264. The gripping features 6277 improve the ability of the jaw 6270 to adhere to tissue, and resist tissue slippage with respect to the jaw 6270.
In the illustrated examples, the walls 6268 extend diagonally from a first lateral side of the jaw 6270 to a second lateral side of the jaw 6270. The walls 6268 intersect at structural nodes. In the illustrated example, intersecting walls 6268 define pockets 6271 that are covered from the top and/or bottom by the outer layer 6269. Various methods for manufacturing the jaw 6270 are described below.
Accordingly, a jaw 1270′″ manufactured by the method 1281 includes a tapered electrode 1274′″ that is comprised of narrow raised electrically conductive portion 1274e extending alongside the skeleton 1273′″, which can help focus the energy delivered from the skeleton 1273′″ to the tissue, wherein the portion 1274e has a conductive external surface that is flush with the coating 1264.
In another manufacturing process 6200, the jaw 6270 can be prepared as depicted in
Referring to
In various aspects, the coating 1264 may comprise coating materials such as Titanium Nitride, Diamond-Like coating (DLC), Chromium Nitride, Graphit iC™, etc. In at least one example, the DLC is comprised of an amorphous carbon-hydrogen network with graphite and diamond bondings between the carbon atoms. The DLC coating 1264 can form films with low friction and high hardness characteristics around the skeletons 1253, 1273 (
Referring still to
In the illustrated example, the composite skeleton 6290 comprises a ceramic base 6291 formed by three-dimensional printing, for example. Additionally, the composite skeleton 6290 includes a titanium crown 6292 prepared separately from the ceramic base 6291 using, for example, three-dimensional printing. The base 6291 and the crown 6292 include complementing attachment features 6294. In the illustrated example, the base 6291 includes posts or projections that are received in corresponding apertures of the crown 6292. The attachment features 6294 also control shrinking. Additionally, or alternatively, contacting surfaces of the base 6291 and the crown 6292 include complementing surface irregularities 6296 specifically design for a mating engagement with one another. The surface irregularities 6296 also resist shrinking caused by the different material compositions of the base 6291 and the crown 6292. In various examples, the composite skeleton 6290 is selectively coated with an insulative coating 1264 leaving exposed certain portions of the crown 6292, which define electrodes, as described above in connection with the jaws 1250, 1270, for example.
In addition, the jaw 1290 is similar to the jaw 6270 in that the jaw 1290 also presents a thermal mitigation improvement. Like the jaw 6270, the jaw 1290 includes a conductive skeleton 1293 that has a thermally insulative portion and a thermally conductive portion integral with, or attached to, the thermally insulative portion. The thermally conductive portion defines a heat sink and the thermally insulative portion resists heat transfer. In certain examples, the thermally insulative portion of the conductive skeleton 1293 comprises a conductive inner core 1297 with inner gaps, voids, or pockets that effectively isolate the thermal mass of the outer surface of the jaw 1290, which defines an electrode 1294 that is directly in contact with the tissue, without compromising the electrical conductivity of the jaw 1290. The thermally conductive portions define a conductive outer layer 1303 that surrounds, or at least partially surrounds, the conductive inner core 1297. In at least one example, the conductive inner core 1297 comprises gap-setting members 1299, which can be in the form of pillars, columns, and/or walls extending between opposite sides of the outer layer 1303 of the jaw 1290 with gaps, voids, or pockets extending between the gap setting members.
Alternatively, or additionally, the conductive inner core 1297 may include micro pockets of air, which could be homogeneously, or non-homogenously, distributed in the conductive inner core 1297. The pockets can comprise predefined, or random shapes, and can be dispersed at predetermined, or random, portions of the conductive inner core 1297. In at least one example, the pockets are dispersed in a manner that creates a more homogeneous stress-strain distribution within the jaw 1290. In various aspects, the skeleton 1293 can be prepared by three-dimensional printing, and may include three dimensionally printed interior pockets that produce electrically conductive but proportionally thermally insulated cores.
Accordingly, the jaw 1290 comprises selective thermal and electrical conductivity that controls/focuses the energy interaction with tissue, while reducing thermal spread and thermal mass. The thermally insulated portions of the conductive skeleton 1293 limit the thermal load on the electrodes of the jaw 1290 during use.
The conductive zones 1294a, 1294b, 1294c define energy concentration locations along the jaw 1290 based on the geometry of the zones 1294a, 1294b, 1294c. Further, the size, shape, and arrangement of the conductive zones 1294a, 1294b, 1294c and insulative zones 1298 causes coagulation energy transmitted through the electrode 1294 to be directed into the tissue in predefined treatment regions thereby preventing parasitic leaching of both the energy and heat from the treatment regions. Furthermore, the thermally insulative conductive inner core 1297 resists heat transfer to portions of the jaw 1290 that do not form treatment regions, which prevents inadvertent collateral thermal damage by incidental contact of tissue with non-treatment areas of the jaw 1290.
The electrode 1294 is selectively interrupted by the regions 1298. Selective application of the high temperature PolyTetraFluoroEthylene (e.g. Teflon®) coating to portions of the electrode 1294 yields selectively exposed metallic internal portions that define a three-dimensional geometric electron modulation (GEM) for a focused dissection and coagulation at the conductive zones 1294a, 1294b, 1294c of the electrode 1294. The regions 1298 are selectively deposited onto the electrode 1294, as illustrated in
Referring to
In one example, the angles (α1, α2, α3) comprise the same, or at least substantially the same, values. In another example, at least two of the angles (α1, α2, α3) comprise different values. In another example, at least one of the angles (α1, α2, α3) comprises a value selected from a range of about 120° to about 175°. In yet another example, at least one of the angles (α1, α2, α3) comprises a value selected from a range of about 130° to about 170°.
Furthermore, due to the gradually narrowing profile of the jaw 1290, the portion 1290a, which is a proximal portion, is larger than the portion 1290b, which is an intermediate portion. Similarly, the intermediate portion 1290b is larger than the portion 1290d that defines a distal portion of the jaw 1290. In other examples, the distal portion can be larger than the intermediate and/or proximal portions. In other examples, the intermediate portion is larger than the proximal and/or distal portions. In addition, the electrode 1294 of the jaw 1290 comprises an angular profile that is similar to the angular profile of the jaw 1290.
Referring to
Referring now to
Like the jaws 1250, 1270, the jaws 1450, 1470 include generally angular profiles formed from linear portions that are angled with respect to one another, yielding a bent or finger-like shape, as illustrated in
The thermally conductive portions comprise conductive outer layers 1469, 1469′ that surround, or at least partially surround, the inner conductive cores. In at least one example, the inner conductive cores comprise gap-setting members, which can be in the form of pillars, columns, and/or walls extending between opposite sides of the outer layers 1469, 1469′ of each of the jaws 1250, 1270 with gaps, voids, or pockets extending between the gap setting members. In at least one example, the gap-setting members form honeycomb-like lattice structures 1467, 1467′.
Further to the above, the conductive skeletons 1453, 1473 include first conductive portions 1453a, 1473a extending distally along the angular profile of the jaws 1450, 1470 and second conductive portions 1453b, 1473b defining a tapered electrodes protruding from the first conductive portions 1453a, 1473a and extending distally along at least a portion of the gradually narrowing body of the skeletons 1453, 1473. In at least on example, the first conductive portions 1453a, 1473a are thicker than the second conductive portions 1453b, 1473b in a transverse cross-section (e.g.
As described above, the first conductive portions 1453a, 1473a are generally thicker than the second conductive portions 1453b, 1473b, and are wrapped with the electrically insulative layers 1464, 1464′, which causes the second conductive portions 1453b, 1473b to become high energy density areas. In at least one example, the electrically insulative layers 1464, 1464′ are comprised of high temperature PolyTetraFluoroEthylene (e.g. Teflon®) coatings, DLC coatings, and/or ceramic coatings for insulation and resistance to char sticking. In various examples, the thicker first conductive portion 1453a conducts more potential power with a smaller resistance to the tissue-contacting second conductive portion 1453b yielding the higher energy density at the electrode 1452.
In various aspects, the outer surfaces of the electrodes 1452, 1472 include consecutive linear segments that extend along angled tissue treatment surfaces of the jaws 1450, 1470. The linear segments intersect at predefined angles, and comprise widths that gradually narrow as the linear segments extend distally. In the example illustrated in
In various aspects, as illustrated in
The electrode 1474 includes a base 1474e positioned in a cradle 1480 extending distally along the angular profile of the second jaw 1470 from a cradle proximal 1480a and to a cradle distal end 1480b. The cradle 1480 is centrally situated with respect to lateral edges 1470e, 1470f of the second jaw 1470. The electrode 1474 further comprises a tapered edge 1474f extending from the base 1474e beyond sidewalls of the cradle 1480. In addition, the cradle 1480 is partially embedded in a valley defined in an outer tissue-treatment surface of the narrowing curved body. The cradle 1480 is spaced apart from the gradually narrowing body of the skeleton 1473 by the electrically insulative coating 1464′. As illustrated in
In various examples, the cradle 1480 is comprised of a compliant substrate. In an uncompressed state, as illustrated in
One or more of the jaws described by the present disclosure include stop members or gap-setting members, which are features extending outwardly from one or both of the tissue treatment surfaces of the jaws of an end effector. The stop members help maintain a separation or a predetermined gap between the jaws in a closed configuration with no tissue between the jaws. In at least one example, the sidewalls of the cradle 1480 define such stop members. In another example, the stop members can be in the form of insulative pillars or laterally extending spring-biased features that allow the gap between opposing jaws and the closed configuration to vary based on clamping loads.
Most electrosurgery generators use constant power modes. With constant power modes, the power output remains constant as impedance increases. In constant power modes, the voltage increases as the impedance increases. Increased voltage causes thermal damage to tissue. GEM focuses the energy output of the jaws 1250, 1270, for example, by controlling the size and shape of the electrodes 1252, 1272, 1274, 1260, 1294, 1472, 1452, 1474, as described above, and modulating the power level based on tissue impedance to create a low voltage plasma.
In certain instances, GEM maintains a constant minimum voltage required for cutting at the surgical site. The generator (e.g. 1100) modulates the power in order to maintain the voltage as close as possible to the minimum voltage required for cutting at the surgical site. In order to obtain an arc plasma and cut, current is pushed by voltage from gradually narrowing portions of the electrodes 1252, 1272, 1274, 1260, 1294, 1472, 1452, 1474, to the tissue. In certain examples, a minimum voltage of approximately 200 Volts is maintained. Cutting with greater than 200 Volts increases thermal damage and cutting with less than 200 Volts results in minimal arcing and drag in the tissue. Accordingly, the generator (e.g. 1100) modulates the power to ensure utilizing the minimum voltage possible that will still form an arc plasma and cut.
Referring primarily to
The end effector 1400 comprises an end effector frame assembly 11210 that comprises a distal frame member 11220 that is rotatably supported in a proximal frame housing 11230. In the illustrated example, the distal frame member 11220 is rotatably attached to the proximal frame housing 11230 by an annular rib on the distal frame member 11220 that is received within an annular groove in the proximal frame housing 11230.
Electrical energy is transmitted to the electrodes 1452, 1472, 1474 of the end effector 1400 by one or more flex circuits extending distally through, or alongside, the distal frame member 11220. In the illustrated example, a flex circuit 1490 is fixedly attached to the first jaw 1450. More particularly, the flex circuit 1490 includes a distal portion 1492 that can be fixedly attached to an exposed portion 1491 of the first jaw 1450, which is not covered by the insulative layer 1464.
A slip ring assembly 1550 within the proximal frame housing 11230 allows free rotation of the end effector 1400 about a shaft of the surgical instrument 1500 without entanglement of the wires of the circuits transmitting electrical energy to the electrodes 1452, 1472, 1474. In the illustrated example, the flex circuit 1490 includes an electrical contact 1493 in movable engagement with a slip ring 1550a of the slip ring assembly 1550. Electrical energy is transmitted from the slip ring 1550a to the conductive skeleton 1453, and then to the electrode 1452, through the flex circuit 1490. Since the electrical contact 1493 is not fixedly attached to the slip ring 1550a, the rotation of the end effector 1400 about the shaft of the surgical instrument 1500 is permissible without losing the electrical connection between the electrical contact 1493 and the slip ring 1550a. Further, a similar electrical contact transmits the electrical energy to the slip ring 1550a.
In the example illustrated in
In various examples, the slip rings 1550a, 1550b, 1550c are integrated electrical slip rings with mechanical features 1556a, 1556b, 1556c configured to couple the slip rings 1550a, 1550b, 1550c to an insulative support structure 1557, or a conductive support structure coated with an insulative material, as illustrated in
The surgical end effector 12200 comprises a first jaw 12250 and a second jaw 12270. In the illustrated example, the first jaw 12250 is pivotally pinned to the distal frame member 12220 for selective pivotal travel relative thereto about a first jaw axis FJA defined by a first jaw pin 12221. The second jaw 12270 is pivotally pinned to the first jaw 12250 for selective pivotal travel relative to the first jaw 12250 about a second jaw axis SJA that is defined by a second jaw pin 12272. In the illustrated example, the surgical end effector 12200 employs an actuator yoke assembly 12610 that is pivotally coupled to the second jaw 12270 by a second jaw attachment pin 12273 for pivotal travel about a jaw actuation axis JAA that is proximal and parallel to the first jaw axis FJA and the second jaw axis SJA. The actuator yoke assembly 12610 comprises a proximal threaded drive shaft 12614 that is threadably received in a threaded bore 12632 in a distal lock plate 12630. The threaded drive shaft 12614 is mounted to the actuator yoke assembly 12610 for relative rotation therebetween. The distal lock plate 12630 is supported for rotational travel within the distal frame member 12220. Thus rotation of the distal lock plate 12630 will result in the axial travel of the actuator yoke assembly 12610.
In certain instances, the distal lock plate 12630 comprises a portion of an end effector locking system 12225. The end effector locking system 12225 further comprises a dual-acting rotary lock head 12640 that is attached to a rotary drive shaft 12602 of the various types disclosed herein. The lock head 12640 comprises a first plurality of radially arranged distal lock features 12642 that are adapted to lockingly engage a plurality of proximally-facing, radial grooves or recesses 12634 that are formed in the distal lock plate 12630. When the distal lock features 12642 are in locking engagement with the radial grooves 12634 in the distal lock plate 12630, rotation of the rotary lock head 12640 will cause the distal lock plate 12630 to rotate within the distal frame member 12220. Also in at least one example, the rotary lock head 12640 further comprises a second series of proximally-facing proximal lock features 12644 that are adapted to lockingly engage a corresponding series of lock grooves that are provided in the distal frame member 12220. A locking spring 12646 serves to bias the rotary lock head distally into locking engagement with the distal lock plate 12630. In various instances, the rotary lock head 12640 may be pulled proximally by an unlocking cable or other member in the manner described herein. In another arrangement, the rotary drive shaft 12602 may be configured to also move axially to move the rotary lock head 12640 axially within the distal frame member 12220. When the proximal lock features 12644 in the rotary lock head 12640 are in locking engagement with the series of lock grooves in the distal frame member 12220, rotation of the rotary drive shaft 12602 will result in rotation of the surgical end effector 12200 about the shaft axis SA.
In certain instances, the first and second jaws 12250, 12270 are opened and closed as follows. To open and close the jaws, as was discussed in detail above, the rotary lock head 12640 is in locking engagement with the distal lock plate 12630. Thereafter, rotation of the rotary drive shaft 12602 in a first direction will rotate the distal lock plate 12630 which will axially drive the actuator yoke assembly 12610 in the distal direction DD and move the first jaw 12250 and the second jaw 12270 toward an open position. Rotation of the rotary drive shaft 12602 in an opposite second direction will axially drive the actuator yoke assembly 12610 proximally and pull the jaws 12250, 12270 toward a closed position. To rotate the surgical end effector 12200 about the shaft axis SA, the locking cable or member is pulled proximally to cause the rotary lock head 12640 to disengage from the distal lock plate 12630 and engage the distal frame member 12220. Thereafter, when the rotary drive shaft 12602 is rotated in a desired direction, the distal frame member 12220 (and the surgical end effector 12200) will rotate about the shaft axis SA.
In the illustrated example, the electrical pathways 5001, 5002 are implemented using a flex circuit 5004 extending, at least partially, through a coil tube 5005. As illustrated in
In alternative examples, as illustrated in
Further to the above, the pathways 5001, 5002 are defined by trace portions 5006a-5006g, 5007a-5007g, respectively. The trace portions 5006b, 5006c and the trace portions 5007b, 5007c are in the form of rings that define a ring assembly 5010 which maintains electrical connections through the pathways 5001, 5002 while allowing rotation of the end effector 12200 relative to the shaft of the surgical instrument 12000. Further, trace portions 5006e, 5007e are disposed on opposite sides of the actuator yoke assembly 12610. In the illustrated example, the portions 5006e, 5007e are disposed around holes configured to receive the second jaw attachment pin 12273, as illustrated in
Referring to
Referring to
In the illustrated example, the electrosurgical system 3100 further includes a feedback system 3109 in communication with the control circuit 3101. The feedback system 3109 can be a standalone system, or can be integrated with the surgical instrument 1500, for example. In various aspects, the feedback system 3109 can be employed by the control circuit 3101 to perform a predetermined function such as, for example, issuing an alert when one or more predetermined conditions are met. In certain instances, the feedback system 3109 may comprise one or more visual feedback systems such as display screens, backlights, and/or LEDs, for example. In certain instances, the feedback system 3109 may comprise one or more audio feedback systems such as speakers and/or buzzers, for example. In certain instances, the feedback system 3109 may comprise one or more haptic feedback systems, for example. In certain instances, the feedback system 3109 may comprise combinations of visual, audio, and/or haptic feedback systems, for example. Additionally, the electrosurgical system 3100 further includes a user interface 3110 in communication with the control circuit 3101. The user interface 3110 can be a standalone interface, or can be integrated with the surgical instrument 1500, for example.
The graph 3000 depicts power (W) on the y-axis and time on the x-axis. A bipolar energy curve 3020 spans the tissue coagulation stage 3005, and a monopolar energy curve 3030 starts in the tissue coagulation stage 3006 and terminates at the end of the tissue transection stage 3007. Accordingly, tissue treatment cycle 3001 is configured to apply a bipolar energy to the tissue throughout the tissue coagulation stage 3006, but not the tissue transection stage 3007, and apply a monopolar energy to the tissue in a portion of the coagulation stage 3006 and the transection stage 3007, as illustrated in
In various aspects, a user input can be received by the control circuit 3101 from the user interface 3110. The user input causes the control circuit 3101 to initialize execution of the power scheme 3005′ at time t1. Alternatively, the initialization of the execution of the power scheme 3005′ can be triggered automatically by sensor signals from one or more sensors 3111 in communication with the control circuit 3101. For example, the power scheme 3005′ can be triggered automatically by the control circuit 3101 in response to a sensor signal indicative of a predetermined gap between the jaws 1450, 1470 of the end effector 1400.
During the feathering segment 3008, the control circuit 3101 causes generator 3107 to gradually increase the bipolar energy power supplied to the end effector 1400 to a predetermined power value P1 (e.g. 100 W), and to maintain the bipolar energy power at, or substantially at, the predetermined power value P1 throughout the remainder of the feathering segment 3008 and the tissue-warming segment 3009. The predetermined power value P1 can be stored in the memory 3103 and/or can be provided by a user through the user interface 3110. During the sealing segment 3010, the control circuit 3101 causes generator 3107 to gradually decrease the bipolar energy power. Bipolar energy application is terminated at the end of the sealing segment 3010 of the tissue coagulation stage 3006, and prior to the beginning of the cutting/transecting stage 3007.
Further to the above, at t2, the control circuit 3101 causes generator 3107 to begin supplying monopolar energy power to the electrode 1474 of the end effector 1400, for example. The monopolar energy application to the tissue commences at the end of the feathering segment 3008 and the beginning of the tissue-warming segment 3009. The control circuit 3101 causes generator 3107 to gradually increase the monopolar energy power to a predetermined power level P2 (e.g. 75 W), and to maintain, or at least substantially maintain, the predetermined power level P2 for the remainder of the tissue-warming segment 3009 and a first portion of the sealing segment 3010. The predetermined power level P2 can also be stored in the memory 3103 and/or can be provided by a user through the user interface 3110.
During the sealing segment 3010 of the tissue coagulation stage 3006, the control circuit 3101 causes generator 3107 to gradually increase the monopolar energy power supplied to the end effector 1400. The beginning of the tissue transection stage 3007 is ushered by an inflection point in the monopolar energy curve 3030 where the previous gradual increase in monopolar energy, experienced during the sealing segment 3010, is followed by a step up to a predetermined maximum threshold power level P3 (e.g. 150 W) sufficient to transect the coagulated tissue.
At t4, the control circuit 3101 causes generator 3107 to step up the monopolar energy power supplied to the end effector 1400 to the predetermined maximum threshold power level P3, and to maintain, or at least substantially maintain, predetermined maximum threshold power level P3 for a predetermined time period (t4-t5), or to the end of the tissue transection stage 3007. In the illustrated example, the monopolar energy power is terminated by the control circuit 3101 at t5. The tissue transection continues mechanically, as the jaws 1450, 1470 continue to apply pressure on the grasped tissue until the end of the issue transection stage 3007 at t6. Alternatively, in other examples, the control circuit 3101 may cause the generator 3107 to continue supplying monopolar energy power to the end effector 1400 to the end of the tissue transection stage 3007.
Sensor readings of the sensors 3111 and/or a timer clock of the processor 3102 can be employed by the control circuit 3101 to determine when to cause the generator 3107 and/or the generator 3106 to begin, increase, decrease, and/or terminate energy supply to the end effector 1400, in accordance with a power scheme such as, for example, the power scheme 3005′. The control circuit 3101 may execute the power scheme 3005′ by causing one or more timer clocks to count down from one or more predetermined time periods (e.g. t1-t2, t2-t3, t3-t4, t5-t6) that can be stored in the memory 3103, for example. Although the power scheme 3005′ is time based, the control circuit 3101 may adjust predetermined time periods for any of the individual segments 3008, 3009, 3010 and/or the stages 3006, 3007 based on sensor readings received from one or more of the sensors 3111 such as, for example, a tissue impedance sensor.
The end effector 1400 is configured to deliver three different energy modalities to the grasped tissue. The first energy modality, which is applied to the tissue during the feathering segment 3008, includes bipolar energy but not monopolar energy. The second energy modality is a blended energy modality that includes a combination of monopolar energy and bipolar energy, and is applied to the tissue during the tissue warming stage 3009 and the tissue sealing stage 3010. Lastly, the third energy modality includes monopolar energy but not bipolar energy, and is applied to the tissue during the cutting stage 3007. In various aspects, the second energy modality comprises a power level that is the sum 3040 of the power levels of monopolar energy and bipolar energy. In at least one example, the power level of the second energy modality includes a maximum threshold Ps (e.g. 120 W).
In various aspects, the control circuit 3101 causes the monopolar energy and the bipolar energy to be delivered to the end effector 1400 from two different electrical generators 3106, 3107. In at least one example, energy from one of the generators 3106, 3107 can be detected using a return path of the other generator, or utilizing attached electrodes of the other generator to short to an unintended tissue interaction. Accordingly, a parasitic loss of energy through a return path that is not the intended can be detected by a generator connected to the return path. The inadvertent conductive path can be mitigated by effecting the voltage, power, waveform, or timing between uses.
Integrated sensors within the flex circuits of the surgical instrument 1500 can detect energizing/shorting of an electrode/conductive path when no potential should be present and the ability to prevent that conductive path once inadvertent use is sensed. Further, directional electronic gating elements that prevent cross talk from one generator down the source of the other generator can also be utilized.
One or more of the electrodes described by the present disclosure (e.g. electrodes 1452, 1472, 1474 in connection with the jaws 1450, 1470) may include a segmented pattern with segments that are linked together when the electrode is energized by a generator (e.g. generator 1100). However, when the electrode is not energized, the segments are separated to prevent circuit shorting across the electrode to other areas of the jaw.
In various aspects, thermal resistive electrode material are utilized with the end effector 1400. The material can be configured to inhibit electrical flow through electrodes that are at or above a predefined temperature level but continues to allow the energizing of other portions of the electrodes that are below the temperature threshold.
In the illustrated example, jaw apertures d0, d1, d2, d3, d4 from the power scheme 3005″ correspond to the time values t1, t2, t3, t4 from the power scheme 3005′. Accordingly, the feathering segment corresponds to a jaw aperture from about d1 to about d2 (e.g. from about 0.700″ to about 0.500″). In addition, the tissue-warming segment corresponds to a jaw aperture from about d2 to about d3 (e.g. from about 0.500″ to about 0.300″). Further, the sealing segment corresponds to a jaw aperture from about d2 to about d3 (e.g. from about 0.030″ to about 0.010″). Further, the tissue cutting stage corresponds to a jaw aperture from about d3 to about d4 (e.g. from about 0.010″ to about 0.003″).
Accordingly, the control circuit 3101 is configured to cause the generator 3106 to begin supplying bipolar energy power to the end effector 1400 when readings from one or more of the sensors 3111 corresponds to the predetermined jaw aperture d1, for example, thereby initializing the feathering segment. Likewise, the control circuit 3101 is configured to cause the generator 3106 to stop supplying bipolar energy power to the end effector 1400 when readings from one or more of the sensors 3111 corresponds to the predetermined jaw aperture d2, for example, thereby terminating the feathering segment. Likewise, the control circuit 3101 is configured to cause the generator 3107 to begin supplying monopolar energy power to the end effector 1400 when readings from one or more of the sensors 3111 corresponds to the predetermined jaw aperture d2, for example, thereby initializing the warming segment.
In the illustrated example, the jaw aperture is defined by the distance between two corresponding datum points on the jaws 1450, 1470. The corresponding datum points are in contact with one another when the jaws 1450, 1470 are in a closed configuration with no tissue therebetween. Alternatively, the jaw aperture can be defined by a distance between the jaws 1450, 1470 measured along a line intersecting the jaws 1450, 1470 and perpendicularly intersecting a longitudinal axis extending centrally through the end effector 1500. Alternatively, the jaw aperture can be defined by a distance between first and second parallel lines intersecting the jaws 1450, 1470, respectively. The distance is measured along a line extending perpendicularly to the first and second parallel lines, and extending through the intersection point between the first parallel line and the first jaw 1450, and through the intersection point between the second parallel line and the second jaw 1470.
Referring to
In various aspects, the control circuit 3101 causes the generators 3106, 3107 to adjust the bipolar and/or monopolar power levels of the power scheme 3005 applied to the tissue treatment region by the end effector 1400 based on one or more measured parameters including tissue impedance 4002, jaw motor velocity 27920d, jaw motor force 27920c, jaws aperture 27920b of the end effector 1400, and/or current draw of the motor effecting the end effector closure.
In various examples, the control circuit 3101 causes the generators 3106, 3107 to adjust the power levels of a power scheme (e.g. power schemes 3005, 3005′) applied by the end effector 1400 to the tissue treatment region based on one or more parameters (e.g. tissue impedance 4002, jaw/closure motor velocity 27920d, jaw/closure motor force 27920c, jaws gap/aperture 27920b of the end effector 1400, and/or current draw of the motor) determined by one or more sensors 3111. For example, the control circuit 3101 may cause the generators 3106, 3107 to adjust the power levels based on the pressure within the jaws 1450, 1470.
In at least one example, the power levels are inversely proportional to the pressure within the jaws 1450, 1470. The control circuit 3101 may utilize such an inverse correlation to select the power levels based on the pressure values. In at least one example, current draw of the motor effecting the end effector closure is employed to determine the pressure values. Alternatively, the inverse correlation utilized by the control circuit 3101 can be directly based on the current draw as a proxy for the pressure. In various examples, the greater the compression applied by the jaws 1450, 1470 onto the tissue treatment region, the lower the power levels set by the control circuit 3101, which aids in minimizing sticking and inadvertent cutting of the tissue.
Graph 4000 provides several cues in the measured parameters of tissue impedance 4002, jaw/closure motor velocity 27920d, jaw/closure motor force 27920c, jaws gap/aperture 27920b of the end effector 1400, and/or current draw of the motor effecting the end effector closure, which can trigger an activation, an adjustment, and/or a termination of the bipolar energy and/or the monopolar energy application to tissue during the tissue treatment cycle 4003.
The control circuit 3101 may rely on one or more of such cues in executing and/or adjusting the default power scheme 3005 in the tissue treatment cycle 4003. In certain examples, the control circuit 3101 may rely on sensor readings of the one or more sensors 3111 to detect when one or more monitored parameters satisfy one or more predetermined conditions that can be stored in the memory 3103, for example. The one or more predetermined conditions can be reaching a predetermined threshold and/or detecting a meaningful increase and/or decrease in one or more of the monitored parameters. Satisfaction of the predetermined conditions, or the lack thereof, constitutes trigger/confirmation points for executing and/or adjusting portions of the default power scheme 3005 in the tissue treatment cycle 4003. The control circuit 3101 may rely exclusively on the cues in executing and/or adjusting a power scheme or, alternatively, use the cues to guide, or adjust, a timer clock of a time-based power scheme such as, for example, the power scheme 3005′.
For example, a sudden decrease (A1) in tissue impedance to a predetermined threshold value (Z1), occurring alone or coinciding with an increase (A2) in jaw motor force to a predetermined threshold value (F1) and/or a decrease (A3) in jaw aperture to a predetermined threshold value (d1) (e.g. 0.5″) may trigger the control circuit 3101 to begin the feathering segment 4008 of the tissue coagulation stage 4006 by activating the application of bipolar energy to the tissue treatment region. The control circuit 3101 may signal the generator 3106 to begin supplying bipolar power to the end effector 1400.
Furthermore, a decrease (B1) in jaw motor velocity to a predetermined value (v1) following the activation of the bipolar energy triggers the control circuit 3101 to signal the generator 3106 to stabilize (B2) the power level for bipolar energy at a constant, or at least substantially constant, value (e.g. 100 V.
In yet another example, the shifting from the feathering segment 4008 to the warming segment 4009 at t2, which triggers an activation (D1) of the monopolar energy application to the tissue treatment region, coincides with an increase (C2) in the jaw motor force to a predetermined threshold (F2), a decrease (C3) in the jaw aperture to a predetermined threshold (e.g. 0.03″), and/or a decrease (C1) in tissue impedance to a predetermined value Z2. Satisfaction of one, or in certain instances two, or in certain instances all, of the conditions C1, C2, C3 causes the control circuit 3101 to cause the generator 3101 to begin application of monopolar energy to the tissue treatment region. In another example, satisfaction of one, or in certain instances two, or in certain instances all, of the conditions C1, C2, C3 at, or about, the time t2, triggers the application of monopolar energy to the tissue treatment region.
Activation of the monopolar energy by the generator 3107, in response to activation signals by the control circuit 3101, causes a blend (D1) of the monopolar energy and bipolar energy to be delivered to the tissue treatment region, which causes a shift in the impedance curve characterized by a quicker decrease (E1) in impedance from Z2 to Z3 in comparison to a steady decrease (C1) prior to activation of the monopolar energy. In the illustrated example, the tissue impedance Z3 defines a minimum impedance for the tissue treatment cycle 4003.
In the illustrated example, the control circuit 3101 determines that an acceptable seal is being achieved if (E1) the minimum impedance value Z3 coincides, or at least substantially coincides, with (E3) a predetermined maximum jaw motor force threshold (F3) and/or (E2) a predetermined jaw aperture threshold range (e.g. 0.01″-0.003″). Satisfaction of one, or in certain instances two, or in certain instances all, of the conditions E1, E2, E3 signals the control circuit 3101 to shift from the warming segment 4009 to the sealing segment 4010.
Further to the above, beyond the minimum impedance value Z3, the impedance level gradually increases to a threshold value Z4 corresponding to the end of the sealing segment 4010, at t4. Satisfaction of the threshold value Z4 causes the control circuit 3101 to signal the generator 3107 to step up the monopolar power level to commence the tissue transection stage 4007, and signal the generator 3106 to terminate application of the bipolar energy application to the tissue treatment region.
In various examples, the control circuit 3101 can be configured to (G2) verify that the jaw motor force is decreasing as (G1) the impedance gradually increases from its minimum value Z3, and/or (G3) that the jaw aperture has decreased to a predetermined threshold (e.g. 0.01″-0.003″), prior to stepping up the power level of the monopolar energy to cut the tissue.
If, however, the jaw motor force continues to increase, the control circuit 3101 may pause application of the monopolar energy to the tissue treatment region for a predetermined time period to allow the jaw motor force to begin decreasing. Alternatively, the control circuit may signal the generator 3107 to deactivate the monopolar energy, and complete the seal using only the bipolar energy.
In certain instances, the control circuit 3101 may employ the feedback system 3109 to alert a user and/or provide instructions or recommendations to pause the application of the monopolar energy. In certain instances, the control circuit 3101 may instruct the user to utilize on a mechanical knife to transect the tissue.
In the illustrated example, the control circuit 3101 maintains (H) the stepped up monopolar power until a spike (I) is detected in tissue impedance. The control circuit 3101 may cause the generator 3107 to terminate (J) application of the monopolar energy to the tissue upon detection of the spike (I) in the impedance level to Z5 following the gradual increase from Z3 to Z4. The spike indicates completion of the tissue treatment cycle 4003.
In various examples, the control circuit 3101 prevents the electrodes of the jaws 1450, 1470 from being energized before a suitable closure threshold is reached. The closure threshold can be based on a predetermined jaw aperture threshold and/or a predetermined jaw motor force threshold, for example, which can be stored in the memory 3103. In such examples, the control circuit 3101 may not act on user inputs through the user interface 3110 requesting of the treatment cycle 4003. In certain instances, the control circuit 3101 may respond by alerting the user through the feedback system 3109 that the suitable closure threshold has not been reached. The control circuit 3101 may also offer the user an override option.
Ultimately between time t4 and t5, monopolar energy is the only energy being delivered in order to cut the patient tissue. While the patient tissue is being cut, the force to clamp the jaws of the end effector may vary. In instances where the force to clamp the jaws decreases 27952 from its steady-state level maintained between time t3 and t4, an efficient and/or effective tissue cut is recognized by the surgical instrument and/or the surgical hub. In instances where the force to clamp the jaws increases 27954 from its steady-state level maintained between time t3 and t4, an inefficient and/or ineffective tissue cut is recognized by the surgical instrument and/or the surgical hub. In such instances, an error can be communicated to the user.
Referring to
In various aspects, the electrosurgical instrument 1601 further includes a control circuit 1604 configured to adjust levels of the monopolar energy and the bipolar energy delivered to the tissue to minimize unintended thermal damage to surrounding tissue. The adjustments can be based on readings of at least one sensor such as, for example, a temperature sensor, an impedance sensor, and/or a current sensor. In the example illustrated in
In the illustrated example, the control circuit 1604 includes a controller 3104 with a storage medium in the form of a memory 3103 and a processor 3102. The memory 3103 stores program instructions that, when executed by the processor 3102, cause the processor 3102 to adjust levels of the monopolar energy and the bipolar energy delivered to the tissue based on sensor readings received from one or more sensors such as, for example, the temperature sensors 1651, 1671. In various examples, as described in greater detail below, the control circuit 1604 may adjust a default power scheme 1701 based on readings from one or more sensors such as, for example, the temperature sensors 1651, 1671. The power scheme 1701 is similar in many respects to the power scheme 3005′, which are not repeated herein in the same level of detail for brevity.
In the illustrated example, during a tissue-sealing segment (t3-t4), the control circuit 1604 detects that the tissue temperature has reached the upper limit of the predetermined range based on readings the temperature sensors 1651, 1671. The control circuit 1604 responds by stepping down the power level of the monopolar energy. In other examples, the reduction can be performed gradually. In certain examples, the reduction value, or a manner for determining the reduction value such as, for example, a table or an equation can be stored in the memory 3103. In certain examples, the reduction value can be a percentage of the present power level of the monopolar energy. In other examples, the reduction value can be based on a previous power level of the monopolar energy that corresponded to a tissue temperature within the predetermined range. In certain examples, the reduction can be performed in multiple steps that are temporally spaced apart. After each downward step, the control circuit 1604 allows a predetermined time period to pass before evaluating the tissue temperature.
In the illustrated example, the control circuit 1604 maintains the power level of the bipolar energy in accordance with the default power scheme 1701, but reduces the power level of the monopolar energy to maintain the temperature of the tissue within the predetermined range, while tissue sealing is completed. In other examples, the reduction in the power level of the monopolar energy is combined, or replaced, by a reduction in the power level of the bipolar energy.
Further to the above, an alert can be issued, through the feedback system 3109, to complete transection of the tissue using a mechanical knife, for example, instead of the monopolar energy to avoid unintended lateral thermal damage to surrounding tissue. In certain examples, the control circuit 1604 may temporarily pause the monopolar energy and/or the bipolar energy until the temperature of the tissue returns to a level within the predetermined temperature range. Monopolar energy can then be reactivated to perform a transection of the sealed tissue.
Referring to
In various aspects, the control circuit 1604 monitors thermal effects at the treatment region 1683 resulting from application of the monopolar energy to the treatment region 1683. The control circuit 1604 can further detect a failure of the monitored thermal effects to comply with a predetermined correlation between the applied monopolar energy and thermal effects expected from application of the monopolar energy at the treatment region. In the illustrated example, the inadvertent energy draw at the constricted portion of the artery reduces the thermal effects at the treatment region, which is detected by the control circuit 1604.
In certain examples, the memory 3103 stores a predetermined correlation algorithm between monopolar energy level, as applied to a tissue treatment region grasped by the end effector 1600, and the thermal effects expected to result from application of the monopolar energy to the tissue treatment region. The correlation algorithm can be in the form of, for example, an array, lookup table, database, mathematical equation, or formula, etc. In at least one example, the stored correlation algorithm defines a correlation between power levels of the monopolar energy and expected temperatures. The control circuit 1604 can monitor the temperature of the tissue at the treatment region 1683 using the temperature sensors 1651, 1671, and can determine if a monitored temperature reading corresponds to an expected temperature reading at a certain power level.
The control circuit 1604 can be configured to take certain actions if a failure to comply with the stored correlation is detected. For example, the control circuit 1604 may alert a user of the failure. Additionally, or alternatively, the control circuit 1604 may reduce or pause delivery of the monopolar energy to the treatment region. In at least one example, the control circuit 1604 may adjust, or shift, from the monopolar energy to a bipolar energy application to the tissue treatment region to confirm the presence of a parasitic power draw. The control circuit 1604 may continue using bipolar energy at the treatment region if the parasitic power draw is confirmed. If, however, the control circuit 1604 refutes the presence of a parasitic power draw, the control circuit 1604 may reactivate, or re-increase, the monopolar power level. Changes to the monopolar and/or bipolar power levels can be achieved by the control circuit 1604 by signaling the monopolar power source 1620 and/or the bipolar power source 1610, for example.
In various aspects, one or more imaging devices such as, for example, a multi-spectral scope 1690 and/or an infrared imaging device can be utilized to monitor spectral tissue changes and/or the thermal effects at a tissue treatment region 1691, as illustrated in
In other examples, the heat signature captured by the one or more imaging devices is not converted into an estimated temperature. Instead, it is directly compared heat signatures stored into the memory 3103 to assess whether a power level adjustment is needed.
In certain examples, the memory 3103 stores a predetermined a correlation algorithm between power levels of the monopolar energy, as applied to a tissue treatment region 1691 by the end effector 1600, and the heat signatures expected to result from application of the monopolar energy to the tissue treatment region. The correlation algorithm can be in the form of, for example, an array, lookup table, database, mathematical equation, or formula, etc. In at least one example, the stored correlation algorithm defines a correlation between power levels of the monopolar energy and expected heat signatures, or temperatures associated with the expected heat signatures.
Referring to
In the illustrated example, the bipolar energy and monopolar energy are generated by separate generators 1880, 1881, and are provided to the tissue by separate electrical circuits 1882, 1883 that connect the generator 1880 to the electrodes 1852, 1872, and the generator 1881 to the electrode 1874 and the return pad 1803, respectively. The power levels associated was the bipolar energy delivered to the tissue by the electrodes 1852, 1872 is set by the generator 1880, and the power levels associated with the monopolar energy delivered to the tissue by the electrode 1874 is set by the generator 1881, in accordance with the power scheme 3005′, for example.
In use, as illustrated in
In various aspects, the surgical system 1807 further includes a control circuit 1809 coupled to the impedance sensors 1810, 1811, 1812, 1813. The control circuit 1809 can detect an off-site, or an unintended, thermal damage based on one or more readings of the impedance sensors 1810, 1811, 1812, 1813. In response, the control circuit 1809 may alert a user to the off-site thermal damage, and instruct the user to pause energy delivery to the tissue treatment region 1804, or automatically pause the energy delivery, while maintaining the bipolar energy in accordance with a predetermined power scheme (e.g. power scheme 3005′) to complete the tissue sealing. In certain instances, the control circuit 1809 may instruct the user to employ a mechanical knife to transect the tissue to avoid further off-site thermal damage.
Referring still to
In various aspects, the off-site thermal damage occurs in tissue on one side (left/right) of the end effector 1800. The control circuit 1809 may detect the side on which the off-site thermal damage has occurred by comparing the readings of the impedance sensors 1810, 1811, 1812, 1813. In one example, a non-proportional change in the monopolar and bipolar impedance readings is indicative of an off-site thermal damage. On the contrary, if proportionality in the impedance readings is detected, the control circuit 1809 maintains that no off-site thermal damage has occurred. In one example, as described in greater detail below, the off-site thermal damage can be detected by the control circuit 1809 from a ratio of the bipolar to monopolar impedances.
The control circuit 3101 may determine whether energy is being diverted to a non-tissue therapy directed site during a tissue treatment cycle by causing the sensing pings 1903, 1904 to be delivered at predetermined time intervals. The control circuit 3101 may then assess return-path conductivity based on the delivered sensing pings. If it is determined that energy is being diverted from a target site, the control circuit 3101 can take one or more reactive measures. For example, the control circuit 3101 can adjust the power scheme 1901 to be applied by the generators 1880 (GEN. 2), 1881 (GEN. 1). The control circuit 3101 may pause bipolar and/or monopolar energy application to the target site. Further, the control circuit 3101 may issue an alert to a user through feedback system 3109, for example. If, however, determines that no energy diversion is detected, the control circuit 3101 continues execution of the power scheme 1901.
In various aspects, the control circuit 3101 assesses return-path conductivity by comparing a measured return-conductivity to a predetermined return-path conductivity stored in the memory 3103, for example. If the comparison indicates that the measured and predetermined return-path conductivities are different beyond a predetermined threshold, the control circuit 3101 concludes that energy is being diverted to a non-tissue therapy directed site, and performs one or more of the previously described reactive measures.
In various aspects, the control circuit 1809 monitors the impedance ratio 2030 to assess whether the monopolar energy is diverting to non-tissue therapy directed site. The diversion changes the proportionality of the detected values of the bipolar impedance 2011 (Zbipolar) and monopolar impedance 2021 (Zmonopolar), which changes the impedance ratio 2030. A change in the impedance ratio 2030 within the predetermined range 2031 may cause the control circuit 1908 to issue a warning. If, however, the change extends to, or below, a lower threshold of the predetermined range 2031 the control circuit 1908 may take additional reactive measures.
In the illustrated example, the impedance ratio 2030 (Zmonopolar/Zbipolar) remains constant, or at least substantially constant, for an initial part of treatment cycle that involves a blended monopolar and bipolar energy application to the tissue. At B1, however, a discrepancy occurs where the monopolar impedance (Zmonopolar) drops unexpectedly, or un-proportionally with, the bipolar impedance (Zbipolar) indicating a potential off-site thermal damage. In at least one example, the control circuit 1809 monitors changes in the ratio of ratio (Zmonopolar/Zbipolar) of the monopolar impedance to the bipolar impedance, and detects an off-site thermal damage if the changes persist for a predetermined amount of time, and/or change in value to, or below, a lower threshold of the predetermined range 2031. At B1, since the detected the impedance ratio 2030 is still within the predetermined range 2031, the control circuit 3101 only issues a warning through the feedback system 3109 that an off-site thermal damage has been detected, and continues to monitor the impedance ratio 2030.
At t3′, the control circuit 3101 further detects that the impedance ratio 2030 has changed to a value at, or below, a lower threshold of the predetermined range 2031. In response, the control circuit 3101 may issue another warning and, optionally, may instruct the user to pause energy delivery to the tissue, or automatically pause the energy delivery, at B2, while maintaining or adjusting the power level of the bipolar energy to complete the tissue sealing without monopolar energy. In certain examples, the control circuit 1809 further instructs the user to employ a mechanical knife (t4′) to transect the tissue to avoid further off-site thermal damage. In the illustrated example, the control circuit 1809 further causes the generator 1880 to adjust its power level to complete the tissue sealing without monopolar energy, and increases the time period allotted for the tissue sealing segment from time t4 to time t4′. In other words, the control circuit 1809 increases the bipolar energy delivery to the tissue to compensate for the loss of monopolar energy by increasing the bipolar power level and its delivery time.
Various aspects of the subject matter described herein are set out in the following examples.
Various aspects of the subject matter described herein are set out in the following examples.
Example 1—An electrosurgical instrument comprising an end effector. The end effector comprises a first jaw and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The second jaw comprises a gradually narrowing body extending from a proximal end to a distal end. The gradually narrowing body comprises a conductive material. The gradually narrowing body comprises a first conductive portion extending from the proximal end to the distal end and a second conductive portion defining a tapered electrode protruding from the first conductive portion and extending distally along at least a portion of the gradually narrowing body. The second conductive portion is integral with the first conductive portion. The first conductive portion is thicker than the second conductive portion in a transverse cross-section of the gradually narrowing body. The second jaw further comprises an electrically insulative layer configured to electrically insulate the first conductive portion from the tissue but not the second conductive portion. The first conductive portion is configured to transmit an electrical energy to the tissue only through the second conductive portion.
Example 2—The electrosurgical instrument of Example 1, wherein the tapered electrode comprises an outer surface flush with an outer surface of the electrically insulative layer.
Example 3—The electrosurgical instrument of Examples 1 or 2, wherein the tapered electrode comprises a width that gradually narrows as the tapered electrode extends from the proximal end toward the distal end.
Example 4—The electrosurgical instrument of Examples 1, 2, or 3, wherein the electrical energy is delivered to the tissue through an outer surface of the tapered electrode.
Example 5—The electrosurgical instrument of Examples 1, 2, 3, or 4, wherein the first jaw comprises a first electrode extending distally along at least a portion of the first jaw, wherein the tapered electrode is a second electrode, and wherein the first electrode is laterally offset from the second electrode in the closed configuration.
Example 6—The electrosurgical instrument of Example 5, wherein the second jaw further comprises a third electrode spaced apart from the narrowing gradually body.
Example 7—The electrosurgical instrument of Example 6, wherein the third electrode extends distally along an angular profile defined by the second jaw from an electrode proximal end to an electrode distal end.
Example 8—The electrosurgical instrument of Example 7, wherein the third electrode comprises a base positioned in a cradle extending distally along the angular profile of the second jaw from a cradle proximal and to a cradle distal end.
Example 9—The electrosurgical instrument of Example 8, wherein the cradle is centrally situated with respect to lateral edges the second jaw.
Example 10—The electrosurgical instrument of Examples 8 or 9, wherein the third electrode further comprises a tapered edge extending from the base beyond sidewalls of the cradle.
Example 11—The electrosurgical instrument of Examples 8, 9, or 10, wherein the cradle is comprised of a compliant substrate.
Example 12—The electrosurgical instrument of Examples 8, 9, 10, or 11, wherein the cradle is partially embedded in a valley defined in the gradually narrowing body.
Example 13—The electrosurgical instrument of Examples 8, 9, 10, 11, or 12, wherein the cradle is spaced apart from the gradually narrowing body by an electrically insulative coating.
Example 14—The electrosurgical instrument of Examples 8, 9, 10, 11, 12, or 13, wherein the base comprises a base proximal end, a base distal end, and a width that gradually narrows as the base extends along the angular profile from the base proximal end to the base distal end.
Example 15—An electrosurgical instrument comprising an end effector. The end effector comprises a first jaw and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The second jaw comprises a conductive body comprising a tapered angular profile extending from a proximal end to a distal end. The conductive body comprises a first conductive portion extending from the proximal end to the distal end and a second conductive portion defining a tapered electrode protruding from the first conductive portion and extending distally along at least a portion of the conductive body. The second conductive portion is integral with the first conductive portion. The first conductive portion is thicker than the second conductive portion. The second jaw further comprises an electrically insulative layer configured to electrically insulate the first conductive portion from the tissue but not the second conductive portion. The first conductive portion is configured to transmit an electrical energy to the tissue only through the second conductive portion.
Example 16—The electrosurgical instrument of Example 15, wherein the tapered electrode comprises a width that gradually narrows as the tapered electrode extends from the proximal end toward the distal end.
Example 17—The electrosurgical instrument of Examples 15 or 16, wherein the first jaw comprises a first electrode extending distally along at least a portion of the first jaw, wherein the tapered electrode is a second electrode, and wherein the first electrode is laterally offset from the second electrode in the closed configuration.
Example 18—The electrosurgical instrument of Examples 15, 16, or 17, wherein the second jaw further comprises a third electrode spaced apart from the conductive body.
Example 19—The electrosurgical instrument of Example 18, wherein the third electrode extends distally along at least a portion of the tapered angular profile.
Example 20—The electrosurgical instrument of Example 19, wherein the third electrode comprises a base positioned in a cradle extending distally along the at least a portion of the tapered angular profile from a cradle proximal and to a cradle distal end, and wherein the cradle is comprised of a compliant substrate.
Example 1—An electrosurgical instrument comprising an end effector. The end effector comprises a first jaw and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The second jaw comprises linear portions cooperating to form an angular profile and a treatment surface comprising segments extending along the angular profile. The segments comprise different geometries and different conductivities. The segments are configured to produce variable energy densities along the treatment surface.
Example 2—The electrosurgical instrument of Example 1, wherein the segments comprise a proximal segment and a distal segment. The proximal segment comprises a first surface area. The distal segment comprises a second surface area. The second surface area is smaller than the first surface area.
Example 3—The electrosurgical instrument of Examples 1 or 2, wherein at least one of the segments comprises conductive treatment regions longitudinally interrupted by nonconductive treatment regions.
Example 4—The electrosurgical instrument of Examples 1, 2, or 3, wherein the variable energy densities are predetermined based on a selection of the different geometries and different conductivities of the segments.
Example 5—The electrosurgical instrument of Examples 1, 2, 3, or 4, wherein at least one of the segments comprises a gradually narrowing width along its length.
Example 6—The electrosurgical instrument of Examples 1, 2, 3, 4, or 5, wherein the segments extend along a peripheral side of the second jaw.
Example 7—The electrosurgical instrument of Examples 1, 2, 3, 4, 5, or 6, wherein the segments are defined in the second jaw but not the first jaw.
Example 8—The electrosurgical instrument of Examples 1, 2, 3, 4, 5, 6, or 7, wherein the second jaw comprises an electrically conductive skeleton partially coated with a first material and a second material, wherein the first material is thermally conductive but electrically insulative, and wherein the second material is thermally and electrically insulative.
Example 9—The electrosurgical instrument of Example 8, wherein the first material comprises diamond-like carbon.
Example 10—The electrosurgical instrument of Examples 8 or 9, wherein the second material comprises PolyTetraFluoroEthylene.
Example 11—An electrosurgical instrument comprising an end effector. The end effector comprises a first jaw and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The second jaw comprises a gradually narrowing body extending from a proximal end to a distal end. The gradually narrowing body comprises a tissue contacting surface. The tissue contacting surface comprises an insulative layer comprising a first material. The insulative layer extends on opposite sides of an intermediate area extending along a length of the gradually narrowing body. The tissue contacting surface further comprises segments configured to yield variable energy densities along the tissue contacting surface. The segments comprise conductive segments and insulative segments alternating with the conductive segments along the intermediate area. The insulative segments comprise a second material different from the first material.
Example 12—The electrosurgical instrument of Example 11, wherein the conductive segments comprise a proximal segment and a distal segment. The proximal segment comprises a first surface area. The distal segment comprises a second surface area. The second surface area is smaller than the first surface area.
Example 13—The electrosurgical instrument of Examples 11 or 12, wherein the second jaw comprises an electrically conductive skeleton partially coated with the first material.
Example 14—The electrosurgical instrument of Example 13, wherein the electrically conductive skeleton comprises an inner thermally-insulative core and an outer thermally-conductive layer at least partially surrounding the inner thermally-insulative core.
Example 15—The electrosurgical instrument of Examples 11, 12, 13, or 14, wherein the variable energy densities are predetermined based on a selection of different geometries and different conductivities of the conductive segments.
Example 16—The electrosurgical instrument of Examples 11, 12, 13, 14, or 15, wherein at least one of the segments comprises a gradually narrowing width along its length.
Example 17—The electrosurgical instrument of Examples 11, 12, 13, 14, 15, or 16, wherein the segments extend along a peripheral side of the second jaw.
Example 18—The electrosurgical instrument of Examples 11, 12, 13, 14, 15, 16, or 17, wherein the segments are defined in the second jaw but not the first jaw.
Example 19—The electrosurgical instrument of Examples 11, 12, 13, 14, 15, 16, 17, or 18, wherein the first material comprises diamond-like carbon.
Example 20—The electrosurgical instrument of Examples 11, 12, 13, 14, 15, 16, 17, 18, or 19, wherein the second material comprises PolyTetraFluoroEthylene.
Example 1—An electrosurgical instrument comprising an end effector. The end effector comprises a first jaw, a second jaw, and an electrical circuit. The first jaw comprises a first electrically conductive skeleton, a first insulative coating selectively covering portions of the first electrically conductive skeleton, and first-jaw electrodes comprising exposed portions of the first electrically conductive skeleton. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The second jaw comprises a second electrically conductive skeleton, a second insulative coating selectively covering portions of the second electrically conductive skeleton, and second-jaw electrodes comprising exposed portions of the second electrically conductive skeleton. The electrical circuit is configured to transmit a bipolar RF energy and a monopolar RF energy to the tissue through the first-jaw electrodes and the second-jaw electrodes. The monopolar RF energy shares a first electrical pathway and a second electrical pathway defined by the electrical circuit for transmission of the bipolar RF energy.
Example 2—The electrosurgical instrument of Example 1, wherein the electrical circuit defines a third electrical pathway separate from the first electrical pathway and the second electrical pathway.
Example 3—The electrosurgical instrument of Example 1 or 2, wherein the end effector comprises a cutting electrode electrically insulated from the first electrically conductive skeleton and the second electrically conductive skeleton.
Example 4—The electrosurgical instrument of Example 3, wherein the cutting electrode is configured to receive a cutting monopolar RF energy through the third electrical pathway.
Example 5—The electrosurgical instrument of Example 4, wherein the cutting electrode is configured to cut the tissue with the cutting monopolar RF energy after coagulation of the tissue has commenced with the bipolar RF energy.
Example 6—The electrosurgical instrument of Examples 3, 4 or 5, wherein the cutting electrode is centrally located in one of the first jaw and the second jaw.
Example 7—The electrosurgical instrument of Examples 4 or 5, wherein the end effector is configured to simultaneously deliver the cutting monopolar RF energy and the bipolar RF energy to the tissue.
Example 8—The electrosurgical instrument of Examples 1, 2, 3, 4, 5, 6, or 7, wherein the first-jaw electrodes comprise a first distal-tip electrode, and wherein the second-jaw electrodes comprise a second distal-tip electrode.
Example 9—The electrosurgical instrument of Example 8, wherein first electrically conductive skeleton and the second electrically conductive skeleton are energized simultaneously to deliver the monopolar RF energy to a tissue surface through the first distal-tip electrode and the second distal-tip electrode.
Example 10—The electrosurgical instrument of Examples 1, 2, 3, 4, 5, 6, 7, 8, or 9, wherein the second jaw comprises a dissection electrode extending along a peripheral surface of the second jaw.
Example 11—An electrosurgical instrument comprising an end effector and an electrical circuit. The end effector comprises at least two electrode sets, a first jaw, and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The end effector is configured to deliver a combination of bipolar RF energy and monopolar RF energy to the grasped tissue from the at least two electrode sets. The electrical circuit is configured to transmit the bipolar RF energy and the monopolar RF energy. The monopolar RF energy shares an active pathway and a return pathway defined by the electrical circuit for transmission of the bipolar RF energy.
Example 12—The electrosurgical instrument of Example 11, wherein the at least two electrodes sets comprise three electrical interconnections that are used together in the electrical circuit.
Example 13—The electrosurgical instrument of Examples 11 or 12, wherein the at least two electrodes sets comprise three electrical interconnections that define at least a portion of the electrical circuit and another separate electrical circuit.
Example 14—The electrosurgical instrument of Example 13, wherein the separate electrical circuit leads to a cutting electrode of the at least two electrode sets that is isolated and centrally located in one of the first jaw and the second jaw.
Example 15—The electrosurgical instrument of Example 14, wherein the cutting electrode is configured to cut the tissue after coagulation of the tissue has commenced using second and third electrodes of the at least two electrode sets.
Example 16—The electrosurgical instrument of Examples 14 or 15, wherein the at least two electrode sets are configured to simultaneously deliver the monopolar RF energy and the bipolar RF energy to the tissue.
Example 17—An electrosurgical instrument comprising an end effector. The end effector comprises a first jaw and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The second jaw comprises a composite skeleton of at least two different materials that are configured to selectively yield electrically conductive portions and thermally insulted portions.
Example 18—The electrosurgical instrument of Example 17, wherein the composite skeleton comprises a titanium ceramic-composite.
Example 19—The electrosurgical instrument of Examples 17 or 18, wherein the composite skeleton comprises a ceramic base and a titanium crown attachable to the ceramic base.
Example 20—The electrosurgical instrument of Examples 17, 18, or 19, wherein the composite skeleton is at least partially coated with an electrically insulative material.
Example 21—A method for manufacturing a jaw of an end effector of an electrosurgical instrument. The method comprises preparing a composite skeleton of the jaw by fusing a titanium powder with a ceramic powder in a metal injection molding process and selectively coating the composite skeleton with an electrically insulative material to yield a plurality of electrodes.
Example 1—An electrosurgical instrument comprising a first jaw and a second jaw. The first jaw is configured to define a first electrode. The first jaw comprises a first electrically conductive skeleton and a first electrically insulative layer. The first electrically conductive skeleton comprises a first thermally insulative core and a first thermally conductive outer layer integral with and extending at least partially around the first thermally insulative core. The first electrode is defined by selective application of the first electrically insulative layer to an outer surface of the first thermally conductive outer layer. The second jaw is configured to define a second electrode. The second jaw comprises a second electrically conductive skeleton and a second electrically insulative layer. The second electrically conductive skeleton comprises a second thermally insulative core and a second thermally conductive outer layer integral with and extending at least partially around the second thermally insulative core. The second electrode is defined by selective application of the second electrically insulative layer to an outer surface of the second thermally conductive outer layer.
Example 2—The electrosurgical instrument of Example 1, wherein the first electrode is configured to transmit an RF energy to the second electrode through tissue positioned therebetween in a bipolar energy mode of operation.
Example 3—The electrosurgical instrument of Examples 1 or 2, wherein the first thermally insulative core comprises air pockets.
Example 4—The electrosurgical instrument of Examples 1, 2, or 3, wherein the first thermally insulative core comprises a lattice structure.
Example 5—The electrosurgical instrument of Examples 1, 2, 3, or 4, wherein the second jaw comprises a third electrode, and wherein the third electrode is defined by selective application of the second electrically insulative layer to the outer surface of the second thermally conductive outer layer.
Example 6—The electrosurgical instrument of Example 5, wherein the third electrode is configured to deliver an RF energy to tissue in contact with the third electrode in a monopolar energy mode of operation.
Example 7—The electrosurgical instrument of Examples 1, 2, 3, 4, 5, or 6, wherein at least one of the first electrically insulative layer and the second electrically insulative layer comprises a diamond-like material.
Example 8—The electrosurgical instrument of Examples 1, 2, 3, 4, 5, 6, or 7, wherein the first jaw comprises a tissue-contacting surface, and wherein the first thermally insulative core comprises a lattice structure including walls erected in a direction that transects the tissue-contacting surface.
Example 9—The electrosurgical instrument of Example 8, wherein the direction is perpendicular to the tissue-contacting surface.
Example 10—An electrosurgical instrument comprising a jaw configured to define an electrode. The jaw comprises a first electrically conductive portion, a second electrically conductive portion, and an electrically insulative layer. The first electrically conductive portion is configured to resist heat transfer therethrough. The second electrically conductive portion is integral with and extending at least partially around the first electrically conductive portion. The second electrically conductive portion is configured to define a heat sink. The electrode is defined by selective application of the electrically insulative layer to an outer surface of the second electrically conductive portion.
Example 11—The electrosurgical instrument of Example 10, wherein the electrode is configured to transmit an RF energy to tissue positioned against the electrode.
Example 12—The electrosurgical instrument of Examples 10 or 11, wherein the first electrically conductive portion comprises air pockets.
Example 13—The electrosurgical instrument of Examples 10, 11, or 12, wherein the first electrically conductive portion comprises a lattice structure.
Example 14—The electrosurgical instrument of Examples 10, 11, 12, or 13, wherein the electrically insulative layer comprises a diamond-like material.
Example 15—The electrosurgical instrument of Examples 10, 11, 12, 13, or 14, wherein the jaw comprises a tissue-contacting surface, and wherein the first electrically conductive portion comprises a lattice structure including walls erected in a direction that transects the tissue-contacting surface.
Example 16—The electrosurgical instrument of Example 15, wherein the direction is perpendicular to the tissue-contacting surface.
Example 17—An electrosurgical instrument comprising a jaw configured to define an electrode. The jaw comprises an electrically conductive skeleton and an electrically insulative layer. The electrically conductive skeleton comprises a thermally insulative core and a thermally conductive outer layer integral with and extending at least partially around the thermally insulative core. The electrode is defined by selective application of the electrically insulative layer to an outer surface of the thermally conductive outer layer.
Example 18—The electrosurgical instrument of Example 17, wherein the thermally insulative core comprises a lattice structure.
Example 19—The electrosurgical instrument of Example 18, wherein the jaw comprises a tissue-contacting surface, and wherein the lattice structure includes walls erected in a direction that transects the tissue-contacting surface.
Example 20—The electrosurgical instrument of Example 19, wherein the direction is perpendicular to the tissue-contacting surface.
Example 1—An electrosurgical instrument comprising an end effector. The end effector comprises a first jaw and a second jaw. The first jaw comprises a first electrode. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The second jaw comprises a second electrode configured to deliver a first monopolar energy to the tissue, a third electrode, and a conductive circuit selectively transitionable between a connected configuration with the third electrode and a disconnected configuration with the third electrode. In the connected configuration, the third electrode is configured to cooperate with the first electrode to deliver bipolar energy to the tissue. The conductive circuit defines a return path for the bipolar energy. In the disconnected configuration, the first electrode is configured to deliver a second monopolar energy to the tissue.
Example 2—The electrosurgical instrument of Example 1, further comprising a switching mechanism for alternating between the connected configuration and the disconnected configuration.
Example 3—The electrosurgical instrument of Examples 1 or 2, further comprising a switching mechanism for alternating between delivering the bipolar energy and the second monopolar energy to the tissue through the first electrode.
Example 4—The electrosurgical instrument of Examples 1, 2 or 3, wherein the end effector is configured to deliver the bipolar energy and the first monopolar energy to the tissue simultaneously.
Example 5—The electrosurgical instrument of Examples 1, 2, 3, or 4, wherein the end effector is configured to deliver an energy blend of the bipolar energy and the first monopolar energy to the tissue.
Example 6—The electrosurgical instrument of Example 5, wherein levels of the bipolar energy and the first monopolar energy in the energy blend are determined based on at least one reading of a temperature sensor indicative of at least one temperature of the tissue.
Example 7—The electrosurgical instrument of Examples 5 or 6, wherein levels of the bipolar energy and the first monopolar energy in the energy blend are determined based on at least one reading of an impedance sensor indicative of at least one impedance of the tissue.
Example 8—The electrosurgical instrument of Examples 5, 6, or 7, wherein levels of the bipolar energy and the first monopolar energy in the energy blend are adjusted to reduce a detected lateral thermal damage beyond a tissue treatment region between the first jaw and the second jaw.
Example 9—An electrosurgical instrument comprising an end effector and a control circuit. The end effector comprises a first jaw, a second jaw, and at least one sensor. The first jaw comprises a first electrode. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The second jaw comprises a second electrode configured to deliver a monopolar energy to the tissue and third electrode configured to cooperate with the first electrode to deliver a bipolar energy. The control circuit is configured to execute a predetermined power scheme to seal and cut the tissue in a tissue treatment cycle. The power scheme comprises predetermined power levels of the monopolar energy and the bipolar energy. The control circuit is further configured to adjust at least one of the predetermined power levels of the monopolar energy and the bipolar energy based on readings of at least one sensor during the tissue treatment cycle.
Example 10—The electrosurgical instrument of Example 9, wherein the predetermined power scheme comprises a simultaneous application and a separate application of the bipolar energy and the monopolar energy to the tissue in the tissue treatment cycle.
Example 11—The electrosurgical instrument of Examples 9 or 10, wherein the predetermined power scheme comprises an application of the bipolar energy but not the monopolar energy to the tissue in a feathering segment of the tissue treatment cycle and a simultaneous application of the bipolar energy and the monopolar energy to the tissue in a tissue warming segment and a tissue sealing segment of the tissue treatment cycle.
Example 12—The electrosurgical instrument of Example 11, wherein the power scheme further comprises an application of the monopolar energy but not the bipolar energy to the tissue in a tissue transection segment of the tissue treatment cycle.
Example 13—The electrosurgical instrument of Examples 9, 10, 11, or 12, wherein the at least one sensor comprises impedance sensors.
Example 14—The electrosurgical instrument of Example 13, wherein the control circuit is configured to monitor an impedance ratio of a monopolar tissue-impedance to a bipolar tissue-impedance based on readings from the impedance sensors.
Example 15—The electrosurgical instrument of Example 14, wherein a change in the impedance ratio within a predetermined range causes the control circuit to issue a warning.
Example 16—The electrosurgical instrument of Example 15, wherein a change in the impedance ratio to, or below, a lower threshold of the predetermined range causes the control circuit to adjust the predetermined power scheme.
Example 17—The electrosurgical instrument of Examples 15 or 16, wherein a change in the impedance ratio to, or below, a lower threshold of the predetermined range causes the control circuit to pause an application of the monopolar energy to the tissue.
Example 18—The electrosurgical instrument of Example 17, wherein the change in the impedance ratio to, or below, a lower threshold of the predetermined range further causes the control circuit to adjust an application of the bipolar energy to the tissue to complete sealing the tissue.
Example 19—An electrosurgical instrument comprising an end effector and a control circuit. The end effector comprises a first jaw and a second jaw. The first jaw comprising a first electrode. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The tissue being at a target site. The second jaw comprises a second electrode configured to deliver a monopolar energy to the tissue and a third electrode configured to cooperate with the first electrode to deliver a bipolar energy. The control circuit is configured to execute a predetermined power scheme to seal and cut the tissue in a tissue treatment cycle. The power scheme comprises predetermined power levels of the monopolar energy and the bipolar energy. The control circuit is further configured to detect an energy diversion off the target site and adjust at least one of the predetermined power levels of the monopolar energy and the bipolar energy to mitigate the energy diversion.
Example 20—The electrosurgical instrument of Example 19, wherein the predetermined power scheme comprises a simultaneous application and a separate application of the bipolar energy and the monopolar energy to the tissue in the tissue treatment cycle.
Example 21—The electrosurgical instrument of Examples 19 or 20, wherein the predetermined power scheme comprises an application of the bipolar energy but not the monopolar energy to the tissue in a feathering segment of the tissue treatment cycle and a simultaneous application of the bipolar energy and the monopolar energy to the tissue in a tissue warming segment and a tissue sealing segment of the tissue treatment cycle.
Example 1—An electrosurgical system comprising an end effector and a control circuit. The end effector comprises a first jaw and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The control circuit is configured to cause an application of two different energy modalities to the tissue simultaneously and separately during a tissue treatment cycle comprising a tissue coagulation stage and a tissue transection stage.
Example 2—The electrosurgical system of Example 1, wherein the first energy modality is a monopolar energy modality.
Example 3—The electrosurgical system of Example 2, wherein the second energy modality is a bipolar energy modality.
Example 4—The electrosurgical system of Examples 2 or 3, wherein the control circuit is configured to activate the application of the monopolar energy modality to the tissue prior to a completion of the tissue coagulation stage by the bipolar energy modality.
Example 5—The electrosurgical system of Examples 2 or 3, wherein the control circuit is configured to activate the application of the monopolar energy modality to the tissue prior to deactivation of the bipolar energy modality application to the tissue.
Example 6—The electrosurgical system of Examples 3, 4, or 5, wherein the control circuit is configured to cause a simultaneous application of the monopolar energy modality and the bipolar energy modality to the tissue during the tissue coagulation stage.
Example 7—The electrosurgical system of Examples 1, 2, 3, 4, 5, or 6, wherein the control circuit comprises a processor and a storage medium, and wherein the application of the two different energy modalities to the tissue is based on a default power scheme stored in the storage medium.
Example 8—The electrosurgical system of Example 7, further comprising at least one sensor, and wherein the control circuit is configured to modify the default power scheme based on one more sensor readings of the at least one sensor.
Example 9—An electrosurgical instrument comprising an end effector. The end effector comprises a first jaw and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The end effector is configured to cause an application of three different energy modalities to the tissue during a tissue treatment cycle comprising a tissue coagulation stage and a tissue transection stage.
Example 10—The electrosurgical instrument of Example 9, wherein the first energy modality comprises a bipolar energy.
Example 11—The electrosurgical instrument of Example 10, wherein the second energy modality comprises an energy blend of a monopolar energy and the bipolar energy.
Example 12—The electrosurgical instrument of Example 11, wherein the third energy modality comprises the monopolar energy but not the bipolar energy.
Example 13—The electrosurgical instrument of Examples 11 or 12, wherein an activation of the monopolar energy application to the tissue is configured to begin prior to a completion of the tissue coagulation stage.
Example 14—The electrosurgical instrument of Examples 12 or 13, wherein an activation of the monopolar energy application to the tissue is configured to begin prior to a deactivation of the application of the bipolar energy modality to the tissue.
Example 15—The electrosurgical instrument of Examples 9, 10, 11, 12, 13, or 14, further comprising a control circuit, wherein the control circuit comprises a processor and a storage medium, and wherein the application of the two different energy modalities to the tissue is based on a default power scheme stored in the storage medium.
Example 16—The electrosurgical instrument of Example 15, further comprising at least one sensor, wherein the control circuit is configured to adjust the default power scheme during the tissue treatment cycle based on one more sensor readings of the at least one sensor.
Example 17—An electrosurgical system comprising a first generator configured output a bipolar energy, a second generator configured to output a monopolar energy, a surgical instrument electrically coupled to the first generator and the second generator, and a control circuit. The surgical instrument comprises an end effector. The end effector comprises a first jaw and a second jaw. At least one of the first jaw and the second jaw is movable to transition the end effector from an open configuration to a closed configuration to grasp tissue therebetween. The control circuit comprises a processor and a storage medium comprising program instructions that, when executed by the processor, causes the processor to cause the first generator and the second generator to apply a predetermined power scheme to the end effector. The power scheme comprises a simultaneous application and a separate application of the bipolar energy and the monopolar energy to the tissue in a tissue treatment cycle.
Example 18—The electrosurgical system of Example 17, further comprising at least one sensor, wherein the control circuit is configured to adjust the power scheme during the tissue treatment cycle based on one more sensor readings of the at least one sensor.
Example 19—The electrosurgical system of Examples 17 or 18, wherein the power scheme comprises an application of the bipolar energy but not the monopolar energy to the tissue in a feathering segment of the tissue treatment cycle, and a simultaneous application of the bipolar energy and the monopolar energy to the tissue in a tissue warming segment and a tissue sealing segment of the tissue treatment cycle.
Example 20—The electrosurgical system of Examples 17, 18, or 19, wherein the power scheme further comprises an application of the monopolar energy but not the bipolar energy to the tissue in a tissue transection segment of the tissue treatment cycle.
While several forms have been illustrated and described, it is not the intention of Applicant to restrict or limit the scope of the appended claims to such detail. Numerous modifications, variations, changes, substitutions, combinations, and equivalents to those forms may be implemented and will occur to those skilled in the art without departing from the scope of the present disclosure. Moreover, the structure of each element associated with the described forms can be alternatively described as a means for providing the function performed by the element. Also, where materials are disclosed for certain components, other materials may be used. It is therefore to be understood that the foregoing description and the appended claims are intended to cover all such modifications, combinations, and variations as falling within the scope of the disclosed forms. The appended claims are intended to cover all such modifications, variations, changes, substitutions, modifications, and equivalents.
The foregoing detailed description has set forth various forms of the devices and/or processes via the use of block diagrams, flowcharts, and/or examples. Insofar as such block diagrams, flowcharts, and/or examples contain one or more functions and/or operations, it will be understood by those within the art that each function and/or operation within such block diagrams, flowcharts, and/or examples can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or virtually any combination thereof. Those skilled in the art will recognize that some aspects of the forms disclosed herein, in whole or in part, can be equivalently implemented in integrated circuits, as one or more computer programs running on one or more computers (e.g., as one or more programs running on one or more computer systems), as one or more programs running on one or more processors (e.g., as one or more programs running on one or more microprocessors), as firmware, or as virtually any combination thereof, and that designing the circuitry and/or writing the code for the software and or firmware would be well within the skill of one of skill in the art in light of this disclosure. In addition, those skilled in the art will appreciate that the mechanisms of the subject matter described herein are capable of being distributed as one or more program products in a variety of forms, and that an illustrative form of the subject matter described herein applies regardless of the particular type of signal bearing medium used to actually carry out the distribution.
Instructions used to program logic to perform various disclosed aspects can be stored within a memory in the system, such as dynamic random access memory (DRAM), cache, flash memory, or other storage. Furthermore, the instructions can be distributed via a network or by way of other computer readable media. Thus a machine-readable medium may include any mechanism for storing or transmitting information in a form readable by a machine (e.g., a computer), but is not limited to, floppy diskettes, optical disks, compact disc, read-only memory (CD-ROMs), and magneto-optical disks, read-only memory (ROMs), random access memory (RAM), erasable programmable read-only memory (EPROM), electrically erasable programmable read-only memory (EEPROM), magnetic or optical cards, flash memory, or a tangible, machine-readable storage used in the transmission of information over the Internet via electrical, optical, acoustical or other forms of propagated signals (e.g., carrier waves, infrared signals, digital signals, etc.). Accordingly, the non-transitory computer-readable medium includes any type of tangible machine-readable medium suitable for storing or transmitting electronic instructions or information in a form readable by a machine (e.g., a computer).
As used in any aspect herein, the term “control circuit” may refer to, for example, hardwired circuitry, programmable circuitry (e.g., a computer processor including one or more individual instruction processing cores, processing unit, processor, microcontroller, microcontroller unit, controller, digital signal processor (DSP), programmable logic device (PLD), programmable logic array (PLA), or field programmable gate array (FPGA)), state machine circuitry, firmware that stores instructions executed by programmable circuitry, and any combination thereof. The control circuit may, collectively or individually, be embodied as circuitry that forms part of a larger system, for example, an integrated circuit (IC), an application-specific integrated circuit (ASIC), a system on-chip (SoC), desktop computers, laptop computers, tablet computers, servers, smart phones, etc. Accordingly, as used herein “control circuit” includes, but is not limited to, electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g., a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g., forms of random access memory), and/or electrical circuitry forming a communications device (e.g., a modem, communications switch, or optical-electrical equipment). Those having skill in the art will recognize that the subject matter described herein may be implemented in an analog or digital fashion or some combination thereof.
As used in any aspect herein, the term “logic” may refer to an app, software, firmware and/or circuitry configured to perform any of the aforementioned operations. Software may be embodied as a software package, code, instructions, instruction sets and/or data recorded on non-transitory computer readable storage medium. Firmware may be embodied as code, instructions or instruction sets and/or data that are hard-coded (e.g., nonvolatile) in memory devices.
As used in any aspect herein, the terms “component,” “system,” “module” and the like can refer to a computer-related entity, either hardware, a combination of hardware and software, software, or software in execution.
As used in any aspect herein, an “algorithm” refers to a self-consistent sequence of steps leading to a desired result, where a “step” refers to a manipulation of physical quantities and/or logic states which may, though need not necessarily, take the form of electrical or magnetic signals capable of being stored, transferred, combined, compared, and otherwise manipulated. It is common usage to refer to these signals as bits, values, elements, symbols, characters, terms, numbers, or the like. These and similar terms may be associated with the appropriate physical quantities and are merely convenient labels applied to these quantities and/or states.
A network may include a packet switched network. The communication devices may be capable of communicating with each other using a selected packet switched network communications protocol. One example communications protocol may include an Ethernet communications protocol which may be capable permitting communication using a Transmission Control Protocol/Internet Protocol (TCP/IP). The Ethernet protocol may comply or be compatible with the Ethernet standard published by the Institute of Electrical and Electronics Engineers (IEEE) titled “IEEE 802.3 Standard”, published in December, 2008 and/or later versions of this standard. Alternatively or additionally, the communication devices may be capable of communicating with each other using an X.25 communications protocol. The X.25 communications protocol may comply or be compatible with a standard promulgated by the International Telecommunication Union-Telecommunication Standardization Sector (ITU-T). Alternatively or additionally, the communication devices may be capable of communicating with each other using a frame relay communications protocol. The frame relay communications protocol may comply or be compatible with a standard promulgated by Consultative Committee for International Telegraph and Telephone (CCITT) and/or the American National Standards Institute (ANSI). Alternatively or additionally, the transceivers may be capable of communicating with each other using an Asynchronous Transfer Mode (ATM) communications protocol. The ATM communications protocol may comply or be compatible with an ATM standard published by the ATM Forum titled “ATM-MPLS Network Interworking 2.0” published August 2001, and/or later versions of this standard. Of course, different and/or after-developed connection-oriented network communication protocols are equally contemplated herein.
Unless specifically stated otherwise as apparent from the foregoing disclosure, it is appreciated that, throughout the foregoing disclosure, discussions using terms such as “processing,” “computing,” “calculating,” “determining,” “displaying,” or the like, refer to the action and processes of a computer system, or similar electronic computing device, that manipulates and transforms data represented as physical (electronic) quantities within the computer system's registers and memories into other data similarly represented as physical quantities within the computer system memories or registers or other such information storage, transmission or display devices.
One or more components may be referred to herein as “configured to,” “configurable to,” “operable/operative to,” “adapted/adaptable,” “able to,” “conformable/conformed to,” etc. Those skilled in the art will recognize that “configured to” can generally encompass active-state components and/or inactive-state components and/or standby-state components, unless context requires otherwise.
The terms “proximal” and “distal” are used herein with reference to a clinician manipulating the handle portion of the surgical instrument. The term “proximal” refers to the portion closest to the clinician and the term “distal” refers to the portion located away from the clinician. It will be further appreciated that, for convenience and clarity, spatial terms such as “vertical”, “horizontal”, “up”, and “down” may be used herein with respect to the drawings. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and/or absolute.
Those skilled in the art will recognize that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to claims containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations.
In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). It will be further understood by those within the art that typically a disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms unless context dictates otherwise. For example, the phrase “A or B” will be typically understood to include the possibilities of “A” or “B” or “A and B.”
With respect to the appended claims, those skilled in the art will appreciate that recited operations therein may generally be performed in any order. Also, although various operational flow diagrams are presented in a sequence(s), it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently. Examples of such alternate orderings may include overlapping, interleaved, interrupted, reordered, incremental, preparatory, supplemental, simultaneous, reverse, or other variant orderings, unless context dictates otherwise. Furthermore, terms like “responsive to,” “related to,” or other past-tense adjectives are generally not intended to exclude such variants, unless context dictates otherwise.
It is worthy to note that any reference to “one aspect,” “an aspect,” “an exemplification,” “one exemplification,” and the like means that a particular feature, structure, or characteristic described in connection with the aspect is included in at least one aspect. Thus, appearances of the phrases “in one aspect,” “in an aspect,” “in an exemplification,” and “in one exemplification” in various places throughout the specification are not necessarily all referring to the same aspect. Furthermore, the particular features, structures or characteristics may be combined in any suitable manner in one or more aspects.
In this specification, unless otherwise indicated, terms “about” or “approximately” as used in the present disclosure, unless otherwise specified, means an acceptable error for a particular value as determined by one of ordinary skill in the art, which depends in part on how the value is measured or determined. In certain embodiments, the term “about” or “approximately” means within 1, 2, 3, or 4 standard deviations. In certain embodiments, the term “about” or “approximately” means within 50%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, or 0.05% of a given value or range.
In this specification, unless otherwise indicated, all numerical parameters are to be understood as being prefaced and modified in all instances by the term “about,” in which the numerical parameters possess the inherent variability characteristic of the underlying measurement techniques used to determine the numerical value of the parameter. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter described herein should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
Any numerical range recited herein includes all sub-ranges subsumed within the recited range. For example, a range of “1 to 10” includes all sub-ranges between (and including) the recited minimum value of 1 and the recited maximum value of 10, that is, having a minimum value equal to or greater than 1 and a maximum value equal to or less than 10. Also, all ranges recited herein are inclusive of the end points of the recited ranges. For example, a range of “1 to 10” includes the end points 1 and 10. Any maximum numerical limitation recited in this specification is intended to include all lower numerical limitations subsumed therein, and any minimum numerical limitation recited in this specification is intended to include all higher numerical limitations subsumed therein. Accordingly, Applicant reserves the right to amend this specification, including the claims, to expressly recite any sub-range subsumed within the ranges expressly recited. All such ranges are inherently described in this specification.
Any patent application, patent, non-patent publication, or other disclosure material referred to in this specification and/or listed in any Application Data Sheet is incorporated by reference herein, to the extent that the incorporated materials is not inconsistent herewith. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
In summary, numerous benefits have been described which result from employing the concepts described herein. The foregoing description of the one or more forms has been presented for purposes of illustration and description. It is not intended to be exhaustive or limiting to the precise form disclosed. Modifications or variations are possible in light of the above teachings. The one or more forms were chosen and described in order to illustrate principles and practical application to thereby enable one of ordinary skill in the art to utilize the various forms and with various modifications as are suited to the particular use contemplated. It is intended that the claims submitted herewith define the overall scope.
This non-provisional application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 62/955,299, entitled DEVICES AND SYSTEMS FOR ELECTROSURGERY, filed Dec. 30, 2019, the disclosure of which is incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
969528 | Disbrow | Sep 1910 | A |
1570025 | Young | Jan 1926 | A |
1813902 | Bovie | Jul 1931 | A |
2188497 | Calva | Jan 1940 | A |
2366274 | Luth et al. | Jan 1945 | A |
2425245 | Johnson | Aug 1947 | A |
2442966 | Wallace | Jun 1948 | A |
2458152 | Eakins | Jan 1949 | A |
2510693 | Green | Jun 1950 | A |
2597564 | Bugg | May 1952 | A |
2704333 | Calosi et al. | Mar 1955 | A |
2736960 | Armstrong | Mar 1956 | A |
2748967 | Roach | Jun 1956 | A |
2845072 | Shafer | Jul 1958 | A |
2849788 | Creek | Sep 1958 | A |
2867039 | Zach | Jan 1959 | A |
2874470 | Richards | Feb 1959 | A |
2990616 | Balamuth et al. | Jul 1961 | A |
RE25033 | Balamuth et al. | Aug 1961 | E |
3015961 | Roney | Jan 1962 | A |
3033407 | Alfons | May 1962 | A |
3053124 | Balamuth et al. | Sep 1962 | A |
3082805 | Royce | Mar 1963 | A |
3166971 | Stoecker | Jan 1965 | A |
3322403 | Murphy | May 1967 | A |
3432691 | Shoh | Mar 1969 | A |
3433226 | Boyd | Mar 1969 | A |
3489930 | Shoh | Jan 1970 | A |
3513848 | Winston et al. | May 1970 | A |
3514856 | Camp et al. | Jun 1970 | A |
3525912 | Wallin | Aug 1970 | A |
3526219 | Balamuth | Sep 1970 | A |
3554198 | Tatoian et al. | Jan 1971 | A |
3580841 | Cadotte et al. | May 1971 | A |
3606682 | Camp et al. | Sep 1971 | A |
3614484 | Shoh | Oct 1971 | A |
3616375 | Inoue | Oct 1971 | A |
3629726 | Popescu | Dec 1971 | A |
3636943 | Balamuth | Jan 1972 | A |
3668486 | Silver | Jun 1972 | A |
3702948 | Balamuth | Nov 1972 | A |
3703651 | Blowers | Nov 1972 | A |
3776238 | Peyman et al. | Dec 1973 | A |
3777760 | Essner | Dec 1973 | A |
3805787 | Banko | Apr 1974 | A |
3809977 | Balamuth et al. | May 1974 | A |
3830098 | Antonevich | Aug 1974 | A |
3854737 | Gilliam, Sr. | Dec 1974 | A |
3862630 | Balamuth | Jan 1975 | A |
3875945 | Friedman | Apr 1975 | A |
3885438 | Harris, Sr. et al. | May 1975 | A |
3900823 | Sokal et al. | Aug 1975 | A |
3918442 | Nikolaev et al. | Nov 1975 | A |
3924335 | Balamuth et al. | Dec 1975 | A |
3946738 | Newton et al. | Mar 1976 | A |
3955859 | Stella et al. | May 1976 | A |
3956826 | Perdreaux, Jr. | May 1976 | A |
3989952 | Hohmann | Nov 1976 | A |
4005714 | Hiltebrandt | Feb 1977 | A |
4012647 | Balamuth et al. | Mar 1977 | A |
4034762 | Cosens et al. | Jul 1977 | A |
4058126 | Leveen | Nov 1977 | A |
4074719 | Semm | Feb 1978 | A |
4156187 | Murry et al. | May 1979 | A |
4167944 | Banko | Sep 1979 | A |
4188927 | Harris | Feb 1980 | A |
4200106 | Douvas et al. | Apr 1980 | A |
4203430 | Takahashi | May 1980 | A |
4203444 | Bonnell et al. | May 1980 | A |
4220154 | Semm | Sep 1980 | A |
4237441 | van Konynenburg et al. | Dec 1980 | A |
4244371 | Farin | Jan 1981 | A |
4281785 | Brooks | Aug 1981 | A |
4300083 | Heiges | Nov 1981 | A |
4302728 | Nakamura | Nov 1981 | A |
4304987 | van Konynenburg | Dec 1981 | A |
4306570 | Matthews | Dec 1981 | A |
4314559 | Allen | Feb 1982 | A |
4353371 | Cosman | Oct 1982 | A |
4409981 | Lundberg | Oct 1983 | A |
4445063 | Smith | Apr 1984 | A |
4461304 | Kuperstein | Jul 1984 | A |
4463759 | Garito et al. | Aug 1984 | A |
4491132 | Aikins | Jan 1985 | A |
4492231 | Auth | Jan 1985 | A |
4494759 | Kieffer | Jan 1985 | A |
4504264 | Kelman | Mar 1985 | A |
4512344 | Barber | Apr 1985 | A |
4526571 | Wuchinich | Jul 1985 | A |
4535773 | Yoon | Aug 1985 | A |
4541638 | Ogawa et al. | Sep 1985 | A |
4545374 | Jacobson | Oct 1985 | A |
4545926 | Fouts, Jr. et al. | Oct 1985 | A |
4549147 | Kondo | Oct 1985 | A |
4550870 | Krumme et al. | Nov 1985 | A |
4553544 | Nomoto et al. | Nov 1985 | A |
4562838 | Walker | Jan 1986 | A |
4574615 | Bower et al. | Mar 1986 | A |
4582236 | Hirose | Apr 1986 | A |
4593691 | Lindstrom et al. | Jun 1986 | A |
4608981 | Rothfuss et al. | Sep 1986 | A |
4617927 | Manes | Oct 1986 | A |
4633119 | Thompson | Dec 1986 | A |
4633874 | Chow et al. | Jan 1987 | A |
4634420 | Spinosa et al. | Jan 1987 | A |
4640279 | Beard | Feb 1987 | A |
4641053 | Takeda | Feb 1987 | A |
4646738 | Trott | Mar 1987 | A |
4646756 | Watmough et al. | Mar 1987 | A |
4649919 | Thimsen et al. | Mar 1987 | A |
4662068 | Polonsky | May 1987 | A |
4674502 | Imonti | Jun 1987 | A |
4694835 | Strand | Sep 1987 | A |
4708127 | Abdelghani | Nov 1987 | A |
4712722 | Hood et al. | Dec 1987 | A |
4735603 | Goodson et al. | Apr 1988 | A |
4739759 | Rexroth et al. | Apr 1988 | A |
4761871 | O'Connor et al. | Aug 1988 | A |
4808154 | Freeman | Feb 1989 | A |
4819635 | Shapiro | Apr 1989 | A |
4827911 | Broadwin et al. | May 1989 | A |
4830462 | Karny et al. | May 1989 | A |
4832683 | Idemoto et al. | May 1989 | A |
4836186 | Scholz | Jun 1989 | A |
4838853 | Parisi | Jun 1989 | A |
4844064 | Thimsen et al. | Jul 1989 | A |
4849133 | Yoshida et al. | Jul 1989 | A |
4850354 | McGurk-Burleson et al. | Jul 1989 | A |
4852578 | Companion et al. | Aug 1989 | A |
4860745 | Farin et al. | Aug 1989 | A |
4862890 | Stasz et al. | Sep 1989 | A |
4865159 | Jamison | Sep 1989 | A |
4867157 | McGurk-Burleson et al. | Sep 1989 | A |
4878493 | Pasternak et al. | Nov 1989 | A |
4880015 | Nierman | Nov 1989 | A |
4881550 | Kothe | Nov 1989 | A |
4896009 | Pawlowski | Jan 1990 | A |
4903696 | Stasz et al. | Feb 1990 | A |
4910389 | Sherman et al. | Mar 1990 | A |
4915643 | Samejima et al. | Apr 1990 | A |
4920978 | Colvin | May 1990 | A |
4922902 | Wuchinich et al. | May 1990 | A |
4926860 | Stice et al. | May 1990 | A |
4936842 | D'Amelio et al. | Jun 1990 | A |
4954960 | Lo et al. | Sep 1990 | A |
4965532 | Sakurai | Oct 1990 | A |
4979952 | Kubota et al. | Dec 1990 | A |
4981756 | Rhandhawa | Jan 1991 | A |
5001649 | Lo et al. | Mar 1991 | A |
5003693 | Atkinson et al. | Apr 1991 | A |
5009661 | Michelson | Apr 1991 | A |
5013956 | Kurozumi et al. | May 1991 | A |
5015227 | Broadwin et al. | May 1991 | A |
5020514 | Heckele | Jun 1991 | A |
5026370 | Lottick | Jun 1991 | A |
5026387 | Thomas | Jun 1991 | A |
5035695 | Weber, Jr. et al. | Jul 1991 | A |
5042461 | Inoue et al. | Aug 1991 | A |
5042707 | Taheri | Aug 1991 | A |
5052145 | Wang | Oct 1991 | A |
5061269 | Muller | Oct 1991 | A |
5075839 | Fisher et al. | Dec 1991 | A |
5084052 | Jacobs | Jan 1992 | A |
5099840 | Goble et al. | Mar 1992 | A |
5104025 | Main et al. | Apr 1992 | A |
5105117 | Yamaguchi | Apr 1992 | A |
5106538 | Barma et al. | Apr 1992 | A |
5108383 | White | Apr 1992 | A |
5109819 | Custer et al. | May 1992 | A |
5112300 | Ureche | May 1992 | A |
5113139 | Furukawa | May 1992 | A |
5123903 | Quaid et al. | Jun 1992 | A |
5126618 | Takahashi et al. | Jun 1992 | A |
D327872 | McMills et al. | Jul 1992 | S |
5152762 | McElhenney | Oct 1992 | A |
5156633 | Smith | Oct 1992 | A |
5160334 | Billings et al. | Nov 1992 | A |
5162044 | Gahn et al. | Nov 1992 | A |
5163421 | Bernstein et al. | Nov 1992 | A |
5163537 | Radev | Nov 1992 | A |
5163945 | Ortiz et al. | Nov 1992 | A |
5167619 | Wuchinich | Dec 1992 | A |
5167725 | Clark et al. | Dec 1992 | A |
5172344 | Ehrlich | Dec 1992 | A |
5174276 | Crockard | Dec 1992 | A |
D332660 | Rawson et al. | Jan 1993 | S |
5176677 | Wuchinich | Jan 1993 | A |
5176695 | Dulebohn | Jan 1993 | A |
5184605 | Grzeszykowski | Feb 1993 | A |
5188102 | Idemoto et al. | Feb 1993 | A |
D334173 | Liu et al. | Mar 1993 | S |
5190517 | Zieve et al. | Mar 1993 | A |
5190518 | Takasu | Mar 1993 | A |
5190541 | Abele et al. | Mar 1993 | A |
5196007 | Ellman et al. | Mar 1993 | A |
5203380 | Chikama | Apr 1993 | A |
5205459 | Brinkerhoff et al. | Apr 1993 | A |
5205817 | Idemoto et al. | Apr 1993 | A |
5209719 | Baruch et al. | May 1993 | A |
5213569 | Davis | May 1993 | A |
5214339 | Naito | May 1993 | A |
5217460 | Knopfler | Jun 1993 | A |
5218529 | Meyer et al. | Jun 1993 | A |
5221282 | Wuchinich | Jun 1993 | A |
5222937 | Kagawa | Jun 1993 | A |
5226909 | Evans et al. | Jul 1993 | A |
5226910 | Kajiyama et al. | Jul 1993 | A |
5231989 | Middleman et al. | Aug 1993 | A |
5234428 | Kaufman | Aug 1993 | A |
5241236 | Sasaki et al. | Aug 1993 | A |
5241968 | Slater | Sep 1993 | A |
5242339 | Thornton | Sep 1993 | A |
5242460 | Klein et al. | Sep 1993 | A |
5246003 | DeLonzor | Sep 1993 | A |
5254129 | Alexander | Oct 1993 | A |
5257988 | L'Esperance, Jr. | Nov 1993 | A |
5258004 | Bales et al. | Nov 1993 | A |
5258006 | Rydell et al. | Nov 1993 | A |
5261922 | Hood | Nov 1993 | A |
5263957 | Davison | Nov 1993 | A |
5264925 | Shipp et al. | Nov 1993 | A |
5269297 | Weng et al. | Dec 1993 | A |
5275166 | Vaitekunas et al. | Jan 1994 | A |
5275607 | Lo et al. | Jan 1994 | A |
5275609 | Pingleton et al. | Jan 1994 | A |
5282800 | Foshee et al. | Feb 1994 | A |
5282817 | Hoogeboom et al. | Feb 1994 | A |
5285795 | Ryan et al. | Feb 1994 | A |
5285945 | Brinkerhoff et al. | Feb 1994 | A |
5290286 | Parins | Mar 1994 | A |
5293863 | Zhu et al. | Mar 1994 | A |
5300068 | Rosar et al. | Apr 1994 | A |
5304115 | Pflueger et al. | Apr 1994 | A |
D347474 | Olson | May 1994 | S |
5307976 | Olson et al. | May 1994 | A |
5309927 | Welch | May 1994 | A |
5312023 | Green et al. | May 1994 | A |
5312425 | Evans et al. | May 1994 | A |
5318525 | West et al. | Jun 1994 | A |
5318563 | Malis et al. | Jun 1994 | A |
5318564 | Eggers | Jun 1994 | A |
5318570 | Hood et al. | Jun 1994 | A |
5318589 | Lichtman | Jun 1994 | A |
5322055 | Davison et al. | Jun 1994 | A |
5324299 | Davison et al. | Jun 1994 | A |
5326013 | Green et al. | Jul 1994 | A |
5326342 | Pflueger et al. | Jul 1994 | A |
5330471 | Eggers | Jul 1994 | A |
5330502 | Hassler et al. | Jul 1994 | A |
5334183 | Wuchinich | Aug 1994 | A |
5339723 | Huitema | Aug 1994 | A |
5342356 | Ellman et al. | Aug 1994 | A |
5342359 | Rydell | Aug 1994 | A |
5344420 | Hilal et al. | Sep 1994 | A |
5345937 | Middleman et al. | Sep 1994 | A |
5346502 | Estabrook et al. | Sep 1994 | A |
5353474 | Good et al. | Oct 1994 | A |
5357164 | Imabayashi et al. | Oct 1994 | A |
5357423 | Weaver et al. | Oct 1994 | A |
5359994 | Krauter et al. | Nov 1994 | A |
5361583 | Huitema | Nov 1994 | A |
5366466 | Christian et al. | Nov 1994 | A |
5368557 | Nita et al. | Nov 1994 | A |
5370645 | Klicek et al. | Dec 1994 | A |
5371429 | Manna | Dec 1994 | A |
5374813 | Shipp | Dec 1994 | A |
D354564 | Medema | Jan 1995 | S |
5381067 | Greenstein et al. | Jan 1995 | A |
5383874 | Jackson et al. | Jan 1995 | A |
5383917 | Desai et al. | Jan 1995 | A |
5387207 | Dyer et al. | Feb 1995 | A |
5387215 | Fisher | Feb 1995 | A |
5389098 | Tsuruta et al. | Feb 1995 | A |
5394187 | Shipp | Feb 1995 | A |
5395033 | Byrne et al. | Mar 1995 | A |
5395312 | Desai | Mar 1995 | A |
5395363 | Billings et al. | Mar 1995 | A |
5395364 | Anderhub et al. | Mar 1995 | A |
5396266 | Brimhall | Mar 1995 | A |
5396900 | Slater et al. | Mar 1995 | A |
5400267 | Denen et al. | Mar 1995 | A |
5403312 | Yates et al. | Apr 1995 | A |
5403334 | Evans et al. | Apr 1995 | A |
5406503 | Williams, Jr. et al. | Apr 1995 | A |
5408268 | Shipp | Apr 1995 | A |
D358887 | Feinberg | May 1995 | S |
5411481 | Allen et al. | May 1995 | A |
5417709 | Slater | May 1995 | A |
5419761 | Narayanan et al. | May 1995 | A |
5421829 | Olichney et al. | Jun 1995 | A |
5423844 | Miller | Jun 1995 | A |
5428504 | Bhatla | Jun 1995 | A |
5429131 | Scheinman et al. | Jul 1995 | A |
5438997 | Sieben et al. | Aug 1995 | A |
5441499 | Fritzsch | Aug 1995 | A |
5443463 | Stern et al. | Aug 1995 | A |
5445638 | Rydell et al. | Aug 1995 | A |
5445639 | Kuslich et al. | Aug 1995 | A |
5447509 | Mills et al. | Sep 1995 | A |
5449370 | Vaitekunas | Sep 1995 | A |
5451053 | Garrido | Sep 1995 | A |
5451161 | Sharp | Sep 1995 | A |
5451220 | Ciervo | Sep 1995 | A |
5451227 | Michaelson | Sep 1995 | A |
5456684 | Schmidt et al. | Oct 1995 | A |
5458598 | Feinberg et al. | Oct 1995 | A |
5462604 | Shibano et al. | Oct 1995 | A |
5465895 | Knodel et al. | Nov 1995 | A |
5471988 | Fujio et al. | Dec 1995 | A |
5472443 | Cordis et al. | Dec 1995 | A |
5476479 | Green et al. | Dec 1995 | A |
5478003 | Green et al. | Dec 1995 | A |
5480409 | Riza | Jan 1996 | A |
5483501 | Park et al. | Jan 1996 | A |
5484436 | Eggers et al. | Jan 1996 | A |
5486162 | Brumbach | Jan 1996 | A |
5486189 | Mudry et al. | Jan 1996 | A |
5490860 | Middle et al. | Feb 1996 | A |
5496317 | Goble et al. | Mar 1996 | A |
5499992 | Meade et al. | Mar 1996 | A |
5500216 | Julian et al. | Mar 1996 | A |
5501654 | Failla et al. | Mar 1996 | A |
5504650 | Katsui et al. | Apr 1996 | A |
5505693 | Mackool | Apr 1996 | A |
5507297 | Slater et al. | Apr 1996 | A |
5507738 | Ciervo | Apr 1996 | A |
5509922 | Aranyi et al. | Apr 1996 | A |
5511556 | DeSantis | Apr 1996 | A |
5520704 | Castro et al. | May 1996 | A |
5522832 | Kugo et al. | Jun 1996 | A |
5522839 | Pilling | Jun 1996 | A |
5527331 | Kresch et al. | Jun 1996 | A |
5531744 | Nardella et al. | Jul 1996 | A |
5536267 | Edwards et al. | Jul 1996 | A |
5540681 | Strul et al. | Jul 1996 | A |
5540684 | Hassler, Jr. | Jul 1996 | A |
5540693 | Fisher | Jul 1996 | A |
5542916 | Hirsch et al. | Aug 1996 | A |
5548286 | Craven | Aug 1996 | A |
5549637 | Crainich | Aug 1996 | A |
5553675 | Pitzen et al. | Sep 1996 | A |
5558671 | Yates | Sep 1996 | A |
5562609 | Brumbach | Oct 1996 | A |
5562610 | Brumbach | Oct 1996 | A |
5562659 | Morris | Oct 1996 | A |
5562703 | Desai | Oct 1996 | A |
5563179 | Stone et al. | Oct 1996 | A |
5569164 | Lurz | Oct 1996 | A |
5571121 | Heifetz | Nov 1996 | A |
5573424 | Poppe | Nov 1996 | A |
5573533 | Strul | Nov 1996 | A |
5573534 | Stone | Nov 1996 | A |
5577654 | Bishop | Nov 1996 | A |
5584830 | Ladd et al. | Dec 1996 | A |
5591187 | Dekel | Jan 1997 | A |
5593414 | Shipp et al. | Jan 1997 | A |
5599350 | Schulze et al. | Feb 1997 | A |
5600526 | Russell et al. | Feb 1997 | A |
5601601 | Tal et al. | Feb 1997 | A |
5603773 | Campbell | Feb 1997 | A |
5607436 | Pratt et al. | Mar 1997 | A |
5607450 | Zvenyatsky et al. | Mar 1997 | A |
5609573 | Sandock | Mar 1997 | A |
5611813 | Lichtman | Mar 1997 | A |
5618304 | Hart et al. | Apr 1997 | A |
5618307 | Donlon et al. | Apr 1997 | A |
5618492 | Auten et al. | Apr 1997 | A |
5620447 | Smith et al. | Apr 1997 | A |
5624452 | Yates | Apr 1997 | A |
5626587 | Bishop et al. | May 1997 | A |
5626595 | Sklar et al. | May 1997 | A |
5626608 | Cuny et al. | May 1997 | A |
5628760 | Knopfler | May 1997 | A |
5630420 | Vaitekunas | May 1997 | A |
5632432 | Schulze et al. | May 1997 | A |
5632717 | Yoon | May 1997 | A |
5638827 | Palmer et al. | Jun 1997 | A |
5640741 | Yano | Jun 1997 | A |
D381077 | Hunt | Jul 1997 | S |
5647871 | Levine et al. | Jul 1997 | A |
5649937 | Bito et al. | Jul 1997 | A |
5649955 | Hashimoto et al. | Jul 1997 | A |
5651780 | Jackson et al. | Jul 1997 | A |
5653713 | Michelson | Aug 1997 | A |
5655100 | Ebrahim et al. | Aug 1997 | A |
5658281 | Heard | Aug 1997 | A |
5662662 | Bishop et al. | Sep 1997 | A |
5662667 | Knodel | Sep 1997 | A |
5665085 | Nardella | Sep 1997 | A |
5665100 | Yoon | Sep 1997 | A |
5669922 | Hood | Sep 1997 | A |
5674219 | Monson et al. | Oct 1997 | A |
5674220 | Fox et al. | Oct 1997 | A |
5674235 | Parisi | Oct 1997 | A |
5678568 | Uchikubo et al. | Oct 1997 | A |
5688270 | Yates et al. | Nov 1997 | A |
5690269 | Bolanos et al. | Nov 1997 | A |
5693042 | Boiarski et al. | Dec 1997 | A |
5693051 | Schulze et al. | Dec 1997 | A |
5694936 | Fujimoto et al. | Dec 1997 | A |
5695510 | Hood | Dec 1997 | A |
5700261 | Brinkerhoff | Dec 1997 | A |
5704534 | Huitema et al. | Jan 1998 | A |
5704791 | Gillio | Jan 1998 | A |
5707369 | Vaitekunas et al. | Jan 1998 | A |
5709680 | Yates et al. | Jan 1998 | A |
5711472 | Bryan | Jan 1998 | A |
5713896 | Nardella | Feb 1998 | A |
5715817 | Stevens-Wright et al. | Feb 1998 | A |
5716366 | Yates | Feb 1998 | A |
5717306 | Shipp | Feb 1998 | A |
5720742 | Zacharias | Feb 1998 | A |
5720744 | Eggleston et al. | Feb 1998 | A |
5722980 | Schulz et al. | Mar 1998 | A |
5723970 | Bell | Mar 1998 | A |
5728130 | Ishikawa et al. | Mar 1998 | A |
5730752 | Alden et al. | Mar 1998 | A |
5733074 | Stock et al. | Mar 1998 | A |
5735848 | Yates et al. | Apr 1998 | A |
5741226 | Strukel et al. | Apr 1998 | A |
5743906 | Parins et al. | Apr 1998 | A |
5752973 | Kieturakis | May 1998 | A |
5755717 | Yates et al. | May 1998 | A |
5759183 | VanDusseldorp | Jun 1998 | A |
5762255 | Chrisman et al. | Jun 1998 | A |
5766164 | Mueller et al. | Jun 1998 | A |
5772659 | Becker et al. | Jun 1998 | A |
5776130 | Buysse et al. | Jul 1998 | A |
5776155 | Beaupre et al. | Jul 1998 | A |
5779130 | Alesi et al. | Jul 1998 | A |
5779701 | McBrayer et al. | Jul 1998 | A |
5782834 | Lucey et al. | Jul 1998 | A |
5792135 | Madhani et al. | Aug 1998 | A |
5792138 | Shipp | Aug 1998 | A |
5792165 | Klieman et al. | Aug 1998 | A |
5796188 | Bays | Aug 1998 | A |
5797941 | Schulze et al. | Aug 1998 | A |
5797958 | Yoon | Aug 1998 | A |
5797959 | Castro et al. | Aug 1998 | A |
5800432 | Swanson | Sep 1998 | A |
5800448 | Banko | Sep 1998 | A |
5800449 | Wales | Sep 1998 | A |
5805140 | Rosenberg et al. | Sep 1998 | A |
5807393 | Williamson, IV et al. | Sep 1998 | A |
5808396 | Boukhny | Sep 1998 | A |
5810811 | Yates et al. | Sep 1998 | A |
5810828 | Lightman et al. | Sep 1998 | A |
5810859 | DiMatteo et al. | Sep 1998 | A |
5817033 | DeSantis et al. | Oct 1998 | A |
5817084 | Jensen | Oct 1998 | A |
5817093 | Williamson, IV et al. | Oct 1998 | A |
5817119 | Klieman et al. | Oct 1998 | A |
5823197 | Edwards | Oct 1998 | A |
5827271 | Buysse et al. | Oct 1998 | A |
5827323 | Klieman et al. | Oct 1998 | A |
5828160 | Sugishita | Oct 1998 | A |
5833696 | Whitfield et al. | Nov 1998 | A |
5836897 | Sakurai et al. | Nov 1998 | A |
5836909 | Cosmescu | Nov 1998 | A |
5836943 | Miller, III | Nov 1998 | A |
5836957 | Schulz et al. | Nov 1998 | A |
5836990 | Li | Nov 1998 | A |
5843109 | Mehta et al. | Dec 1998 | A |
5851212 | Zirps et al. | Dec 1998 | A |
5853412 | Mayenberger | Dec 1998 | A |
5854590 | Dalstein | Dec 1998 | A |
5858018 | Shipp et al. | Jan 1999 | A |
5865361 | Milliman et al. | Feb 1999 | A |
5873873 | Smith et al. | Feb 1999 | A |
5873882 | Straub et al. | Feb 1999 | A |
5876401 | Schulze et al. | Mar 1999 | A |
5878193 | Wang et al. | Mar 1999 | A |
5879364 | Bromfield et al. | Mar 1999 | A |
5880668 | Hall | Mar 1999 | A |
5883615 | Fago et al. | Mar 1999 | A |
5891142 | Eggers et al. | Apr 1999 | A |
5893835 | Witt et al. | Apr 1999 | A |
5897523 | Wright et al. | Apr 1999 | A |
5897569 | Kellogg et al. | Apr 1999 | A |
5903607 | Tailliet | May 1999 | A |
5904681 | West, Jr. | May 1999 | A |
5906625 | Bito et al. | May 1999 | A |
5906627 | Spaulding | May 1999 | A |
5906628 | Miyawaki et al. | May 1999 | A |
5910129 | Koblish et al. | Jun 1999 | A |
5911699 | Anis et al. | Jun 1999 | A |
5913823 | Hedberg et al. | Jun 1999 | A |
5916229 | Evans | Jun 1999 | A |
5921956 | Grinberg et al. | Jul 1999 | A |
5929846 | Rosenberg et al. | Jul 1999 | A |
5935143 | Hood | Aug 1999 | A |
5935144 | Estabrook | Aug 1999 | A |
5938633 | Beaupre | Aug 1999 | A |
5944718 | Austin et al. | Aug 1999 | A |
5944737 | Tsonton et al. | Aug 1999 | A |
5947984 | Whipple | Sep 1999 | A |
5954717 | Behl et al. | Sep 1999 | A |
5954736 | Bishop et al. | Sep 1999 | A |
5954746 | Holthaus et al. | Sep 1999 | A |
5957882 | Nita et al. | Sep 1999 | A |
5957943 | Vaitekunas | Sep 1999 | A |
5968007 | Simon et al. | Oct 1999 | A |
5968060 | Kellogg | Oct 1999 | A |
5974342 | Petrofsky | Oct 1999 | A |
D416089 | Barton et al. | Nov 1999 | S |
5980510 | Tsonton et al. | Nov 1999 | A |
5980546 | Hood | Nov 1999 | A |
5984938 | Yoon | Nov 1999 | A |
5987344 | West | Nov 1999 | A |
5989274 | Davison et al. | Nov 1999 | A |
5989275 | Estabrook et al. | Nov 1999 | A |
5993465 | Shipp et al. | Nov 1999 | A |
5993972 | Reich et al. | Nov 1999 | A |
5994855 | Lundell et al. | Nov 1999 | A |
6003517 | Sheffield et al. | Dec 1999 | A |
6004335 | Vaitekunas et al. | Dec 1999 | A |
6011416 | Mizuno et al. | Jan 2000 | A |
6013052 | Durman et al. | Jan 2000 | A |
6024741 | Williamson, IV et al. | Feb 2000 | A |
6024744 | Kese et al. | Feb 2000 | A |
6024750 | Mastri et al. | Feb 2000 | A |
6027515 | Cimino | Feb 2000 | A |
6031526 | Shipp | Feb 2000 | A |
6033375 | Brumbach | Mar 2000 | A |
6033399 | Gines | Mar 2000 | A |
6036667 | Manna et al. | Mar 2000 | A |
6036707 | Spaulding | Mar 2000 | A |
6039734 | Goble | Mar 2000 | A |
6048224 | Kay | Apr 2000 | A |
6050943 | Slayton et al. | Apr 2000 | A |
6050996 | Schmaltz et al. | Apr 2000 | A |
6051010 | DiMatteo et al. | Apr 2000 | A |
6056735 | Okada et al. | May 2000 | A |
6063098 | Houser et al. | May 2000 | A |
6066132 | Chen et al. | May 2000 | A |
6066151 | Miyawaki et al. | May 2000 | A |
6068627 | Orszulak et al. | May 2000 | A |
6068629 | Haissaguerre et al. | May 2000 | A |
6068647 | Witt et al. | May 2000 | A |
6074389 | Levine et al. | Jun 2000 | A |
6077285 | Boukhny | Jun 2000 | A |
6080149 | Huang et al. | Jun 2000 | A |
6083191 | Rose | Jul 2000 | A |
6086584 | Miller | Jul 2000 | A |
6090120 | Wright et al. | Jul 2000 | A |
6091995 | Ingle et al. | Jul 2000 | A |
6096033 | Tu et al. | Aug 2000 | A |
6099483 | Palmer et al. | Aug 2000 | A |
6099542 | Cohn et al. | Aug 2000 | A |
6099550 | Yoon | Aug 2000 | A |
6102909 | Chen et al. | Aug 2000 | A |
6109500 | Alli et al. | Aug 2000 | A |
6110127 | Suzuki | Aug 2000 | A |
6113594 | Savage | Sep 2000 | A |
6113598 | Baker | Sep 2000 | A |
6117152 | Huitema | Sep 2000 | A |
H1904 | Yates et al. | Oct 2000 | H |
6126629 | Perkins | Oct 2000 | A |
6126658 | Baker | Oct 2000 | A |
6129735 | Okada et al. | Oct 2000 | A |
6129740 | Michelson | Oct 2000 | A |
6132368 | Cooper | Oct 2000 | A |
6132427 | Jones et al. | Oct 2000 | A |
6132429 | Baker | Oct 2000 | A |
6132448 | Perez et al. | Oct 2000 | A |
6139320 | Hahn | Oct 2000 | A |
6139561 | Shibata et al. | Oct 2000 | A |
6142615 | Qiu et al. | Nov 2000 | A |
6142994 | Swanson et al. | Nov 2000 | A |
6144402 | Norsworthy et al. | Nov 2000 | A |
6147560 | Erhage et al. | Nov 2000 | A |
6152902 | Christian et al. | Nov 2000 | A |
6152923 | Ryan | Nov 2000 | A |
6154198 | Rosenberg | Nov 2000 | A |
6156029 | Mueller | Dec 2000 | A |
6159160 | Hsei et al. | Dec 2000 | A |
6159175 | Strukel et al. | Dec 2000 | A |
6162194 | Shipp | Dec 2000 | A |
6162208 | Hipps | Dec 2000 | A |
6165150 | Banko | Dec 2000 | A |
6174309 | Wrublewski et al. | Jan 2001 | B1 |
6174310 | Kirwan, Jr. | Jan 2001 | B1 |
6176857 | Ashley | Jan 2001 | B1 |
6179853 | Sachse et al. | Jan 2001 | B1 |
6183426 | Akisada et al. | Feb 2001 | B1 |
6187003 | Buysse et al. | Feb 2001 | B1 |
6190386 | Rydell | Feb 2001 | B1 |
6193709 | Miyawaki et al. | Feb 2001 | B1 |
6204592 | Hur | Mar 2001 | B1 |
6205383 | Hermann | Mar 2001 | B1 |
6205855 | Pfeiffer | Mar 2001 | B1 |
6206844 | Reichel et al. | Mar 2001 | B1 |
6206876 | Levine et al. | Mar 2001 | B1 |
6210337 | Dunham et al. | Apr 2001 | B1 |
6210402 | Olsen et al. | Apr 2001 | B1 |
6210403 | Klicek | Apr 2001 | B1 |
6214023 | Whipple et al. | Apr 2001 | B1 |
6228080 | Gines | May 2001 | B1 |
6231565 | Tovey et al. | May 2001 | B1 |
6232899 | Craven | May 2001 | B1 |
6233476 | Strommer et al. | May 2001 | B1 |
6238366 | Savage et al. | May 2001 | B1 |
6238384 | Peer | May 2001 | B1 |
6241724 | Fleischman et al. | Jun 2001 | B1 |
6245065 | Panescu et al. | Jun 2001 | B1 |
6251110 | Wampler | Jun 2001 | B1 |
6252110 | Uemura et al. | Jun 2001 | B1 |
D444365 | Bass et al. | Jul 2001 | S |
D445092 | Lee | Jul 2001 | S |
D445764 | Lee | Jul 2001 | S |
6254623 | Haibel, Jr. et al. | Jul 2001 | B1 |
6257241 | Wampler | Jul 2001 | B1 |
6258034 | Hanafy | Jul 2001 | B1 |
6259230 | Chou | Jul 2001 | B1 |
6261286 | Goble et al. | Jul 2001 | B1 |
6267761 | Ryan | Jul 2001 | B1 |
6270831 | Kumar et al. | Aug 2001 | B2 |
6273852 | Lehe et al. | Aug 2001 | B1 |
6274963 | Estabrook et al. | Aug 2001 | B1 |
6277115 | Saadat | Aug 2001 | B1 |
6277117 | Tetzlaff et al. | Aug 2001 | B1 |
6278218 | Madan et al. | Aug 2001 | B1 |
6280407 | Manna et al. | Aug 2001 | B1 |
6283981 | Beaupre | Sep 2001 | B1 |
6287344 | Wampler et al. | Sep 2001 | B1 |
6290575 | Shipp | Sep 2001 | B1 |
6292700 | Morrison et al. | Sep 2001 | B1 |
6299591 | Banko | Oct 2001 | B1 |
6306131 | Hareyama et al. | Oct 2001 | B1 |
6306157 | Shchervinsky | Oct 2001 | B1 |
6309400 | Beaupre | Oct 2001 | B2 |
6311783 | Harpell | Nov 2001 | B1 |
6319221 | Savage et al. | Nov 2001 | B1 |
6325795 | Lindemann et al. | Dec 2001 | B1 |
6325799 | Goble | Dec 2001 | B1 |
6325811 | Messerly | Dec 2001 | B1 |
6328751 | Beaupre | Dec 2001 | B1 |
6332891 | Himes | Dec 2001 | B1 |
6338657 | Harper et al. | Jan 2002 | B1 |
6340352 | Okada et al. | Jan 2002 | B1 |
6340878 | Oglesbee | Jan 2002 | B1 |
6350269 | Shipp et al. | Feb 2002 | B1 |
6352532 | Kramer et al. | Mar 2002 | B1 |
6356224 | Wohlfarth | Mar 2002 | B1 |
6358246 | Behl et al. | Mar 2002 | B1 |
6358264 | Banko | Mar 2002 | B2 |
6364888 | Niemeyer et al. | Apr 2002 | B1 |
6379320 | Lafon et al. | Apr 2002 | B1 |
D457958 | Dycus et al. | May 2002 | S |
6383194 | Pothula | May 2002 | B1 |
6384690 | Wilhelmsson et al. | May 2002 | B1 |
6387094 | Eitenmuller | May 2002 | B1 |
6387109 | Davison et al. | May 2002 | B1 |
6388657 | Natoli | May 2002 | B1 |
6390973 | Ouchi | May 2002 | B1 |
6391026 | Hung et al. | May 2002 | B1 |
6391042 | Cimino | May 2002 | B1 |
6398779 | Buysse et al. | Jun 2002 | B1 |
6402743 | Orszulak et al. | Jun 2002 | B1 |
6402748 | Schoenman et al. | Jun 2002 | B1 |
6405184 | Bohme et al. | Jun 2002 | B1 |
6405733 | Fogarty et al. | Jun 2002 | B1 |
6409722 | Hoey et al. | Jun 2002 | B1 |
H2037 | Yates et al. | Jul 2002 | H |
6416469 | Phung et al. | Jul 2002 | B1 |
6416486 | Wampler | Jul 2002 | B1 |
6417969 | DeLuca et al. | Jul 2002 | B1 |
6419675 | Gallo, Sr. | Jul 2002 | B1 |
6423073 | Bowman | Jul 2002 | B2 |
6423082 | Houser et al. | Jul 2002 | B1 |
6425906 | Young et al. | Jul 2002 | B1 |
6428538 | Blewett et al. | Aug 2002 | B1 |
6428539 | Baxter et al. | Aug 2002 | B1 |
6430446 | Knowlton | Aug 2002 | B1 |
6432118 | Messerly | Aug 2002 | B1 |
6436114 | Novak et al. | Aug 2002 | B1 |
6436115 | Beaupre | Aug 2002 | B1 |
6436129 | Sharkey et al. | Aug 2002 | B1 |
6440062 | Ouchi | Aug 2002 | B1 |
6443968 | Holthaus et al. | Sep 2002 | B1 |
6443969 | Novak et al. | Sep 2002 | B1 |
6449006 | Shipp | Sep 2002 | B1 |
6454781 | Witt et al. | Sep 2002 | B1 |
6454782 | Schwemberger | Sep 2002 | B1 |
6458128 | Schulze | Oct 2002 | B1 |
6458130 | Frazier et al. | Oct 2002 | B1 |
6458142 | Faller et al. | Oct 2002 | B1 |
6459363 | Walker et al. | Oct 2002 | B1 |
6461363 | Gadberry et al. | Oct 2002 | B1 |
6464689 | Qin et al. | Oct 2002 | B1 |
6464702 | Schulze et al. | Oct 2002 | B2 |
6468270 | Hovda et al. | Oct 2002 | B1 |
6475211 | Chess et al. | Nov 2002 | B2 |
6475215 | Tanrisever | Nov 2002 | B1 |
6480796 | Wiener | Nov 2002 | B2 |
6485490 | Wampler et al. | Nov 2002 | B2 |
6491690 | Goble et al. | Dec 2002 | B1 |
6491701 | Tierney et al. | Dec 2002 | B2 |
6491708 | Madan et al. | Dec 2002 | B2 |
6497715 | Satou | Dec 2002 | B2 |
6500112 | Khouri | Dec 2002 | B1 |
6500176 | Truckai et al. | Dec 2002 | B1 |
6500188 | Harper et al. | Dec 2002 | B2 |
6500312 | Wedekamp | Dec 2002 | B2 |
6503248 | Levine | Jan 2003 | B1 |
6506208 | Hunt et al. | Jan 2003 | B2 |
6511478 | Burnside et al. | Jan 2003 | B1 |
6511480 | Tetzlaff et al. | Jan 2003 | B1 |
6511493 | Moutafis et al. | Jan 2003 | B1 |
6514252 | Nezhat et al. | Feb 2003 | B2 |
6514267 | Jewett | Feb 2003 | B2 |
6517565 | Whitman et al. | Feb 2003 | B1 |
6524251 | Rabiner et al. | Feb 2003 | B2 |
6524316 | Nicholson et al. | Feb 2003 | B1 |
6527736 | Attinger et al. | Mar 2003 | B1 |
6531846 | Smith | Mar 2003 | B1 |
6533784 | Truckai et al. | Mar 2003 | B2 |
6537272 | Christopherson et al. | Mar 2003 | B2 |
6537291 | Friedman et al. | Mar 2003 | B2 |
6543452 | Lavigne | Apr 2003 | B1 |
6543456 | Freeman | Apr 2003 | B1 |
6544260 | Markel et al. | Apr 2003 | B1 |
6551309 | LePivert | Apr 2003 | B1 |
6554829 | Schulze et al. | Apr 2003 | B2 |
6558376 | Bishop | May 2003 | B2 |
6558380 | Lingenfelder et al. | May 2003 | B2 |
6561983 | Cronin et al. | May 2003 | B2 |
6562035 | Levin | May 2003 | B1 |
6562037 | Paton et al. | May 2003 | B2 |
6565558 | Lindenmeier et al. | May 2003 | B1 |
6572563 | Ouchi | Jun 2003 | B2 |
6572632 | Zisterer et al. | Jun 2003 | B2 |
6572639 | Ingle et al. | Jun 2003 | B1 |
6575969 | Rittman, III et al. | Jun 2003 | B1 |
6582427 | Goble et al. | Jun 2003 | B1 |
6582451 | Marucci et al. | Jun 2003 | B1 |
6584360 | Francischelli et al. | Jun 2003 | B2 |
D477408 | Bromley | Jul 2003 | S |
6585735 | Frazier et al. | Jul 2003 | B1 |
6588277 | Giordano et al. | Jul 2003 | B2 |
6589200 | Schwemberger et al. | Jul 2003 | B1 |
6589239 | Khandkar et al. | Jul 2003 | B2 |
6590733 | Wilson et al. | Jul 2003 | B1 |
6599288 | Maguire et al. | Jul 2003 | B2 |
6602252 | Mollenauer | Aug 2003 | B2 |
6602262 | Griego et al. | Aug 2003 | B2 |
6607540 | Shipp | Aug 2003 | B1 |
6610059 | West, Jr. | Aug 2003 | B1 |
6610060 | Mulier et al. | Aug 2003 | B2 |
6611793 | Burnside et al. | Aug 2003 | B1 |
6616450 | Mossle et al. | Sep 2003 | B2 |
6619529 | Green et al. | Sep 2003 | B2 |
6620161 | Schulze et al. | Sep 2003 | B2 |
6622731 | Daniel et al. | Sep 2003 | B2 |
6623482 | Pendekanti et al. | Sep 2003 | B2 |
6623500 | Cook et al. | Sep 2003 | B1 |
6623501 | Heller et al. | Sep 2003 | B2 |
6626848 | Neuenfeldt | Sep 2003 | B2 |
6626926 | Friedman et al. | Sep 2003 | B2 |
6629974 | Penny et al. | Oct 2003 | B2 |
6632221 | Edwards et al. | Oct 2003 | B1 |
6633234 | Wiener et al. | Oct 2003 | B2 |
6635057 | Harano et al. | Oct 2003 | B2 |
6644532 | Green et al. | Nov 2003 | B2 |
6651669 | Burnside | Nov 2003 | B1 |
6652513 | Panescu et al. | Nov 2003 | B2 |
6652539 | Shipp et al. | Nov 2003 | B2 |
6652545 | Shipp et al. | Nov 2003 | B2 |
6656132 | Ouchi | Dec 2003 | B1 |
6656177 | Truckai et al. | Dec 2003 | B2 |
6656198 | Tsonton et al. | Dec 2003 | B2 |
6660017 | Beaupre | Dec 2003 | B2 |
6662127 | Wiener et al. | Dec 2003 | B2 |
6663941 | Brown et al. | Dec 2003 | B2 |
6666860 | Takahashi | Dec 2003 | B1 |
6666875 | Sakurai et al. | Dec 2003 | B1 |
6669690 | Okada et al. | Dec 2003 | B1 |
6669710 | Moutafis et al. | Dec 2003 | B2 |
6673248 | Chowdhury | Jan 2004 | B2 |
6676660 | Wampler et al. | Jan 2004 | B2 |
6678621 | Wiener et al. | Jan 2004 | B2 |
6679875 | Honda et al. | Jan 2004 | B2 |
6679882 | Kornerup | Jan 2004 | B1 |
6679899 | Wiener et al. | Jan 2004 | B2 |
6682501 | Nelson et al. | Jan 2004 | B1 |
6682544 | Mastri et al. | Jan 2004 | B2 |
6685700 | Behl et al. | Feb 2004 | B2 |
6685701 | Orszulak et al. | Feb 2004 | B2 |
6685703 | Pearson et al. | Feb 2004 | B2 |
6689145 | Lee et al. | Feb 2004 | B2 |
6689146 | Himes | Feb 2004 | B1 |
6690960 | Chen et al. | Feb 2004 | B2 |
6695840 | Schulze | Feb 2004 | B2 |
6702821 | Bonutti | Mar 2004 | B2 |
6716215 | David et al. | Apr 2004 | B1 |
6719692 | Kleffner et al. | Apr 2004 | B2 |
6719765 | Bonutti | Apr 2004 | B2 |
6719776 | Baxter et al. | Apr 2004 | B2 |
6722552 | Fenton, Jr. | Apr 2004 | B2 |
6723091 | Goble et al. | Apr 2004 | B2 |
D490059 | Conway et al. | May 2004 | S |
6730080 | Harano et al. | May 2004 | B2 |
6731047 | Kauf et al. | May 2004 | B2 |
6733498 | Paton et al. | May 2004 | B2 |
6733506 | McDevitt et al. | May 2004 | B1 |
6736813 | Yamauchi et al. | May 2004 | B2 |
6739872 | Turri | May 2004 | B1 |
6740079 | Eggers et al. | May 2004 | B1 |
D491666 | Kimmell et al. | Jun 2004 | S |
6743245 | Lobdell | Jun 2004 | B2 |
6746284 | Spink, Jr. | Jun 2004 | B1 |
6746443 | Morley et al. | Jun 2004 | B1 |
6752815 | Beaupre | Jun 2004 | B2 |
6755825 | Shoenman et al. | Jun 2004 | B2 |
6761698 | Shibata et al. | Jul 2004 | B2 |
6762535 | Take et al. | Jul 2004 | B2 |
6766202 | Underwood et al. | Jul 2004 | B2 |
6770072 | Truckai et al. | Aug 2004 | B1 |
6773409 | Truckai et al. | Aug 2004 | B2 |
6773434 | Ciarrocca | Aug 2004 | B2 |
6773435 | Schulze et al. | Aug 2004 | B2 |
6773443 | Truwit et al. | Aug 2004 | B2 |
6773444 | Messerly | Aug 2004 | B2 |
6775575 | Bommannan et al. | Aug 2004 | B2 |
6778023 | Christensen | Aug 2004 | B2 |
6783524 | Anderson et al. | Aug 2004 | B2 |
6786382 | Hoffman | Sep 2004 | B1 |
6786383 | Stegelmann | Sep 2004 | B2 |
6789939 | Schrodinger et al. | Sep 2004 | B2 |
6790173 | Saadat et al. | Sep 2004 | B2 |
6790216 | Ishikawa | Sep 2004 | B1 |
6794027 | Araki et al. | Sep 2004 | B1 |
6796981 | Wham et al. | Sep 2004 | B2 |
D496997 | Dycus et al. | Oct 2004 | S |
6800085 | Selmon et al. | Oct 2004 | B2 |
6802843 | Truckai et al. | Oct 2004 | B2 |
6808525 | Latterell et al. | Oct 2004 | B2 |
6809508 | Donofrio | Oct 2004 | B2 |
6810281 | Brock et al. | Oct 2004 | B2 |
6811842 | Ehrnsperger et al. | Nov 2004 | B1 |
6814731 | Swanson | Nov 2004 | B2 |
6819027 | Saraf | Nov 2004 | B2 |
6821273 | Mollenauer | Nov 2004 | B2 |
6827712 | Tovey et al. | Dec 2004 | B2 |
6828712 | Battaglin et al. | Dec 2004 | B2 |
6835082 | Gonnering | Dec 2004 | B2 |
6835199 | McGuckin, Jr. et al. | Dec 2004 | B2 |
6840938 | Morley et al. | Jan 2005 | B1 |
6843789 | Goble | Jan 2005 | B2 |
6849073 | Hoey et al. | Feb 2005 | B2 |
6860878 | Brock | Mar 2005 | B2 |
6860880 | Treat et al. | Mar 2005 | B2 |
6863676 | Lee et al. | Mar 2005 | B2 |
6866671 | Tierney et al. | Mar 2005 | B2 |
6869439 | White et al. | Mar 2005 | B2 |
6875220 | Du et al. | Apr 2005 | B2 |
6877647 | Green et al. | Apr 2005 | B2 |
6882439 | Ishijima | Apr 2005 | B2 |
6887209 | Kadziauskas et al. | May 2005 | B2 |
6887252 | Okada et al. | May 2005 | B1 |
6893435 | Goble | May 2005 | B2 |
6898536 | Wiener et al. | May 2005 | B2 |
6899685 | Kermode et al. | May 2005 | B2 |
6905497 | Truckai et al. | Jun 2005 | B2 |
6908463 | Treat et al. | Jun 2005 | B2 |
6908472 | Wiener et al. | Jun 2005 | B2 |
6913579 | Truckai et al. | Jul 2005 | B2 |
6915623 | Dey et al. | Jul 2005 | B2 |
6923804 | Eggers et al. | Aug 2005 | B2 |
6923806 | Hooven et al. | Aug 2005 | B2 |
6926712 | Phan | Aug 2005 | B2 |
6926716 | Baker et al. | Aug 2005 | B2 |
6926717 | Garito et al. | Aug 2005 | B1 |
6929602 | Hirakui et al. | Aug 2005 | B2 |
6929622 | Chian | Aug 2005 | B2 |
6929632 | Nita et al. | Aug 2005 | B2 |
6929644 | Truckai et al. | Aug 2005 | B2 |
6933656 | Matsushita et al. | Aug 2005 | B2 |
D509589 | Wells | Sep 2005 | S |
6942660 | Pantera et al. | Sep 2005 | B2 |
6942677 | Nita et al. | Sep 2005 | B2 |
6945981 | Donofrio et al. | Sep 2005 | B2 |
6946779 | Birgel | Sep 2005 | B2 |
6948503 | Refior et al. | Sep 2005 | B2 |
6953461 | McClurken et al. | Oct 2005 | B2 |
6958070 | Witt et al. | Oct 2005 | B2 |
D511145 | Donofrio et al. | Nov 2005 | S |
6974450 | Weber et al. | Dec 2005 | B2 |
6976844 | Hickok et al. | Dec 2005 | B2 |
6976969 | Messerly | Dec 2005 | B2 |
6977495 | Donofrio | Dec 2005 | B2 |
6979332 | Adams | Dec 2005 | B2 |
6981628 | Wales | Jan 2006 | B2 |
6984220 | Wuchinich | Jan 2006 | B2 |
6984231 | Goble et al. | Jan 2006 | B2 |
6988295 | Tillim | Jan 2006 | B2 |
6988649 | Shelton, IV et al. | Jan 2006 | B2 |
6994708 | Manzo | Feb 2006 | B2 |
6994709 | Iida | Feb 2006 | B2 |
7000818 | Shelton, IV et al. | Feb 2006 | B2 |
7001335 | Adachi et al. | Feb 2006 | B2 |
7001379 | Behl et al. | Feb 2006 | B2 |
7001382 | Gallo, Sr. | Feb 2006 | B2 |
7004951 | Gibbens, III | Feb 2006 | B2 |
7011657 | Truckai et al. | Mar 2006 | B2 |
7014638 | Michelson | Mar 2006 | B2 |
7018389 | Camerlengo | Mar 2006 | B2 |
7025732 | Thompson et al. | Apr 2006 | B2 |
7033356 | Latterell et al. | Apr 2006 | B2 |
7033357 | Baxter et al. | Apr 2006 | B2 |
7037306 | Podany et al. | May 2006 | B2 |
7041083 | Chu et al. | May 2006 | B2 |
7041088 | Nawrocki et al. | May 2006 | B2 |
7041102 | Truckai et al. | May 2006 | B2 |
7044949 | Orszulak et al. | May 2006 | B2 |
7052494 | Goble et al. | May 2006 | B2 |
7052496 | Yamauchi | May 2006 | B2 |
7055731 | Shelton, IV et al. | Jun 2006 | B2 |
7063699 | Hess et al. | Jun 2006 | B2 |
7066893 | Hibner et al. | Jun 2006 | B2 |
7066895 | Podany | Jun 2006 | B2 |
7066936 | Ryan | Jun 2006 | B2 |
7070597 | Truckai et al. | Jul 2006 | B2 |
7074218 | Washington et al. | Jul 2006 | B2 |
7074219 | Levine et al. | Jul 2006 | B2 |
7077039 | Gass et al. | Jul 2006 | B2 |
7077845 | Hacker et al. | Jul 2006 | B2 |
7077853 | Kramer et al. | Jul 2006 | B2 |
7083075 | Swayze et al. | Aug 2006 | B2 |
7083613 | Treat | Aug 2006 | B2 |
7083618 | Couture et al. | Aug 2006 | B2 |
7083619 | Truckai et al. | Aug 2006 | B2 |
7087054 | Truckai et al. | Aug 2006 | B2 |
7090637 | Danitz et al. | Aug 2006 | B2 |
7090672 | Underwood et al. | Aug 2006 | B2 |
7094235 | Francischelli | Aug 2006 | B2 |
7101371 | Dycus et al. | Sep 2006 | B2 |
7101372 | Dycus et al. | Sep 2006 | B2 |
7101373 | Dycus et al. | Sep 2006 | B2 |
7101378 | Salameh et al. | Sep 2006 | B2 |
7104834 | Robinson et al. | Sep 2006 | B2 |
7108695 | Witt et al. | Sep 2006 | B2 |
7111769 | Wales et al. | Sep 2006 | B2 |
7112201 | Truckai et al. | Sep 2006 | B2 |
7113831 | Hooven | Sep 2006 | B2 |
D531311 | Guerra et al. | Oct 2006 | S |
7117034 | Kronberg | Oct 2006 | B2 |
7118564 | Ritchie et al. | Oct 2006 | B2 |
7118570 | Tetzlaff et al. | Oct 2006 | B2 |
7118587 | Dycus et al. | Oct 2006 | B2 |
7119516 | Denning | Oct 2006 | B2 |
7124932 | Isaacson et al. | Oct 2006 | B2 |
7125409 | Truckai et al. | Oct 2006 | B2 |
7128720 | Podany | Oct 2006 | B2 |
7131860 | Sartor et al. | Nov 2006 | B2 |
7131970 | Moses et al. | Nov 2006 | B2 |
7135018 | Ryan et al. | Nov 2006 | B2 |
7135030 | Schwemberger et al. | Nov 2006 | B2 |
7137980 | Buysse et al. | Nov 2006 | B2 |
7143925 | Shelton, IV et al. | Dec 2006 | B2 |
7144403 | Booth | Dec 2006 | B2 |
7147138 | Shelton, IV | Dec 2006 | B2 |
7153315 | Miller | Dec 2006 | B2 |
D536093 | Nakajima et al. | Jan 2007 | S |
7156189 | Bar-Cohen et al. | Jan 2007 | B1 |
7156846 | Dycus et al. | Jan 2007 | B2 |
7156853 | Muratsu | Jan 2007 | B2 |
7157058 | Marhasin et al. | Jan 2007 | B2 |
7159750 | Racenet et al. | Jan 2007 | B2 |
7160259 | Tardy et al. | Jan 2007 | B2 |
7160296 | Pearson et al. | Jan 2007 | B2 |
7160298 | Lawes et al. | Jan 2007 | B2 |
7160299 | Baily | Jan 2007 | B2 |
7163548 | Stulen et al. | Jan 2007 | B2 |
7166103 | Carmel et al. | Jan 2007 | B2 |
7169144 | Hoey et al. | Jan 2007 | B2 |
7169146 | Truckai et al. | Jan 2007 | B2 |
7169156 | Hart | Jan 2007 | B2 |
7179254 | Pendekanti et al. | Feb 2007 | B2 |
7179271 | Friedman et al. | Feb 2007 | B2 |
7186253 | Truckai et al. | Mar 2007 | B2 |
7189233 | Truckai et al. | Mar 2007 | B2 |
7195631 | Dumbauld | Mar 2007 | B2 |
D541418 | Schechter et al. | Apr 2007 | S |
7198635 | Danek et al. | Apr 2007 | B2 |
7204820 | Akahoshi | Apr 2007 | B2 |
7207471 | Heinrich et al. | Apr 2007 | B2 |
7207997 | Shipp et al. | Apr 2007 | B2 |
7208005 | Frecker et al. | Apr 2007 | B2 |
7210881 | Greenberg | May 2007 | B2 |
7211079 | Treat | May 2007 | B2 |
7217128 | Atkin et al. | May 2007 | B2 |
7217269 | El-Galley et al. | May 2007 | B2 |
7220951 | Truckai et al. | May 2007 | B2 |
7223229 | Inman et al. | May 2007 | B2 |
7225964 | Mastri et al. | Jun 2007 | B2 |
7226447 | Uchida et al. | Jun 2007 | B2 |
7226448 | Bertolero et al. | Jun 2007 | B2 |
7229455 | Sakurai et al. | Jun 2007 | B2 |
7232440 | Dumbauld et al. | Jun 2007 | B2 |
7235071 | Gonnering | Jun 2007 | B2 |
7235073 | Levine et al. | Jun 2007 | B2 |
7241294 | Reschke | Jul 2007 | B2 |
7244262 | Wiener et al. | Jul 2007 | B2 |
7251531 | Mosher et al. | Jul 2007 | B2 |
7252641 | Thompson et al. | Aug 2007 | B2 |
7252667 | Moses et al. | Aug 2007 | B2 |
7258688 | Shah et al. | Aug 2007 | B1 |
7264618 | Murakami et al. | Sep 2007 | B2 |
7267677 | Johnson et al. | Sep 2007 | B2 |
7267685 | Butaric et al. | Sep 2007 | B2 |
7269873 | Brewer et al. | Sep 2007 | B2 |
7273483 | Wiener et al. | Sep 2007 | B2 |
D552241 | Bromley et al. | Oct 2007 | S |
7282048 | Goble et al. | Oct 2007 | B2 |
7285895 | Beaupre | Oct 2007 | B2 |
7287682 | Ezzat et al. | Oct 2007 | B1 |
7297149 | Vitali et al. | Nov 2007 | B2 |
7300431 | Dubrovsky | Nov 2007 | B2 |
7300435 | Wham et al. | Nov 2007 | B2 |
7300446 | Beaupre | Nov 2007 | B2 |
7300450 | Vleugels et al. | Nov 2007 | B2 |
7303531 | Lee et al. | Dec 2007 | B2 |
7303557 | Wham et al. | Dec 2007 | B2 |
7306597 | Manzo | Dec 2007 | B2 |
7307313 | Ohyanagi et al. | Dec 2007 | B2 |
7309849 | Truckai et al. | Dec 2007 | B2 |
7311706 | Schoenman et al. | Dec 2007 | B2 |
7311709 | Truckai et al. | Dec 2007 | B2 |
7317955 | McGreevy | Jan 2008 | B2 |
7318831 | Alvarez et al. | Jan 2008 | B2 |
7318832 | Young et al. | Jan 2008 | B2 |
7326236 | Andreas et al. | Feb 2008 | B2 |
7329257 | Kanehira et al. | Feb 2008 | B2 |
7331410 | Yong et al. | Feb 2008 | B2 |
7335165 | Truwit et al. | Feb 2008 | B2 |
7335997 | Wiener | Feb 2008 | B2 |
7337010 | Howard et al. | Feb 2008 | B2 |
7353068 | Tanaka et al. | Apr 2008 | B2 |
7354440 | Truckal et al. | Apr 2008 | B2 |
7357287 | Shelton, IV et al. | Apr 2008 | B2 |
7357802 | Palanker et al. | Apr 2008 | B2 |
7361172 | Cimino | Apr 2008 | B2 |
7364577 | Wham et al. | Apr 2008 | B2 |
7367976 | Lawes et al. | May 2008 | B2 |
7371227 | Zeiner | May 2008 | B2 |
RE40388 | Gines | Jun 2008 | E |
7380695 | Doll et al. | Jun 2008 | B2 |
7380696 | Shelton, IV et al. | Jun 2008 | B2 |
7381209 | Truckai et al. | Jun 2008 | B2 |
7384420 | Dycus et al. | Jun 2008 | B2 |
7390317 | Taylor et al. | Jun 2008 | B2 |
7396356 | Mollenauer | Jul 2008 | B2 |
7403224 | Fuller et al. | Jul 2008 | B2 |
7404508 | Smith et al. | Jul 2008 | B2 |
7407077 | Ortiz et al. | Aug 2008 | B2 |
7408288 | Hara | Aug 2008 | B2 |
7412008 | Lliev | Aug 2008 | B2 |
7416101 | Shelton, IV et al. | Aug 2008 | B2 |
7416437 | Sartor et al. | Aug 2008 | B2 |
D576725 | Shumer et al. | Sep 2008 | S |
7419490 | Falkenstein et al. | Sep 2008 | B2 |
7422139 | Shelton, IV et al. | Sep 2008 | B2 |
7422463 | Kuo | Sep 2008 | B2 |
7422582 | Malackowski et al. | Sep 2008 | B2 |
D578643 | Shumer et al. | Oct 2008 | S |
D578644 | Shumer et al. | Oct 2008 | S |
D578645 | Shumer et al. | Oct 2008 | S |
7431694 | Stefanchik et al. | Oct 2008 | B2 |
7431704 | Babaev | Oct 2008 | B2 |
7431720 | Pendekanti et al. | Oct 2008 | B2 |
7435582 | Zimmermann et al. | Oct 2008 | B2 |
7441684 | Shelton, IV et al. | Oct 2008 | B2 |
7442193 | Shields et al. | Oct 2008 | B2 |
7445621 | Dumbauld et al. | Nov 2008 | B2 |
7449004 | Yamada et al. | Nov 2008 | B2 |
7451904 | Shelton, IV | Nov 2008 | B2 |
7455208 | Wales et al. | Nov 2008 | B2 |
7455641 | Yamada et al. | Nov 2008 | B2 |
7462181 | Kraft et al. | Dec 2008 | B2 |
7464846 | Shelton, IV et al. | Dec 2008 | B2 |
7464849 | Shelton, IV et al. | Dec 2008 | B2 |
7472815 | Shelton, IV et al. | Jan 2009 | B2 |
7473145 | Ehr et al. | Jan 2009 | B2 |
7473253 | Dycus et al. | Jan 2009 | B2 |
7473263 | Johnston et al. | Jan 2009 | B2 |
7479148 | Beaupre | Jan 2009 | B2 |
7479160 | Branch et al. | Jan 2009 | B2 |
7481775 | Weikel, Jr. et al. | Jan 2009 | B2 |
7488285 | Honda et al. | Feb 2009 | B2 |
7488319 | Yates | Feb 2009 | B2 |
7491201 | Shields et al. | Feb 2009 | B2 |
7491202 | Odom et al. | Feb 2009 | B2 |
7494468 | Rabiner et al. | Feb 2009 | B2 |
7494501 | Ahlberg et al. | Feb 2009 | B2 |
7498080 | Tung et al. | Mar 2009 | B2 |
7502234 | Goliszek et al. | Mar 2009 | B2 |
7503893 | Kucklick | Mar 2009 | B2 |
7503895 | Rabiner et al. | Mar 2009 | B2 |
7506790 | Shelton, IV | Mar 2009 | B2 |
7506791 | Omaits et al. | Mar 2009 | B2 |
7507239 | Shadduck | Mar 2009 | B2 |
7510107 | Timm et al. | Mar 2009 | B2 |
7510556 | Nguyen et al. | Mar 2009 | B2 |
7513025 | Fischer | Apr 2009 | B2 |
7517349 | Truckai et al. | Apr 2009 | B2 |
7520865 | Radley Young et al. | Apr 2009 | B2 |
7524320 | Tierney et al. | Apr 2009 | B2 |
7525309 | Sherman et al. | Apr 2009 | B2 |
7530986 | Beaupre et al. | May 2009 | B2 |
7534243 | Chin et al. | May 2009 | B1 |
7535233 | Kojovic et al. | May 2009 | B2 |
D594983 | Price et al. | Jun 2009 | S |
7540871 | Gonnering | Jun 2009 | B2 |
7540872 | Schechter et al. | Jun 2009 | B2 |
7543730 | Marczyk | Jun 2009 | B1 |
7544200 | Houser | Jun 2009 | B2 |
7549564 | Boudreaux | Jun 2009 | B2 |
7550216 | Ofer et al. | Jun 2009 | B2 |
7553309 | Buysse et al. | Jun 2009 | B2 |
7554343 | Bromfield | Jun 2009 | B2 |
7559450 | Wales et al. | Jul 2009 | B2 |
7559452 | Wales et al. | Jul 2009 | B2 |
7563259 | Takahashi | Jul 2009 | B2 |
7566318 | Haefner | Jul 2009 | B2 |
7567012 | Namikawa | Jul 2009 | B2 |
7568603 | Shelton, IV et al. | Aug 2009 | B2 |
7569057 | Liu et al. | Aug 2009 | B2 |
7572266 | Young et al. | Aug 2009 | B2 |
7572268 | Babaev | Aug 2009 | B2 |
7578820 | Moore et al. | Aug 2009 | B2 |
7582084 | Swanson et al. | Sep 2009 | B2 |
7582086 | Privitera et al. | Sep 2009 | B2 |
7582087 | Tetzlaff et al. | Sep 2009 | B2 |
7582095 | Shipp et al. | Sep 2009 | B2 |
7585181 | Olsen | Sep 2009 | B2 |
7586289 | Andruk et al. | Sep 2009 | B2 |
7587536 | McLeod | Sep 2009 | B2 |
7588176 | Timm et al. | Sep 2009 | B2 |
7588177 | Racenet | Sep 2009 | B2 |
7594925 | Danek et al. | Sep 2009 | B2 |
7597693 | Garrison | Oct 2009 | B2 |
7601119 | Shahinian | Oct 2009 | B2 |
7601136 | Akahoshi | Oct 2009 | B2 |
7604150 | Boudreaux | Oct 2009 | B2 |
7607557 | Shelton, IV et al. | Oct 2009 | B2 |
7617961 | Viola | Nov 2009 | B2 |
7621930 | Houser | Nov 2009 | B2 |
7625370 | Hart et al. | Dec 2009 | B2 |
7628791 | Garrison et al. | Dec 2009 | B2 |
7628792 | Guerra | Dec 2009 | B2 |
7632267 | Dahla | Dec 2009 | B2 |
7632269 | Truckai et al. | Dec 2009 | B2 |
7637410 | Marczyk | Dec 2009 | B2 |
7641653 | Dalla Betta et al. | Jan 2010 | B2 |
7641671 | Crainich | Jan 2010 | B2 |
7644848 | Swayze et al. | Jan 2010 | B2 |
7645240 | Thompson et al. | Jan 2010 | B2 |
7645277 | McClurken et al. | Jan 2010 | B2 |
7645278 | Ichihashi et al. | Jan 2010 | B2 |
7648499 | Orszulak et al. | Jan 2010 | B2 |
7649410 | Andersen et al. | Jan 2010 | B2 |
7654431 | Hueil et al. | Feb 2010 | B2 |
7655003 | Lorang et al. | Feb 2010 | B2 |
7658311 | Boudreaux | Feb 2010 | B2 |
7659833 | Warner et al. | Feb 2010 | B2 |
7662151 | Crompton, Jr. et al. | Feb 2010 | B2 |
7665647 | Shelton, IV et al. | Feb 2010 | B2 |
7666206 | Taniguchi et al. | Feb 2010 | B2 |
7667592 | Ohyama et al. | Feb 2010 | B2 |
7670334 | Hueil et al. | Mar 2010 | B2 |
7670338 | Albrecht et al. | Mar 2010 | B2 |
7674263 | Ryan | Mar 2010 | B2 |
7678069 | Baker et al. | Mar 2010 | B1 |
7678105 | McGreevy et al. | Mar 2010 | B2 |
7678125 | Shipp | Mar 2010 | B2 |
7682366 | Sakurai et al. | Mar 2010 | B2 |
7686770 | Cohen | Mar 2010 | B2 |
7686826 | Lee et al. | Mar 2010 | B2 |
7688028 | Phillips et al. | Mar 2010 | B2 |
7691095 | Bednarek et al. | Apr 2010 | B2 |
7691098 | Wallace et al. | Apr 2010 | B2 |
7696441 | Kataoka | Apr 2010 | B2 |
7699846 | Ryan | Apr 2010 | B2 |
7703459 | Saadat et al. | Apr 2010 | B2 |
7703653 | Shah et al. | Apr 2010 | B2 |
7708735 | Chapman et al. | May 2010 | B2 |
7708751 | Hughes et al. | May 2010 | B2 |
7708758 | Lee et al. | May 2010 | B2 |
7708768 | Danek et al. | May 2010 | B2 |
7713202 | Boukhny et al. | May 2010 | B2 |
7713267 | Pozzato | May 2010 | B2 |
7714481 | Sakai | May 2010 | B2 |
7717312 | Beetel | May 2010 | B2 |
7717914 | Kimura | May 2010 | B2 |
7717915 | Miyazawa | May 2010 | B2 |
7721935 | Racenet et al. | May 2010 | B2 |
7722527 | Bouchier et al. | May 2010 | B2 |
7722607 | Dumbauld et al. | May 2010 | B2 |
D618797 | Price et al. | Jun 2010 | S |
7726537 | Olson et al. | Jun 2010 | B2 |
7727177 | Bayat | Jun 2010 | B2 |
7731717 | Odom et al. | Jun 2010 | B2 |
7738969 | Bleich | Jun 2010 | B2 |
7740594 | Hibner | Jun 2010 | B2 |
7744615 | Couture | Jun 2010 | B2 |
7749240 | Takahashi et al. | Jul 2010 | B2 |
7751115 | Song | Jul 2010 | B2 |
7753245 | Boudreaux et al. | Jul 2010 | B2 |
7753904 | Shelton, IV et al. | Jul 2010 | B2 |
7753908 | Swanson | Jul 2010 | B2 |
7762445 | Heinrich et al. | Jul 2010 | B2 |
D621503 | Otten et al. | Aug 2010 | S |
7766210 | Shelton, IV et al. | Aug 2010 | B2 |
7766693 | Sartor et al. | Aug 2010 | B2 |
7766910 | Hixson et al. | Aug 2010 | B2 |
7768510 | Tsai et al. | Aug 2010 | B2 |
7770774 | Mastri et al. | Aug 2010 | B2 |
7770775 | Shelton, IV et al. | Aug 2010 | B2 |
7771425 | Dycus et al. | Aug 2010 | B2 |
7771444 | Patel et al. | Aug 2010 | B2 |
7775972 | Brock et al. | Aug 2010 | B2 |
7776036 | Schechter et al. | Aug 2010 | B2 |
7776037 | Odom | Aug 2010 | B2 |
7778733 | Nowlin et al. | Aug 2010 | B2 |
7780054 | Wales | Aug 2010 | B2 |
7780593 | Ueno et al. | Aug 2010 | B2 |
7780651 | Madhani et al. | Aug 2010 | B2 |
7780659 | Okada et al. | Aug 2010 | B2 |
7780663 | Yates et al. | Aug 2010 | B2 |
7784662 | Wales et al. | Aug 2010 | B2 |
7784663 | Shelton, IV | Aug 2010 | B2 |
7789883 | Takashino et al. | Sep 2010 | B2 |
7793814 | Racenet et al. | Sep 2010 | B2 |
7794475 | Hess et al. | Sep 2010 | B2 |
7796969 | Kelly et al. | Sep 2010 | B2 |
7798386 | Schall et al. | Sep 2010 | B2 |
7799020 | Shores et al. | Sep 2010 | B2 |
7799027 | Hafner | Sep 2010 | B2 |
7799045 | Masuda | Sep 2010 | B2 |
7803151 | Whitman | Sep 2010 | B2 |
7803152 | Honda et al. | Sep 2010 | B2 |
7803156 | Eder et al. | Sep 2010 | B2 |
7803168 | Gifford et al. | Sep 2010 | B2 |
7806891 | Nowlin et al. | Oct 2010 | B2 |
7810693 | Broehl et al. | Oct 2010 | B2 |
7811283 | Moses et al. | Oct 2010 | B2 |
7815238 | Cao | Oct 2010 | B2 |
7815641 | Dodde et al. | Oct 2010 | B2 |
7819298 | Hall et al. | Oct 2010 | B2 |
7819299 | Shelton, IV et al. | Oct 2010 | B2 |
7819819 | Quick et al. | Oct 2010 | B2 |
7819872 | Johnson et al. | Oct 2010 | B2 |
7821143 | Wiener | Oct 2010 | B2 |
D627066 | Romero | Nov 2010 | S |
7824401 | Manzo et al. | Nov 2010 | B2 |
7832408 | Shelton, IV et al. | Nov 2010 | B2 |
7832611 | Boyden et al. | Nov 2010 | B2 |
7832612 | Baxter, III et al. | Nov 2010 | B2 |
7834484 | Sartor | Nov 2010 | B2 |
7837699 | Yamada et al. | Nov 2010 | B2 |
7845537 | Shelton, IV et al. | Dec 2010 | B2 |
7846155 | Houser et al. | Dec 2010 | B2 |
7846159 | Morrison et al. | Dec 2010 | B2 |
7846160 | Payne et al. | Dec 2010 | B2 |
7846161 | Dumbauld et al. | Dec 2010 | B2 |
7854735 | Houser et al. | Dec 2010 | B2 |
D631155 | Peine et al. | Jan 2011 | S |
7861906 | Doll et al. | Jan 2011 | B2 |
7862560 | Marion | Jan 2011 | B2 |
7862561 | Swanson et al. | Jan 2011 | B2 |
7867228 | Nobis et al. | Jan 2011 | B2 |
7871392 | Sartor | Jan 2011 | B2 |
7871423 | Livneh | Jan 2011 | B2 |
7876030 | Taki et al. | Jan 2011 | B2 |
D631965 | Price et al. | Feb 2011 | S |
7877852 | Unger et al. | Feb 2011 | B2 |
7878991 | Babaev | Feb 2011 | B2 |
7879029 | Jimenez | Feb 2011 | B2 |
7879033 | Sartor et al. | Feb 2011 | B2 |
7879035 | Garrison et al. | Feb 2011 | B2 |
7879070 | Ortiz et al. | Feb 2011 | B2 |
7883475 | Dupont et al. | Feb 2011 | B2 |
7892606 | Thies et al. | Feb 2011 | B2 |
7896875 | Heim et al. | Mar 2011 | B2 |
7897792 | Iikura et al. | Mar 2011 | B2 |
7901400 | Wham et al. | Mar 2011 | B2 |
7901423 | Stulen et al. | Mar 2011 | B2 |
7905881 | Masuda et al. | Mar 2011 | B2 |
7909220 | Viola | Mar 2011 | B2 |
7909820 | Lipson et al. | Mar 2011 | B2 |
7909824 | Masuda et al. | Mar 2011 | B2 |
7918848 | Lau et al. | Apr 2011 | B2 |
7919184 | Mohapatra et al. | Apr 2011 | B2 |
7922061 | Shelton, IV et al. | Apr 2011 | B2 |
7922651 | Yamada et al. | Apr 2011 | B2 |
7931611 | Novak et al. | Apr 2011 | B2 |
7931649 | Couture et al. | Apr 2011 | B2 |
D637288 | Houghton | May 2011 | S |
D638540 | Ijiri et al. | May 2011 | S |
7935114 | Takashino et al. | May 2011 | B2 |
7936203 | Zimlich | May 2011 | B2 |
7951095 | Makin et al. | May 2011 | B2 |
7951165 | Golden et al. | May 2011 | B2 |
7954682 | Giordano et al. | Jun 2011 | B2 |
7955331 | Truckai et al. | Jun 2011 | B2 |
7956620 | Gilbert | Jun 2011 | B2 |
7959050 | Smith et al. | Jun 2011 | B2 |
7959626 | Hong et al. | Jun 2011 | B2 |
7963963 | Francischelli et al. | Jun 2011 | B2 |
7967602 | Lindquist | Jun 2011 | B2 |
7972328 | Wham et al. | Jul 2011 | B2 |
7972329 | Refior et al. | Jul 2011 | B2 |
7975895 | Milliman | Jul 2011 | B2 |
7976544 | McClurken et al. | Jul 2011 | B2 |
7980443 | Scheib et al. | Jul 2011 | B2 |
7981050 | Ritchart et al. | Jul 2011 | B2 |
7981113 | Truckai et al. | Jul 2011 | B2 |
7997278 | Utley et al. | Aug 2011 | B2 |
7998157 | Culp et al. | Aug 2011 | B2 |
8002732 | Visconti | Aug 2011 | B2 |
8002770 | Swanson et al. | Aug 2011 | B2 |
8020743 | Shelton, IV | Sep 2011 | B2 |
8025672 | Novak et al. | Sep 2011 | B2 |
8028885 | Smith et al. | Oct 2011 | B2 |
8033173 | Ehlert et al. | Oct 2011 | B2 |
8034049 | Odom et al. | Oct 2011 | B2 |
8038693 | Allen | Oct 2011 | B2 |
8048070 | O'Brien et al. | Nov 2011 | B2 |
8048074 | Masuda | Nov 2011 | B2 |
8052672 | Laufer et al. | Nov 2011 | B2 |
8055208 | Lilla et al. | Nov 2011 | B2 |
8056720 | Hawkes | Nov 2011 | B2 |
8056787 | Boudreaux et al. | Nov 2011 | B2 |
8057468 | Konesky | Nov 2011 | B2 |
8057498 | Robertson | Nov 2011 | B2 |
8058771 | Giordano et al. | Nov 2011 | B2 |
8061014 | Smith et al. | Nov 2011 | B2 |
8066167 | Measamer et al. | Nov 2011 | B2 |
8070036 | Knodel | Dec 2011 | B1 |
8070711 | Bassinger et al. | Dec 2011 | B2 |
8070762 | Escudero et al. | Dec 2011 | B2 |
8075555 | Truckai et al. | Dec 2011 | B2 |
8075558 | Truckai et al. | Dec 2011 | B2 |
8089197 | Rinner et al. | Jan 2012 | B2 |
8092475 | Cotter et al. | Jan 2012 | B2 |
8096459 | Ortiz et al. | Jan 2012 | B2 |
8097012 | Kagarise | Jan 2012 | B2 |
8100894 | Mucko et al. | Jan 2012 | B2 |
8105230 | Honda et al. | Jan 2012 | B2 |
8105323 | Buysse et al. | Jan 2012 | B2 |
8105324 | Palanker et al. | Jan 2012 | B2 |
8114104 | Young et al. | Feb 2012 | B2 |
8118276 | Sanders et al. | Feb 2012 | B2 |
8128624 | Couture et al. | Mar 2012 | B2 |
8133218 | Daw et al. | Mar 2012 | B2 |
8136712 | Zingman | Mar 2012 | B2 |
8141762 | Bedi et al. | Mar 2012 | B2 |
8142421 | Cooper et al. | Mar 2012 | B2 |
8142461 | Houser et al. | Mar 2012 | B2 |
8147485 | Wham et al. | Apr 2012 | B2 |
8147488 | Masuda | Apr 2012 | B2 |
8147508 | Madan et al. | Apr 2012 | B2 |
8152801 | Goldberg et al. | Apr 2012 | B2 |
8152825 | Madan et al. | Apr 2012 | B2 |
8157145 | Shelton, IV et al. | Apr 2012 | B2 |
8161977 | Shelton, IV et al. | Apr 2012 | B2 |
8162966 | Connor et al. | Apr 2012 | B2 |
8170717 | Sutherland et al. | May 2012 | B2 |
8172846 | Brunnett et al. | May 2012 | B2 |
8172870 | Shipp | May 2012 | B2 |
8177800 | Spitz et al. | May 2012 | B2 |
8182502 | Stulen et al. | May 2012 | B2 |
8186560 | Hess et al. | May 2012 | B2 |
8186877 | Klimovitch et al. | May 2012 | B2 |
8187267 | Pappone et al. | May 2012 | B2 |
D661801 | Price et al. | Jun 2012 | S |
D661802 | Price et al. | Jun 2012 | S |
D661803 | Price et al. | Jun 2012 | S |
D661804 | Price et al. | Jun 2012 | S |
8197472 | Lau et al. | Jun 2012 | B2 |
8197479 | Olson et al. | Jun 2012 | B2 |
8197502 | Smith et al. | Jun 2012 | B2 |
8207651 | Gilbert | Jun 2012 | B2 |
8210411 | Yates et al. | Jul 2012 | B2 |
8211100 | Podhajsky et al. | Jul 2012 | B2 |
8216223 | Wham et al. | Jul 2012 | B2 |
8220688 | Laurent et al. | Jul 2012 | B2 |
8221306 | Okada et al. | Jul 2012 | B2 |
8221415 | Francischelli | Jul 2012 | B2 |
8221418 | Prakash et al. | Jul 2012 | B2 |
8226580 | Govari et al. | Jul 2012 | B2 |
8226665 | Cohen | Jul 2012 | B2 |
8226675 | Houser et al. | Jul 2012 | B2 |
8231607 | Takuma | Jul 2012 | B2 |
8235917 | Joseph et al. | Aug 2012 | B2 |
8236018 | Yoshimine et al. | Aug 2012 | B2 |
8236019 | Houser | Aug 2012 | B2 |
8236020 | Smith et al. | Aug 2012 | B2 |
8241235 | Kahler et al. | Aug 2012 | B2 |
8241271 | Millman et al. | Aug 2012 | B2 |
8241282 | Unger et al. | Aug 2012 | B2 |
8241283 | Guerra et al. | Aug 2012 | B2 |
8241284 | Dycus et al. | Aug 2012 | B2 |
8241312 | Messerly | Aug 2012 | B2 |
8246575 | Viola | Aug 2012 | B2 |
8246615 | Behnke | Aug 2012 | B2 |
8246616 | Amoah et al. | Aug 2012 | B2 |
8246618 | Bucciaglia et al. | Aug 2012 | B2 |
8246642 | Houser et al. | Aug 2012 | B2 |
8251994 | McKenna et al. | Aug 2012 | B2 |
8252012 | Stulen | Aug 2012 | B2 |
8253303 | Giordano et al. | Aug 2012 | B2 |
8257377 | Wiener et al. | Sep 2012 | B2 |
8257387 | Cunningham | Sep 2012 | B2 |
8262563 | Bakos et al. | Sep 2012 | B2 |
8267300 | Boudreaux | Sep 2012 | B2 |
8267935 | Couture et al. | Sep 2012 | B2 |
8273087 | Kimura et al. | Sep 2012 | B2 |
D669992 | Schafer et al. | Oct 2012 | S |
D669993 | Merchant et al. | Oct 2012 | S |
8277446 | Heard | Oct 2012 | B2 |
8277447 | Garrison et al. | Oct 2012 | B2 |
8277471 | Wiener et al. | Oct 2012 | B2 |
8282581 | Zhao et al. | Oct 2012 | B2 |
8282669 | Gerber et al. | Oct 2012 | B2 |
8286846 | Smith et al. | Oct 2012 | B2 |
8287485 | Kimura et al. | Oct 2012 | B2 |
8287528 | Wham et al. | Oct 2012 | B2 |
8287532 | Carroll et al. | Oct 2012 | B2 |
8292886 | Kerr et al. | Oct 2012 | B2 |
8292888 | Whitman | Oct 2012 | B2 |
8292905 | Taylor et al. | Oct 2012 | B2 |
8295902 | Salahieh et al. | Oct 2012 | B2 |
8298223 | Wham et al. | Oct 2012 | B2 |
8298225 | Gilbert | Oct 2012 | B2 |
8298232 | Unger | Oct 2012 | B2 |
8298233 | Mueller | Oct 2012 | B2 |
8303576 | Brock | Nov 2012 | B2 |
8303579 | Shibata | Nov 2012 | B2 |
8303580 | Wham et al. | Nov 2012 | B2 |
8303583 | Hosier et al. | Nov 2012 | B2 |
8303613 | Crandall et al. | Nov 2012 | B2 |
8306629 | Mioduski et al. | Nov 2012 | B2 |
8308040 | Huang et al. | Nov 2012 | B2 |
8308721 | Shibata et al. | Nov 2012 | B2 |
8319400 | Houser et al. | Nov 2012 | B2 |
8323302 | Robertson et al. | Dec 2012 | B2 |
8323310 | Kingsley | Dec 2012 | B2 |
8328061 | Kasvikis | Dec 2012 | B2 |
8328761 | Widenhouse et al. | Dec 2012 | B2 |
8328802 | Deville et al. | Dec 2012 | B2 |
8328833 | Cuny | Dec 2012 | B2 |
8328834 | Isaacs et al. | Dec 2012 | B2 |
8333764 | Francischelli et al. | Dec 2012 | B2 |
8333778 | Smith et al. | Dec 2012 | B2 |
8333779 | Smith et al. | Dec 2012 | B2 |
8334468 | Palmer et al. | Dec 2012 | B2 |
8334635 | Voegele et al. | Dec 2012 | B2 |
8337407 | Quistgaard et al. | Dec 2012 | B2 |
8338726 | Palmer et al. | Dec 2012 | B2 |
8343146 | Godara et al. | Jan 2013 | B2 |
8344596 | Nield et al. | Jan 2013 | B2 |
8348880 | Messerly et al. | Jan 2013 | B2 |
8348947 | Takashino et al. | Jan 2013 | B2 |
8348967 | Stulen | Jan 2013 | B2 |
8353297 | Dacquay et al. | Jan 2013 | B2 |
8357103 | Mark et al. | Jan 2013 | B2 |
8357144 | Whitman et al. | Jan 2013 | B2 |
8357149 | Govari et al. | Jan 2013 | B2 |
8357158 | McKenna et al. | Jan 2013 | B2 |
8360299 | Zemlok et al. | Jan 2013 | B2 |
8361066 | Long et al. | Jan 2013 | B2 |
8361072 | Dumbauld et al. | Jan 2013 | B2 |
8361569 | Saito et al. | Jan 2013 | B2 |
8366727 | Witt et al. | Feb 2013 | B2 |
8372064 | Douglass et al. | Feb 2013 | B2 |
8372099 | Deville et al. | Feb 2013 | B2 |
8372101 | Smith et al. | Feb 2013 | B2 |
8372102 | Stulen et al. | Feb 2013 | B2 |
8374670 | Selkee | Feb 2013 | B2 |
8377044 | Coe et al. | Feb 2013 | B2 |
8377059 | Deville et al. | Feb 2013 | B2 |
8377085 | Smith et al. | Feb 2013 | B2 |
8382748 | Geisel | Feb 2013 | B2 |
8382775 | Bender et al. | Feb 2013 | B1 |
8382782 | Robertson et al. | Feb 2013 | B2 |
8382792 | Chojin | Feb 2013 | B2 |
8388646 | Chojin | Mar 2013 | B2 |
8388647 | Nau, Jr. et al. | Mar 2013 | B2 |
8393514 | Shelton, IV et al. | Mar 2013 | B2 |
8394115 | Houser et al. | Mar 2013 | B2 |
8397971 | Yates et al. | Mar 2013 | B2 |
8398394 | Sauter et al. | Mar 2013 | B2 |
8398674 | Prestel | Mar 2013 | B2 |
8403926 | Nobis et al. | Mar 2013 | B2 |
8403945 | Whitfield et al. | Mar 2013 | B2 |
8403948 | Deville et al. | Mar 2013 | B2 |
8403949 | Palmer et al. | Mar 2013 | B2 |
8403950 | Palmer et al. | Mar 2013 | B2 |
8409234 | Stahler et al. | Apr 2013 | B2 |
8414577 | Boudreaux et al. | Apr 2013 | B2 |
8418073 | Mohr et al. | Apr 2013 | B2 |
8418349 | Smith et al. | Apr 2013 | B2 |
8419757 | Smith et al. | Apr 2013 | B2 |
8419758 | Smith et al. | Apr 2013 | B2 |
8419759 | Dietz | Apr 2013 | B2 |
8423182 | Robinson et al. | Apr 2013 | B2 |
8425410 | Murray et al. | Apr 2013 | B2 |
8425545 | Smith et al. | Apr 2013 | B2 |
8430811 | Hess et al. | Apr 2013 | B2 |
8430874 | Newton et al. | Apr 2013 | B2 |
8430876 | Kappus et al. | Apr 2013 | B2 |
8430897 | Novak et al. | Apr 2013 | B2 |
8430898 | Wiener et al. | Apr 2013 | B2 |
8435257 | Smith et al. | May 2013 | B2 |
8437832 | Govari et al. | May 2013 | B2 |
8439912 | Cunningham et al. | May 2013 | B2 |
8439939 | Deville et al. | May 2013 | B2 |
8444036 | Shelton, IV | May 2013 | B2 |
8444637 | Podmore et al. | May 2013 | B2 |
8444662 | Palmer et al. | May 2013 | B2 |
8444663 | Houser et al. | May 2013 | B2 |
8444664 | Balanev et al. | May 2013 | B2 |
8453906 | Huang et al. | Jun 2013 | B2 |
8454599 | Inagaki et al. | Jun 2013 | B2 |
8454639 | Du et al. | Jun 2013 | B2 |
8459525 | Yates et al. | Jun 2013 | B2 |
8460284 | Aronow et al. | Jun 2013 | B2 |
8460288 | Tamai et al. | Jun 2013 | B2 |
8460292 | Truckai et al. | Jun 2013 | B2 |
8461744 | Wiener et al. | Jun 2013 | B2 |
8469981 | Robertson et al. | Jun 2013 | B2 |
8471685 | Shingai | Jun 2013 | B2 |
8479969 | Shelton, IV | Jul 2013 | B2 |
8480703 | Nicholas et al. | Jul 2013 | B2 |
8484833 | Cunningham et al. | Jul 2013 | B2 |
8485413 | Scheib et al. | Jul 2013 | B2 |
8485970 | Widenhouse et al. | Jul 2013 | B2 |
8486057 | Behnke, II | Jul 2013 | B2 |
8486096 | Robertson et al. | Jul 2013 | B2 |
8491578 | Manwaring et al. | Jul 2013 | B2 |
8491625 | Horner | Jul 2013 | B2 |
8496682 | Guerra et al. | Jul 2013 | B2 |
D687549 | Johnson et al. | Aug 2013 | S |
8506555 | Ruiz Morales | Aug 2013 | B2 |
8509318 | Tailliet | Aug 2013 | B2 |
8512336 | Couture | Aug 2013 | B2 |
8512337 | Francischelli et al. | Aug 2013 | B2 |
8512359 | Whitman et al. | Aug 2013 | B2 |
8512364 | Kowalski et al. | Aug 2013 | B2 |
8512365 | Wiener et al. | Aug 2013 | B2 |
8517239 | Scheib et al. | Aug 2013 | B2 |
8518067 | Masuda et al. | Aug 2013 | B2 |
8521331 | Itkowitz | Aug 2013 | B2 |
8523043 | Ullrich et al. | Sep 2013 | B2 |
8523882 | Huitema et al. | Sep 2013 | B2 |
8523889 | Stulen et al. | Sep 2013 | B2 |
8528563 | Gruber | Sep 2013 | B2 |
8529437 | Taylor et al. | Sep 2013 | B2 |
8529565 | Masuda et al. | Sep 2013 | B2 |
8531064 | Robertson et al. | Sep 2013 | B2 |
8535308 | Govari et al. | Sep 2013 | B2 |
8535311 | Schall | Sep 2013 | B2 |
8535340 | Allen | Sep 2013 | B2 |
8535341 | Allen | Sep 2013 | B2 |
8540128 | Shelton, IV et al. | Sep 2013 | B2 |
8546996 | Messerly et al. | Oct 2013 | B2 |
8546999 | Houser et al. | Oct 2013 | B2 |
8551077 | Main et al. | Oct 2013 | B2 |
8551086 | Kimura et al. | Oct 2013 | B2 |
8556929 | Harper et al. | Oct 2013 | B2 |
8561870 | Baxter, III et al. | Oct 2013 | B2 |
8562592 | Conlon et al. | Oct 2013 | B2 |
8562598 | Falkenstein et al. | Oct 2013 | B2 |
8562600 | Kirkpatrick et al. | Oct 2013 | B2 |
8562604 | Nishimura | Oct 2013 | B2 |
8568390 | Mueller | Oct 2013 | B2 |
8568397 | Horner et al. | Oct 2013 | B2 |
8568400 | Gilbert | Oct 2013 | B2 |
8568412 | Brandt et al. | Oct 2013 | B2 |
8569997 | Lee | Oct 2013 | B2 |
8573461 | Shelton, IV et al. | Nov 2013 | B2 |
8573465 | Shelton, IV | Nov 2013 | B2 |
8574231 | Boudreaux et al. | Nov 2013 | B2 |
8574253 | Gruber et al. | Nov 2013 | B2 |
8579176 | Smith et al. | Nov 2013 | B2 |
8579897 | Vakharia et al. | Nov 2013 | B2 |
8579928 | Robertson et al. | Nov 2013 | B2 |
8579937 | Gresham | Nov 2013 | B2 |
8585727 | Polo | Nov 2013 | B2 |
8588371 | Ogawa et al. | Nov 2013 | B2 |
8591459 | Clymer et al. | Nov 2013 | B2 |
8591506 | Wham et al. | Nov 2013 | B2 |
8591536 | Robertson | Nov 2013 | B2 |
D695407 | Price et al. | Dec 2013 | S |
D696631 | Price et al. | Dec 2013 | S |
8596513 | Olson et al. | Dec 2013 | B2 |
8597193 | Grunwald et al. | Dec 2013 | B2 |
8597287 | Benamou et al. | Dec 2013 | B2 |
8602031 | Reis et al. | Dec 2013 | B2 |
8602288 | Shelton, IV et al. | Dec 2013 | B2 |
8603085 | Jimenez | Dec 2013 | B2 |
8603089 | Viola | Dec 2013 | B2 |
8608044 | Hueil et al. | Dec 2013 | B2 |
8608045 | Smith et al. | Dec 2013 | B2 |
8608745 | Guzman et al. | Dec 2013 | B2 |
8613383 | Beckman et al. | Dec 2013 | B2 |
8616431 | Timm et al. | Dec 2013 | B2 |
8617152 | Werneth et al. | Dec 2013 | B2 |
8617194 | Beaupre | Dec 2013 | B2 |
8622274 | Yates et al. | Jan 2014 | B2 |
8623011 | Spivey | Jan 2014 | B2 |
8623016 | Fischer | Jan 2014 | B2 |
8623027 | Price et al. | Jan 2014 | B2 |
8623040 | Artsyukhovich et al. | Jan 2014 | B2 |
8623044 | Timm et al. | Jan 2014 | B2 |
8628529 | Aldridge et al. | Jan 2014 | B2 |
8628534 | Jones et al. | Jan 2014 | B2 |
8632461 | Glossop | Jan 2014 | B2 |
8636736 | Yates et al. | Jan 2014 | B2 |
8638428 | Brown | Jan 2014 | B2 |
8640788 | Dachs, II et al. | Feb 2014 | B2 |
8641663 | Kirschenman et al. | Feb 2014 | B2 |
8647350 | Mohan et al. | Feb 2014 | B2 |
8650728 | Wan et al. | Feb 2014 | B2 |
8652120 | Giordano et al. | Feb 2014 | B2 |
8652132 | Tsuchiya et al. | Feb 2014 | B2 |
8652155 | Houser et al. | Feb 2014 | B2 |
8657489 | Ladurner et al. | Feb 2014 | B2 |
8659208 | Rose et al. | Feb 2014 | B1 |
8663214 | Weinberg et al. | Mar 2014 | B2 |
8663220 | Wiener et al. | Mar 2014 | B2 |
8663222 | Anderson et al. | Mar 2014 | B2 |
8663223 | Masuda et al. | Mar 2014 | B2 |
8663262 | Smith et al. | Mar 2014 | B2 |
8668691 | Heard | Mar 2014 | B2 |
8668710 | Slipszenko et al. | Mar 2014 | B2 |
8684253 | Giordano et al. | Apr 2014 | B2 |
8685016 | Wham et al. | Apr 2014 | B2 |
8685020 | Weizman et al. | Apr 2014 | B2 |
8690582 | Rohrbach et al. | Apr 2014 | B2 |
8695866 | Leimbach et al. | Apr 2014 | B2 |
8696366 | Chen et al. | Apr 2014 | B2 |
8696665 | Hunt et al. | Apr 2014 | B2 |
8696666 | Sanai et al. | Apr 2014 | B2 |
8696917 | Petisce et al. | Apr 2014 | B2 |
8702609 | Hadjicostis | Apr 2014 | B2 |
8702702 | Edwards et al. | Apr 2014 | B1 |
8702704 | Shelton, IV et al. | Apr 2014 | B2 |
8704425 | Giordano et al. | Apr 2014 | B2 |
8708213 | Shelton, IV et al. | Apr 2014 | B2 |
8709008 | Willis et al. | Apr 2014 | B2 |
8709031 | Stulen | Apr 2014 | B2 |
8709035 | Johnson et al. | Apr 2014 | B2 |
8715270 | Weitzner et al. | May 2014 | B2 |
8715277 | Weizman | May 2014 | B2 |
8721640 | Taylor et al. | May 2014 | B2 |
8721657 | Kondoh et al. | May 2014 | B2 |
8733613 | Huitema et al. | May 2014 | B2 |
8733614 | Ross et al. | May 2014 | B2 |
8734443 | Hixson et al. | May 2014 | B2 |
8738110 | Tabada et al. | May 2014 | B2 |
8747238 | Shelton, IV et al. | Jun 2014 | B2 |
8747351 | Schultz | Jun 2014 | B2 |
8747404 | Boudreaux et al. | Jun 2014 | B2 |
8749116 | Messerly et al. | Jun 2014 | B2 |
8752264 | Ackley et al. | Jun 2014 | B2 |
8752749 | Moore et al. | Jun 2014 | B2 |
8753338 | Widenhouse et al. | Jun 2014 | B2 |
8754570 | Voegele et al. | Jun 2014 | B2 |
8758342 | Bales et al. | Jun 2014 | B2 |
8758352 | Cooper et al. | Jun 2014 | B2 |
8758391 | Swayze et al. | Jun 2014 | B2 |
8764735 | Coe et al. | Jul 2014 | B2 |
8764747 | Cummings et al. | Jul 2014 | B2 |
8767970 | Eppolito | Jul 2014 | B2 |
8770459 | Racenet et al. | Jul 2014 | B2 |
8771269 | Sherman et al. | Jul 2014 | B2 |
8771270 | Burbank | Jul 2014 | B2 |
8771293 | Surti et al. | Jul 2014 | B2 |
8773001 | Wiener et al. | Jul 2014 | B2 |
8777944 | Frankhouser et al. | Jul 2014 | B2 |
8777945 | Floume et al. | Jul 2014 | B2 |
8779648 | Giordano et al. | Jul 2014 | B2 |
8783541 | Shelton, IV et al. | Jul 2014 | B2 |
8784415 | Malackowski et al. | Jul 2014 | B2 |
8784418 | Romero | Jul 2014 | B2 |
8790342 | Stulen et al. | Jul 2014 | B2 |
8795274 | Hanna | Aug 2014 | B2 |
8795275 | Hafner | Aug 2014 | B2 |
8795276 | Dietz et al. | Aug 2014 | B2 |
8795327 | Dietz et al. | Aug 2014 | B2 |
8800838 | Shelton, IV | Aug 2014 | B2 |
8801710 | Ullrich et al. | Aug 2014 | B2 |
8801752 | Fortier et al. | Aug 2014 | B2 |
8807414 | Ross et al. | Aug 2014 | B2 |
8808204 | Irisawa et al. | Aug 2014 | B2 |
8808319 | Houser et al. | Aug 2014 | B2 |
8814856 | Elmouelhi et al. | Aug 2014 | B2 |
8814870 | Paraschiv et al. | Aug 2014 | B2 |
8820605 | Shelton, IV | Sep 2014 | B2 |
8821388 | Naito et al. | Sep 2014 | B2 |
8827992 | Koss et al. | Sep 2014 | B2 |
8827995 | Schaller et al. | Sep 2014 | B2 |
8831779 | Ortmaier et al. | Sep 2014 | B2 |
8834466 | Cummings et al. | Sep 2014 | B2 |
8834518 | Faller et al. | Sep 2014 | B2 |
8844789 | Shelton, IV et al. | Sep 2014 | B2 |
8845537 | Tanaka et al. | Sep 2014 | B2 |
8845630 | Mehta et al. | Sep 2014 | B2 |
8848808 | Dress | Sep 2014 | B2 |
8851354 | Swensgard et al. | Oct 2014 | B2 |
8852184 | Kucklick | Oct 2014 | B2 |
8858547 | Brogna | Oct 2014 | B2 |
8862955 | Cesari | Oct 2014 | B2 |
8864749 | Okada | Oct 2014 | B2 |
8864757 | Klimovitch et al. | Oct 2014 | B2 |
8864761 | Johnson et al. | Oct 2014 | B2 |
8870865 | Frankhouser et al. | Oct 2014 | B2 |
8874220 | Draghici et al. | Oct 2014 | B2 |
8876726 | Amit et al. | Nov 2014 | B2 |
8876858 | Braun | Nov 2014 | B2 |
8882766 | Couture et al. | Nov 2014 | B2 |
8882791 | Stulen | Nov 2014 | B2 |
8888776 | Dietz et al. | Nov 2014 | B2 |
8888783 | Young | Nov 2014 | B2 |
8888809 | Davison et al. | Nov 2014 | B2 |
8899462 | Kostrzewski et al. | Dec 2014 | B2 |
8900259 | Houser et al. | Dec 2014 | B2 |
8906016 | Boudreaux et al. | Dec 2014 | B2 |
8906017 | Rioux et al. | Dec 2014 | B2 |
8911438 | Swoyer et al. | Dec 2014 | B2 |
8911460 | Neurohr et al. | Dec 2014 | B2 |
8920412 | Fritz et al. | Dec 2014 | B2 |
8920414 | Stone et al. | Dec 2014 | B2 |
8920421 | Rupp | Dec 2014 | B2 |
8926607 | Norvell et al. | Jan 2015 | B2 |
8926608 | Bacher et al. | Jan 2015 | B2 |
8926620 | Chasmawala et al. | Jan 2015 | B2 |
8931682 | Timm et al. | Jan 2015 | B2 |
8932282 | Gilbert | Jan 2015 | B2 |
8932299 | Bono et al. | Jan 2015 | B2 |
8936614 | Allen, IV | Jan 2015 | B2 |
8939974 | Boudreaux et al. | Jan 2015 | B2 |
8945126 | Garrison et al. | Feb 2015 | B2 |
8951248 | Messerly et al. | Feb 2015 | B2 |
8951272 | Robertson et al. | Feb 2015 | B2 |
8956349 | Aldridge et al. | Feb 2015 | B2 |
8960520 | McCuen | Feb 2015 | B2 |
8961515 | Twomey et al. | Feb 2015 | B2 |
8961547 | Dietz et al. | Feb 2015 | B2 |
8967443 | McCuen | Mar 2015 | B2 |
8968283 | Kharin | Mar 2015 | B2 |
8968294 | Maass et al. | Mar 2015 | B2 |
8968296 | McPherson | Mar 2015 | B2 |
8968355 | Malkowski et al. | Mar 2015 | B2 |
8974447 | Kimball et al. | Mar 2015 | B2 |
8974477 | Yamada | Mar 2015 | B2 |
8974479 | Ross et al. | Mar 2015 | B2 |
8974932 | McGahan et al. | Mar 2015 | B2 |
8979843 | Timm et al. | Mar 2015 | B2 |
8979844 | White et al. | Mar 2015 | B2 |
8979890 | Boudreaux | Mar 2015 | B2 |
8986287 | Park et al. | Mar 2015 | B2 |
8986297 | Daniel et al. | Mar 2015 | B2 |
8986302 | Aldridge et al. | Mar 2015 | B2 |
8989855 | Murphy et al. | Mar 2015 | B2 |
8989903 | Weir et al. | Mar 2015 | B2 |
8991678 | Wellman et al. | Mar 2015 | B2 |
8992422 | Spivey et al. | Mar 2015 | B2 |
8992526 | Brodbeck et al. | Mar 2015 | B2 |
8998891 | Garito et al. | Apr 2015 | B2 |
9005199 | Beckman et al. | Apr 2015 | B2 |
9011437 | Woodruff et al. | Apr 2015 | B2 |
9011471 | Timm et al. | Apr 2015 | B2 |
9017326 | DiNardo et al. | Apr 2015 | B2 |
9017355 | Smith et al. | Apr 2015 | B2 |
9017370 | Reschke et al. | Apr 2015 | B2 |
9017372 | Artale et al. | Apr 2015 | B2 |
9023035 | Allen, IV et al. | May 2015 | B2 |
9023070 | Levine et al. | May 2015 | B2 |
9023071 | Miller et al. | May 2015 | B2 |
9028397 | Naito | May 2015 | B2 |
9028476 | Bonn | May 2015 | B2 |
9028478 | Mueller | May 2015 | B2 |
9028481 | Behnke, II | May 2015 | B2 |
9028494 | Shelton, IV et al. | May 2015 | B2 |
9028519 | Yates et al. | May 2015 | B2 |
9031667 | Williams | May 2015 | B2 |
9033973 | Krapohl et al. | May 2015 | B2 |
9035741 | Hamel et al. | May 2015 | B2 |
9037259 | Mathur | May 2015 | B2 |
9039690 | Kersten et al. | May 2015 | B2 |
9039691 | Moua et al. | May 2015 | B2 |
9039692 | Behnke, II et al. | May 2015 | B2 |
9039695 | Giordano et al. | May 2015 | B2 |
9039696 | Assmus et al. | May 2015 | B2 |
9039705 | Takashino | May 2015 | B2 |
9039731 | Joseph | May 2015 | B2 |
9043018 | Mohr | May 2015 | B2 |
9044227 | Shelton, IV et al. | Jun 2015 | B2 |
9044230 | Morgan et al. | Jun 2015 | B2 |
9044238 | Orszulak | Jun 2015 | B2 |
9044243 | Johnson et al. | Jun 2015 | B2 |
9044245 | Condie et al. | Jun 2015 | B2 |
9044256 | Cadeddu et al. | Jun 2015 | B2 |
9044261 | Houser | Jun 2015 | B2 |
9050083 | Yates et al. | Jun 2015 | B2 |
9050093 | Aldridge et al. | Jun 2015 | B2 |
9050098 | Deville et al. | Jun 2015 | B2 |
9050123 | Krause et al. | Jun 2015 | B2 |
9050124 | Houser | Jun 2015 | B2 |
9055961 | Manzo et al. | Jun 2015 | B2 |
9059547 | McLawhorn | Jun 2015 | B2 |
9060770 | Shelton, IV et al. | Jun 2015 | B2 |
9060775 | Wiener et al. | Jun 2015 | B2 |
9060776 | Yates et al. | Jun 2015 | B2 |
9060778 | Condie et al. | Jun 2015 | B2 |
9066720 | Ballakur et al. | Jun 2015 | B2 |
9066723 | Beller et al. | Jun 2015 | B2 |
9066747 | Robertson | Jun 2015 | B2 |
9072523 | Houser et al. | Jul 2015 | B2 |
9072535 | Shelton, IV et al. | Jul 2015 | B2 |
9072536 | Shelton, IV et al. | Jul 2015 | B2 |
9072538 | Suzuki et al. | Jul 2015 | B2 |
9072539 | Messerly et al. | Jul 2015 | B2 |
9084624 | Larkin et al. | Jul 2015 | B2 |
9089327 | Worrell et al. | Jul 2015 | B2 |
9089360 | Messerly et al. | Jul 2015 | B2 |
9095333 | Konesky et al. | Aug 2015 | B2 |
9095362 | Dachs, II et al. | Aug 2015 | B2 |
9095367 | Olson et al. | Aug 2015 | B2 |
9099863 | Smith et al. | Aug 2015 | B2 |
9101358 | Kerr et al. | Aug 2015 | B2 |
9101385 | Shelton, IV et al. | Aug 2015 | B2 |
9107684 | Ma | Aug 2015 | B2 |
9107689 | Robertson et al. | Aug 2015 | B2 |
9107690 | Bales, Jr. et al. | Aug 2015 | B2 |
9113900 | Buysse et al. | Aug 2015 | B2 |
9113907 | Allen, IV et al. | Aug 2015 | B2 |
9113940 | Twomey | Aug 2015 | B2 |
9119657 | Shelton, IV et al. | Sep 2015 | B2 |
9119957 | Gantz et al. | Sep 2015 | B2 |
9125662 | Shelton, IV | Sep 2015 | B2 |
9125667 | Stone et al. | Sep 2015 | B2 |
9144453 | Rencher et al. | Sep 2015 | B2 |
9147965 | Lee | Sep 2015 | B2 |
9149324 | Huang et al. | Oct 2015 | B2 |
9149325 | Worrell et al. | Oct 2015 | B2 |
9161803 | Yates et al. | Oct 2015 | B2 |
9165114 | Jain et al. | Oct 2015 | B2 |
9168054 | Turner et al. | Oct 2015 | B2 |
9168085 | Juzkiw et al. | Oct 2015 | B2 |
9168089 | Buysse et al. | Oct 2015 | B2 |
9173656 | Schurr et al. | Nov 2015 | B2 |
9179912 | Yates et al. | Nov 2015 | B2 |
9186199 | Strauss et al. | Nov 2015 | B2 |
9186204 | Nishimura et al. | Nov 2015 | B2 |
9186796 | Ogawa | Nov 2015 | B2 |
9192380 | (Tarinelli) Racenet et al. | Nov 2015 | B2 |
9192421 | Garrison | Nov 2015 | B2 |
9192428 | Houser et al. | Nov 2015 | B2 |
9192431 | Woodruff et al. | Nov 2015 | B2 |
9198714 | Worrell et al. | Dec 2015 | B2 |
9198715 | Livneh | Dec 2015 | B2 |
9198718 | Marczyk et al. | Dec 2015 | B2 |
9198776 | Young | Dec 2015 | B2 |
9204879 | Shelton, IV | Dec 2015 | B2 |
9204891 | Weitzman | Dec 2015 | B2 |
9204918 | Germain et al. | Dec 2015 | B2 |
9204923 | Manzo et al. | Dec 2015 | B2 |
9216050 | Condie et al. | Dec 2015 | B2 |
9216051 | Fischer et al. | Dec 2015 | B2 |
9216062 | Duque et al. | Dec 2015 | B2 |
9220483 | Frankhouser et al. | Dec 2015 | B2 |
9220527 | Houser et al. | Dec 2015 | B2 |
9220559 | Worrell et al. | Dec 2015 | B2 |
9226750 | Weir et al. | Jan 2016 | B2 |
9226751 | Shelton, IV et al. | Jan 2016 | B2 |
9226766 | Aldridge et al. | Jan 2016 | B2 |
9226767 | Stulen et al. | Jan 2016 | B2 |
9232979 | Parihar et al. | Jan 2016 | B2 |
9237891 | Shelton, IV | Jan 2016 | B2 |
9237921 | Messerly et al. | Jan 2016 | B2 |
9241060 | Fujisaki | Jan 2016 | B1 |
9241692 | Gunday et al. | Jan 2016 | B2 |
9241728 | Price et al. | Jan 2016 | B2 |
9241730 | Babaev | Jan 2016 | B2 |
9241731 | Boudreaux et al. | Jan 2016 | B2 |
9241768 | Sandhu et al. | Jan 2016 | B2 |
9247953 | Palmer et al. | Feb 2016 | B2 |
9254165 | Aronow et al. | Feb 2016 | B2 |
9259234 | Robertson et al. | Feb 2016 | B2 |
9259265 | Harris et al. | Feb 2016 | B2 |
9265567 | Orban, III et al. | Feb 2016 | B2 |
9265926 | Strobl et al. | Feb 2016 | B2 |
9265973 | Akagane | Feb 2016 | B2 |
9266310 | Krogdahl et al. | Feb 2016 | B2 |
9277962 | Koss et al. | Mar 2016 | B2 |
9282974 | Shelton, IV | Mar 2016 | B2 |
9283027 | Monson et al. | Mar 2016 | B2 |
9283045 | Rhee et al. | Mar 2016 | B2 |
9283054 | Morgan et al. | Mar 2016 | B2 |
9289256 | Shelton, IV et al. | Mar 2016 | B2 |
9295514 | Shelton, IV et al. | Mar 2016 | B2 |
9301759 | Spivey et al. | Apr 2016 | B2 |
9305497 | Seo et al. | Apr 2016 | B2 |
9307388 | Liang et al. | Apr 2016 | B2 |
9307986 | Hall et al. | Apr 2016 | B2 |
9308009 | Madan et al. | Apr 2016 | B2 |
9308014 | Fischer | Apr 2016 | B2 |
9314261 | Bales, Jr. et al. | Apr 2016 | B2 |
9314292 | Trees et al. | Apr 2016 | B2 |
9314301 | Ben-Haim et al. | Apr 2016 | B2 |
9326754 | Polster | May 2016 | B2 |
9326767 | Koch, Jr. et al. | May 2016 | B2 |
9326787 | Sanai et al. | May 2016 | B2 |
9326788 | Batross et al. | May 2016 | B2 |
9332987 | Leimbach et al. | May 2016 | B2 |
9333025 | Monson et al. | May 2016 | B2 |
9333034 | Hancock | May 2016 | B2 |
9339289 | Robertson | May 2016 | B2 |
9339323 | Eder et al. | May 2016 | B2 |
9339326 | McCullagh et al. | May 2016 | B2 |
9345481 | Hall et al. | May 2016 | B2 |
9345534 | Artale et al. | May 2016 | B2 |
9345900 | Wu et al. | May 2016 | B2 |
9351642 | Nadkarni et al. | May 2016 | B2 |
9351726 | Leimbach et al. | May 2016 | B2 |
9351727 | Leimbach et al. | May 2016 | B2 |
9351754 | Vakharia et al. | May 2016 | B2 |
9352173 | Yamada et al. | May 2016 | B2 |
9358003 | Hall et al. | Jun 2016 | B2 |
9358065 | Ladtkow et al. | Jun 2016 | B2 |
9364171 | Harris et al. | Jun 2016 | B2 |
9364230 | Shelton, IV et al. | Jun 2016 | B2 |
9364279 | Houser et al. | Jun 2016 | B2 |
9370364 | Smith et al. | Jun 2016 | B2 |
9370400 | Parihar | Jun 2016 | B2 |
9370611 | Ross et al. | Jun 2016 | B2 |
9375206 | Vidal et al. | Jun 2016 | B2 |
9375230 | Ross et al. | Jun 2016 | B2 |
9375232 | Hunt et al. | Jun 2016 | B2 |
9375256 | Cunningham et al. | Jun 2016 | B2 |
9375264 | Horner et al. | Jun 2016 | B2 |
9375267 | Kerr et al. | Jun 2016 | B2 |
9385831 | Marr et al. | Jul 2016 | B2 |
9386983 | Swensgard et al. | Jul 2016 | B2 |
9393037 | Olson et al. | Jul 2016 | B2 |
9393070 | Gelfand et al. | Jul 2016 | B2 |
9398911 | Auld | Jul 2016 | B2 |
9402680 | Ginnebaugh et al. | Aug 2016 | B2 |
9402682 | Worrell et al. | Aug 2016 | B2 |
9408606 | Shelton, IV | Aug 2016 | B2 |
9408622 | Stulen et al. | Aug 2016 | B2 |
9408660 | Strobl et al. | Aug 2016 | B2 |
9414853 | Stulen et al. | Aug 2016 | B2 |
9414880 | Monson et al. | Aug 2016 | B2 |
9421014 | Ingmanson et al. | Aug 2016 | B2 |
9421060 | Monson et al. | Aug 2016 | B2 |
9427249 | Robertson et al. | Aug 2016 | B2 |
9427279 | Muniz-Medina et al. | Aug 2016 | B2 |
9439668 | Timm et al. | Sep 2016 | B2 |
9439669 | Wiener et al. | Sep 2016 | B2 |
9439671 | Akagane | Sep 2016 | B2 |
9442288 | Tanimura | Sep 2016 | B2 |
9445784 | O'Keeffe | Sep 2016 | B2 |
9445832 | Wiener et al. | Sep 2016 | B2 |
9451967 | Jordan et al. | Sep 2016 | B2 |
9456863 | Moua | Oct 2016 | B2 |
9456864 | Witt et al. | Oct 2016 | B2 |
9468438 | Baber et al. | Oct 2016 | B2 |
9468498 | Sigmon, Jr. | Oct 2016 | B2 |
9474542 | Slipszenko et al. | Oct 2016 | B2 |
9474568 | Akagane | Oct 2016 | B2 |
9486236 | Price et al. | Nov 2016 | B2 |
9492146 | Kostrzewski et al. | Nov 2016 | B2 |
9492224 | Boudreaux et al. | Nov 2016 | B2 |
9498245 | Voegele et al. | Nov 2016 | B2 |
9498275 | Wham et al. | Nov 2016 | B2 |
9504483 | Houser et al. | Nov 2016 | B2 |
9504520 | Worrell et al. | Nov 2016 | B2 |
9504524 | Behnke, II | Nov 2016 | B2 |
9504855 | Messerly et al. | Nov 2016 | B2 |
9510850 | Robertson et al. | Dec 2016 | B2 |
9510906 | Boudreaux et al. | Dec 2016 | B2 |
9522029 | Yates et al. | Dec 2016 | B2 |
9522032 | Behnke | Dec 2016 | B2 |
9526564 | Rusin | Dec 2016 | B2 |
9526565 | Strobl | Dec 2016 | B2 |
9545253 | Worrell et al. | Jan 2017 | B2 |
9545497 | Wenderow et al. | Jan 2017 | B2 |
9554465 | Liu et al. | Jan 2017 | B1 |
9554794 | Baber et al. | Jan 2017 | B2 |
9554846 | Boudreaux | Jan 2017 | B2 |
9554854 | Yates et al. | Jan 2017 | B2 |
9560995 | Addison et al. | Feb 2017 | B2 |
9561038 | Shelton, IV et al. | Feb 2017 | B2 |
9572592 | Price et al. | Feb 2017 | B2 |
9574644 | Parihar | Feb 2017 | B2 |
9585714 | Livneh | Mar 2017 | B2 |
9592056 | Mozdzierz et al. | Mar 2017 | B2 |
9592072 | Akagane | Mar 2017 | B2 |
9597143 | Madan et al. | Mar 2017 | B2 |
9603669 | Govari et al. | Mar 2017 | B2 |
9610091 | Johnson et al. | Apr 2017 | B2 |
9610114 | Baxter, III et al. | Apr 2017 | B2 |
9615877 | Tyrrell et al. | Apr 2017 | B2 |
9623237 | Turner et al. | Apr 2017 | B2 |
9629623 | Lytle, IV et al. | Apr 2017 | B2 |
9629629 | Leimbach et al. | Apr 2017 | B2 |
9632573 | Ogawa et al. | Apr 2017 | B2 |
9636135 | Stulen | May 2017 | B2 |
9636165 | Larson et al. | May 2017 | B2 |
9636167 | Gregg | May 2017 | B2 |
9638770 | Dietz et al. | May 2017 | B2 |
9642644 | Houser et al. | May 2017 | B2 |
9642669 | Takashino et al. | May 2017 | B2 |
9643052 | Tchao et al. | May 2017 | B2 |
9649110 | Parihar et al. | May 2017 | B2 |
9649111 | Shelton, IV et al. | May 2017 | B2 |
9649126 | Robertson et al. | May 2017 | B2 |
9649173 | Choi et al. | May 2017 | B2 |
9655670 | Larson et al. | May 2017 | B2 |
9662131 | Omori et al. | May 2017 | B2 |
9668806 | Unger et al. | Jun 2017 | B2 |
9671860 | Ogawa et al. | Jun 2017 | B2 |
9674949 | Liu et al. | Jun 2017 | B1 |
9675374 | Stulen et al. | Jun 2017 | B2 |
9675375 | Houser et al. | Jun 2017 | B2 |
9681884 | Clem et al. | Jun 2017 | B2 |
9687230 | Leimbach et al. | Jun 2017 | B2 |
9687290 | Keller | Jun 2017 | B2 |
9690362 | Leimbach et al. | Jun 2017 | B2 |
9693817 | Mehta et al. | Jul 2017 | B2 |
9700309 | Jaworek et al. | Jul 2017 | B2 |
9700339 | Nield | Jul 2017 | B2 |
9700343 | Messerly et al. | Jul 2017 | B2 |
9705456 | Gilbert | Jul 2017 | B2 |
9707004 | Houser et al. | Jul 2017 | B2 |
9707027 | Ruddenklau et al. | Jul 2017 | B2 |
9707030 | Davison et al. | Jul 2017 | B2 |
9713507 | Stulen et al. | Jul 2017 | B2 |
9717548 | Couture | Aug 2017 | B2 |
9717552 | Cosman et al. | Aug 2017 | B2 |
9724094 | Baber et al. | Aug 2017 | B2 |
9724118 | Schulte et al. | Aug 2017 | B2 |
9724120 | Faller et al. | Aug 2017 | B2 |
9724152 | Horlle et al. | Aug 2017 | B2 |
9730695 | Leimbach et al. | Aug 2017 | B2 |
9733663 | Leimbach et al. | Aug 2017 | B2 |
9737301 | Baber et al. | Aug 2017 | B2 |
9737326 | Worrell et al. | Aug 2017 | B2 |
9737355 | Yates et al. | Aug 2017 | B2 |
9737358 | Beckman et al. | Aug 2017 | B2 |
9743929 | Leimbach et al. | Aug 2017 | B2 |
9743946 | Faller et al. | Aug 2017 | B2 |
9743947 | Price et al. | Aug 2017 | B2 |
9750499 | Leimbach et al. | Sep 2017 | B2 |
9757128 | Baber et al. | Sep 2017 | B2 |
9757142 | Shimizu | Sep 2017 | B2 |
9757150 | Alexander et al. | Sep 2017 | B2 |
9757186 | Boudreaux et al. | Sep 2017 | B2 |
9764164 | Wiener et al. | Sep 2017 | B2 |
9770285 | Zoran et al. | Sep 2017 | B2 |
9782169 | Kimsey et al. | Oct 2017 | B2 |
9782214 | Houser et al. | Oct 2017 | B2 |
9788836 | Overmyer et al. | Oct 2017 | B2 |
9788851 | Dannaher et al. | Oct 2017 | B2 |
9795405 | Price et al. | Oct 2017 | B2 |
9795436 | Yates et al. | Oct 2017 | B2 |
9795808 | Messerly et al. | Oct 2017 | B2 |
9801626 | Parihar et al. | Oct 2017 | B2 |
9801648 | Houser et al. | Oct 2017 | B2 |
9802033 | Hibner et al. | Oct 2017 | B2 |
9804618 | Leimbach et al. | Oct 2017 | B2 |
9808244 | Leimbach et al. | Nov 2017 | B2 |
9808246 | Shelton, IV et al. | Nov 2017 | B2 |
9808308 | Faller et al. | Nov 2017 | B2 |
9814460 | Kimsey et al. | Nov 2017 | B2 |
9814514 | Shelton, IV et al. | Nov 2017 | B2 |
9815211 | Cao et al. | Nov 2017 | B2 |
9820738 | Lytle, IV et al. | Nov 2017 | B2 |
9820768 | Gee et al. | Nov 2017 | B2 |
9820771 | Norton et al. | Nov 2017 | B2 |
9820806 | Lee et al. | Nov 2017 | B2 |
9826976 | Parihar et al. | Nov 2017 | B2 |
9826977 | Leimbach et al. | Nov 2017 | B2 |
9839443 | Brockman et al. | Dec 2017 | B2 |
9844368 | Boudreaux et al. | Dec 2017 | B2 |
9844374 | Lytle, IV et al. | Dec 2017 | B2 |
9844375 | Overmyer et al. | Dec 2017 | B2 |
9848901 | Robertson et al. | Dec 2017 | B2 |
9848902 | Price et al. | Dec 2017 | B2 |
9848937 | Trees et al. | Dec 2017 | B2 |
9861381 | Johnson | Jan 2018 | B2 |
9861428 | Trees et al. | Jan 2018 | B2 |
9867612 | Parihar et al. | Jan 2018 | B2 |
9867651 | Wham | Jan 2018 | B2 |
9867670 | Brannan et al. | Jan 2018 | B2 |
9872722 | Lech | Jan 2018 | B2 |
9872725 | Worrell et al. | Jan 2018 | B2 |
9872726 | Morisaki | Jan 2018 | B2 |
9877720 | Worrell et al. | Jan 2018 | B2 |
9877776 | Boudreaux | Jan 2018 | B2 |
9877782 | Voegele et al. | Jan 2018 | B2 |
9878184 | Beaupre | Jan 2018 | B2 |
9883860 | Leimbach et al. | Feb 2018 | B2 |
9883884 | Neurohr et al. | Feb 2018 | B2 |
9888919 | Leimbach et al. | Feb 2018 | B2 |
9888958 | Evans et al. | Feb 2018 | B2 |
9895148 | Shelton, IV et al. | Feb 2018 | B2 |
9895160 | Fan et al. | Feb 2018 | B2 |
9901321 | Harks et al. | Feb 2018 | B2 |
9901342 | Shelton, IV et al. | Feb 2018 | B2 |
9901383 | Hassler, Jr. | Feb 2018 | B2 |
9901754 | Yamada | Feb 2018 | B2 |
9907563 | Germain et al. | Mar 2018 | B2 |
9913642 | Leimbach et al. | Mar 2018 | B2 |
9913656 | Stulen | Mar 2018 | B2 |
9913680 | Voegele et al. | Mar 2018 | B2 |
9918730 | Trees et al. | Mar 2018 | B2 |
9924961 | Shelton, IV et al. | Mar 2018 | B2 |
9925003 | Parihar et al. | Mar 2018 | B2 |
9931118 | Shelton, IV et al. | Apr 2018 | B2 |
9937001 | Nakamura | Apr 2018 | B2 |
9943309 | Shelton, IV et al. | Apr 2018 | B2 |
9949785 | Price et al. | Apr 2018 | B2 |
9949788 | Boudreaux | Apr 2018 | B2 |
9962182 | Dietz et al. | May 2018 | B2 |
9968355 | Shelton, IV et al. | May 2018 | B2 |
9974539 | Yates et al. | May 2018 | B2 |
9987000 | Shelton, IV et al. | Jun 2018 | B2 |
9987033 | Neurohr et al. | Jun 2018 | B2 |
9993248 | Shelton, IV et al. | Jun 2018 | B2 |
9993258 | Shelton, IV et al. | Jun 2018 | B2 |
9993289 | Sobajima et al. | Jun 2018 | B2 |
10004497 | Overmyer et al. | Jun 2018 | B2 |
10004501 | Shelton, IV et al. | Jun 2018 | B2 |
10004526 | Dycus et al. | Jun 2018 | B2 |
10004527 | Gee et al. | Jun 2018 | B2 |
D822206 | Shelton, IV et al. | Jul 2018 | S |
10010339 | Witt et al. | Jul 2018 | B2 |
10010341 | Houser et al. | Jul 2018 | B2 |
10013049 | Leimbach et al. | Jul 2018 | B2 |
10016199 | Baber et al. | Jul 2018 | B2 |
10016207 | Suzuki et al. | Jul 2018 | B2 |
10022142 | Aranyi et al. | Jul 2018 | B2 |
10022567 | Messerly et al. | Jul 2018 | B2 |
10022568 | Messerly et al. | Jul 2018 | B2 |
10028761 | Leimbach et al. | Jul 2018 | B2 |
10028786 | Mucilli et al. | Jul 2018 | B2 |
10034684 | Weisenburgh, II et al. | Jul 2018 | B2 |
10034704 | Asher et al. | Jul 2018 | B2 |
D826405 | Shelton, IV et al. | Aug 2018 | S |
10039588 | Harper et al. | Aug 2018 | B2 |
10041822 | Zemlok | Aug 2018 | B2 |
10045776 | Shelton, IV et al. | Aug 2018 | B2 |
10045779 | Savage et al. | Aug 2018 | B2 |
10045794 | Witt et al. | Aug 2018 | B2 |
10045810 | Schall et al. | Aug 2018 | B2 |
10045819 | Jensen et al. | Aug 2018 | B2 |
10052044 | Shelton, IV et al. | Aug 2018 | B2 |
10052102 | Baxter, III et al. | Aug 2018 | B2 |
10070916 | Artale | Sep 2018 | B2 |
10080609 | Hancock et al. | Sep 2018 | B2 |
10085748 | Morgan et al. | Oct 2018 | B2 |
10085762 | Timm et al. | Oct 2018 | B2 |
10085792 | Johnson et al. | Oct 2018 | B2 |
10092310 | Boudreaux et al. | Oct 2018 | B2 |
10092344 | Mohr et al. | Oct 2018 | B2 |
10092347 | Weisshaupt et al. | Oct 2018 | B2 |
10092348 | Boudreaux | Oct 2018 | B2 |
10092350 | Rothweiler et al. | Oct 2018 | B2 |
10105140 | Malinouskas et al. | Oct 2018 | B2 |
10111679 | Baber et al. | Oct 2018 | B2 |
10111699 | Boudreaux | Oct 2018 | B2 |
10111703 | Cosman, Jr. et al. | Oct 2018 | B2 |
10117649 | Baxter, III et al. | Nov 2018 | B2 |
10117667 | Robertson et al. | Nov 2018 | B2 |
10117702 | Danziger et al. | Nov 2018 | B2 |
10123835 | Keller et al. | Nov 2018 | B2 |
10130367 | Cappola et al. | Nov 2018 | B2 |
10130410 | Strobl et al. | Nov 2018 | B2 |
10130412 | Wham | Nov 2018 | B2 |
10135242 | Baber et al. | Nov 2018 | B2 |
10136887 | Shelton, IV et al. | Nov 2018 | B2 |
10149680 | Parihar et al. | Dec 2018 | B2 |
10154848 | Chernov et al. | Dec 2018 | B2 |
10154852 | Conlon et al. | Dec 2018 | B2 |
10159483 | Beckman et al. | Dec 2018 | B2 |
10159524 | Yates et al. | Dec 2018 | B2 |
10166060 | Johnson et al. | Jan 2019 | B2 |
10172665 | Heckel et al. | Jan 2019 | B2 |
10172669 | Felder et al. | Jan 2019 | B2 |
10178992 | Wise et al. | Jan 2019 | B2 |
10179022 | Yates et al. | Jan 2019 | B2 |
10180463 | Beckman et al. | Jan 2019 | B2 |
10182816 | Shelton, IV et al. | Jan 2019 | B2 |
10182818 | Hensel et al. | Jan 2019 | B2 |
10188385 | Kerr et al. | Jan 2019 | B2 |
10188455 | Hancock et al. | Jan 2019 | B2 |
10194907 | Marczyk et al. | Feb 2019 | B2 |
10194972 | Yates et al. | Feb 2019 | B2 |
10194973 | Wiener et al. | Feb 2019 | B2 |
10194976 | Boudreaux | Feb 2019 | B2 |
10194977 | Yang | Feb 2019 | B2 |
10194999 | Bacher et al. | Feb 2019 | B2 |
10201364 | Leimbach et al. | Feb 2019 | B2 |
10201365 | Boudreaux et al. | Feb 2019 | B2 |
10201382 | Wiener et al. | Feb 2019 | B2 |
10206676 | Shelton, IV | Feb 2019 | B2 |
10226250 | Beckman et al. | Mar 2019 | B2 |
10226273 | Messerly et al. | Mar 2019 | B2 |
10231747 | Stulen et al. | Mar 2019 | B2 |
10238385 | Yates et al. | Mar 2019 | B2 |
10238391 | Leimbach et al. | Mar 2019 | B2 |
10245027 | Shelton, IV et al. | Apr 2019 | B2 |
10245028 | Shelton, IV et al. | Apr 2019 | B2 |
10245029 | Hunter et al. | Apr 2019 | B2 |
10245030 | Hunter et al. | Apr 2019 | B2 |
10245033 | Overmyer et al. | Apr 2019 | B2 |
10245095 | Boudreaux | Apr 2019 | B2 |
10245097 | Honda et al. | Apr 2019 | B2 |
10245104 | McKenna et al. | Apr 2019 | B2 |
10251664 | Shelton, IV et al. | Apr 2019 | B2 |
10258331 | Shelton, IV et al. | Apr 2019 | B2 |
10258505 | Ovchinnikov | Apr 2019 | B2 |
10263171 | Wiener et al. | Apr 2019 | B2 |
10265068 | Harris et al. | Apr 2019 | B2 |
10265117 | Wiener et al. | Apr 2019 | B2 |
10265118 | Gerhardt | Apr 2019 | B2 |
10271840 | Sapre | Apr 2019 | B2 |
10271851 | Shelton, IV et al. | Apr 2019 | B2 |
D847989 | Shelton, IV et al. | May 2019 | S |
10278721 | Dietz et al. | May 2019 | B2 |
10285705 | Shelton, IV et al. | May 2019 | B2 |
10285724 | Faller et al. | May 2019 | B2 |
10285750 | Coulson et al. | May 2019 | B2 |
10292704 | Harris et al. | May 2019 | B2 |
10299810 | Robertson et al. | May 2019 | B2 |
10299821 | Shelton, IV et al. | May 2019 | B2 |
D850617 | Shelton, IV et al. | Jun 2019 | S |
D851762 | Shelton, IV et al. | Jun 2019 | S |
10307159 | Harris et al. | Jun 2019 | B2 |
10314579 | Chowaniec et al. | Jun 2019 | B2 |
10314582 | Shelton, IV et al. | Jun 2019 | B2 |
10314638 | Gee et al. | Jun 2019 | B2 |
10321907 | Shelton, IV et al. | Jun 2019 | B2 |
10321950 | Yates et al. | Jun 2019 | B2 |
D854151 | Shelton, IV et al. | Jul 2019 | S |
10335149 | Baxter, III et al. | Jul 2019 | B2 |
10335182 | Stulen et al. | Jul 2019 | B2 |
10335183 | Worrell et al. | Jul 2019 | B2 |
10335614 | Messerly et al. | Jul 2019 | B2 |
10342543 | Shelton, IV et al. | Jul 2019 | B2 |
10342602 | Strobl et al. | Jul 2019 | B2 |
10342606 | Cosman et al. | Jul 2019 | B2 |
10342623 | Huelman et al. | Jul 2019 | B2 |
10348941 | Elliot, Jr. et al. | Jul 2019 | B2 |
10349999 | Yates et al. | Jul 2019 | B2 |
10350016 | Burbank et al. | Jul 2019 | B2 |
10350025 | Loyd et al. | Jul 2019 | B1 |
10357246 | Shelton, IV et al. | Jul 2019 | B2 |
10357247 | Shelton, IV et al. | Jul 2019 | B2 |
10357303 | Conlon et al. | Jul 2019 | B2 |
10363084 | Friedrichs | Jul 2019 | B2 |
10368861 | Baxter, III et al. | Aug 2019 | B2 |
10368865 | Harris et al. | Aug 2019 | B2 |
10376263 | Morgan et al. | Aug 2019 | B2 |
10376305 | Yates et al. | Aug 2019 | B2 |
10390841 | Shelton, IV et al. | Aug 2019 | B2 |
10398439 | Cabrera et al. | Sep 2019 | B2 |
10398466 | Stulen et al. | Sep 2019 | B2 |
10398497 | Batross et al. | Sep 2019 | B2 |
10405857 | Shelton, IV et al. | Sep 2019 | B2 |
10405863 | Wise et al. | Sep 2019 | B2 |
10413291 | Worthington et al. | Sep 2019 | B2 |
10413293 | Shelton, IV et al. | Sep 2019 | B2 |
10413297 | Harris et al. | Sep 2019 | B2 |
10413352 | Thomas et al. | Sep 2019 | B2 |
10413353 | Kerr et al. | Sep 2019 | B2 |
10420552 | Shelton, IV et al. | Sep 2019 | B2 |
10420579 | Wiener et al. | Sep 2019 | B2 |
10420607 | Woloszko et al. | Sep 2019 | B2 |
D865175 | Widenhouse et al. | Oct 2019 | S |
10426471 | Shelton, IV et al. | Oct 2019 | B2 |
10426507 | Wiener et al. | Oct 2019 | B2 |
10426546 | Graham et al. | Oct 2019 | B2 |
10426978 | Akagane | Oct 2019 | B2 |
10433837 | Worthington et al. | Oct 2019 | B2 |
10433849 | Shelton, IV et al. | Oct 2019 | B2 |
10433865 | Witt et al. | Oct 2019 | B2 |
10433866 | Witt et al. | Oct 2019 | B2 |
10433900 | Harris et al. | Oct 2019 | B2 |
10441279 | Shelton, IV et al. | Oct 2019 | B2 |
10441308 | Robertson | Oct 2019 | B2 |
10441310 | Olson et al. | Oct 2019 | B2 |
10441345 | Aldridge et al. | Oct 2019 | B2 |
10448948 | Shelton, IV et al. | Oct 2019 | B2 |
10448950 | Shelton, IV et al. | Oct 2019 | B2 |
10448986 | Zikorus et al. | Oct 2019 | B2 |
10456140 | Shelton, IV et al. | Oct 2019 | B2 |
10456193 | Yates et al. | Oct 2019 | B2 |
10463421 | Boudreaux et al. | Nov 2019 | B2 |
10463887 | Witt et al. | Nov 2019 | B2 |
10470762 | Leimbach et al. | Nov 2019 | B2 |
10470764 | Baxter, III et al. | Nov 2019 | B2 |
10478182 | Taylor | Nov 2019 | B2 |
10478190 | Miller et al. | Nov 2019 | B2 |
10485542 | Shelton, IV et al. | Nov 2019 | B2 |
10485543 | Shelton, IV et al. | Nov 2019 | B2 |
10485607 | Strobl et al. | Nov 2019 | B2 |
D869655 | Shelton, IV et al. | Dec 2019 | S |
10492785 | Overmyer et al. | Dec 2019 | B2 |
10492849 | Juergens et al. | Dec 2019 | B2 |
10499914 | Huang et al. | Dec 2019 | B2 |
10507033 | Dickerson et al. | Dec 2019 | B2 |
10512795 | Voegele et al. | Dec 2019 | B2 |
10517595 | Hunter et al. | Dec 2019 | B2 |
10517596 | Hunter et al. | Dec 2019 | B2 |
10517627 | Timm et al. | Dec 2019 | B2 |
10524787 | Shelton, IV et al. | Jan 2020 | B2 |
10524789 | Swayze et al. | Jan 2020 | B2 |
10524854 | Woodruff et al. | Jan 2020 | B2 |
10524872 | Stewart et al. | Jan 2020 | B2 |
10531874 | Morgan et al. | Jan 2020 | B2 |
10537324 | Shelton, IV et al. | Jan 2020 | B2 |
10537325 | Bakos et al. | Jan 2020 | B2 |
10537351 | Shelton, IV et al. | Jan 2020 | B2 |
10542979 | Shelton, IV et al. | Jan 2020 | B2 |
10542982 | Beckman et al. | Jan 2020 | B2 |
10542991 | Shelton, IV et al. | Jan 2020 | B2 |
10543008 | Vakharia et al. | Jan 2020 | B2 |
10548504 | Shelton, IV et al. | Feb 2020 | B2 |
10548655 | Scheib et al. | Feb 2020 | B2 |
10555769 | Worrell et al. | Feb 2020 | B2 |
10561560 | Boutoussov et al. | Feb 2020 | B2 |
10568624 | Shelton, IV et al. | Feb 2020 | B2 |
10568625 | Harris et al. | Feb 2020 | B2 |
10568626 | Shelton, IV et al. | Feb 2020 | B2 |
10568632 | Miller et al. | Feb 2020 | B2 |
10575892 | Danziger et al. | Mar 2020 | B2 |
10582928 | Hunter et al. | Mar 2020 | B2 |
10588625 | Weaner et al. | Mar 2020 | B2 |
10588630 | Shelton, IV et al. | Mar 2020 | B2 |
10588631 | Shelton, IV et al. | Mar 2020 | B2 |
10588632 | Shelton, IV et al. | Mar 2020 | B2 |
10588633 | Shelton, IV et al. | Mar 2020 | B2 |
10595929 | Boudreaux et al. | Mar 2020 | B2 |
10595930 | Scheib et al. | Mar 2020 | B2 |
10603036 | Hunter et al. | Mar 2020 | B2 |
10610224 | Shelton, IV et al. | Apr 2020 | B2 |
10610286 | Wiener et al. | Apr 2020 | B2 |
10610313 | Bailey et al. | Apr 2020 | B2 |
10617412 | Shelton, IV et al. | Apr 2020 | B2 |
10617420 | Shelton, IV et al. | Apr 2020 | B2 |
10617464 | Duppuis | Apr 2020 | B2 |
10624635 | Harris et al. | Apr 2020 | B2 |
10624691 | Wiener et al. | Apr 2020 | B2 |
10631858 | Burbank | Apr 2020 | B2 |
10631859 | Shelton, IV et al. | Apr 2020 | B2 |
10631928 | Basu et al. | Apr 2020 | B2 |
10632630 | Cao et al. | Apr 2020 | B2 |
RE47996 | Turner et al. | May 2020 | E |
10639034 | Harris et al. | May 2020 | B2 |
10639035 | Shelton, IV et al. | May 2020 | B2 |
10639037 | Shelton, IV et al. | May 2020 | B2 |
10639092 | Corbett et al. | May 2020 | B2 |
10639098 | Cosman et al. | May 2020 | B2 |
10646269 | Worrell et al. | May 2020 | B2 |
10646292 | Solomon et al. | May 2020 | B2 |
10653413 | Worthington et al. | May 2020 | B2 |
10660692 | Lesko et al. | May 2020 | B2 |
10667809 | Bakos et al. | Jun 2020 | B2 |
10667810 | Shelton, IV et al. | Jun 2020 | B2 |
10667811 | Harris et al. | Jun 2020 | B2 |
10675021 | Harris et al. | Jun 2020 | B2 |
10675024 | Shelton, IV et al. | Jun 2020 | B2 |
10675025 | Swayze et al. | Jun 2020 | B2 |
10675026 | Harris et al. | Jun 2020 | B2 |
10677764 | Ross et al. | Jun 2020 | B2 |
10682136 | Harris et al. | Jun 2020 | B2 |
10682138 | Shelton, IV et al. | Jun 2020 | B2 |
10687806 | Shelton, IV et al. | Jun 2020 | B2 |
10687809 | Shelton, IV et al. | Jun 2020 | B2 |
10687810 | Shelton, IV et al. | Jun 2020 | B2 |
10687884 | Wiener et al. | Jun 2020 | B2 |
10688321 | Wiener et al. | Jun 2020 | B2 |
10695055 | Shelton, IV et al. | Jun 2020 | B2 |
10695057 | Shelton, IV et al. | Jun 2020 | B2 |
10695058 | Lytle, IV et al. | Jun 2020 | B2 |
10695119 | Smith | Jun 2020 | B2 |
10702270 | Shelton, IV et al. | Jul 2020 | B2 |
10702329 | Strobl et al. | Jul 2020 | B2 |
10709446 | Harris et al. | Jul 2020 | B2 |
10709469 | Shelton, IV et al. | Jul 2020 | B2 |
10709906 | Nield | Jul 2020 | B2 |
10716615 | Shelton, IV et al. | Jul 2020 | B2 |
10722233 | Wellman | Jul 2020 | B2 |
D893717 | Messerly et al. | Aug 2020 | S |
10729458 | Stoddard et al. | Aug 2020 | B2 |
10729494 | Parihar et al. | Aug 2020 | B2 |
10736629 | Shelton, IV et al. | Aug 2020 | B2 |
10736685 | Wiener et al. | Aug 2020 | B2 |
10751108 | Yates et al. | Aug 2020 | B2 |
10751138 | Giordano et al. | Aug 2020 | B2 |
10758229 | Shelton, IV et al. | Sep 2020 | B2 |
10758230 | Shelton, IV et al. | Sep 2020 | B2 |
10758232 | Shelton, IV et al. | Sep 2020 | B2 |
10758294 | Jones | Sep 2020 | B2 |
10765427 | Shelton, IV et al. | Sep 2020 | B2 |
10765470 | Yates et al. | Sep 2020 | B2 |
10772629 | Shelton, IV et al. | Sep 2020 | B2 |
10772630 | Wixey | Sep 2020 | B2 |
10779821 | Harris et al. | Sep 2020 | B2 |
10779823 | Shelton, IV et al. | Sep 2020 | B2 |
10779824 | Shelton, IV et al. | Sep 2020 | B2 |
10779825 | Shelton, IV et al. | Sep 2020 | B2 |
10779845 | Timm et al. | Sep 2020 | B2 |
10779849 | Shelton, IV et al. | Sep 2020 | B2 |
10779879 | Yates et al. | Sep 2020 | B2 |
10786253 | Shelton, IV et al. | Sep 2020 | B2 |
10786276 | Hirai et al. | Sep 2020 | B2 |
10806454 | Kopp | Oct 2020 | B2 |
10813638 | Shelton, IV et al. | Oct 2020 | B2 |
10820938 | Fischer et al. | Nov 2020 | B2 |
10828032 | Leimbach et al. | Nov 2020 | B2 |
10828058 | Shelton, IV et al. | Nov 2020 | B2 |
10835245 | Swayze et al. | Nov 2020 | B2 |
10835246 | Shelton, IV et al. | Nov 2020 | B2 |
10835247 | Shelton, IV et al. | Nov 2020 | B2 |
10835307 | Shelton, IV et al. | Nov 2020 | B2 |
10842492 | Shelton, IV et al. | Nov 2020 | B2 |
10842523 | Shelton, IV et al. | Nov 2020 | B2 |
10842563 | Gilbert et al. | Nov 2020 | B2 |
D906355 | Messerly et al. | Dec 2020 | S |
10856867 | Shelton, IV et al. | Dec 2020 | B2 |
10856868 | Shelton, IV et al. | Dec 2020 | B2 |
10856869 | Shelton, IV et al. | Dec 2020 | B2 |
10856870 | Harris et al. | Dec 2020 | B2 |
10856896 | Eichmann et al. | Dec 2020 | B2 |
10856929 | Yates et al. | Dec 2020 | B2 |
10856934 | Trees et al. | Dec 2020 | B2 |
10874465 | Weir et al. | Dec 2020 | B2 |
D908216 | Messerly et al. | Jan 2021 | S |
10881399 | Shelton, IV et al. | Jan 2021 | B2 |
10881401 | Baber et al. | Jan 2021 | B2 |
10881409 | Cabrera | Jan 2021 | B2 |
10881449 | Boudreaux et al. | Jan 2021 | B2 |
10888322 | Morgan et al. | Jan 2021 | B2 |
10888347 | Witt et al. | Jan 2021 | B2 |
10893863 | Shelton, IV et al. | Jan 2021 | B2 |
10893864 | Harris et al. | Jan 2021 | B2 |
10893883 | Dannaher | Jan 2021 | B2 |
10898186 | Bakos et al. | Jan 2021 | B2 |
10898256 | Yates et al. | Jan 2021 | B2 |
10912559 | Harris et al. | Feb 2021 | B2 |
10912580 | Green et al. | Feb 2021 | B2 |
10912603 | Boudreaux et al. | Feb 2021 | B2 |
10918385 | Overmyer et al. | Feb 2021 | B2 |
10925659 | Shelton, IV et al. | Feb 2021 | B2 |
10926022 | Hickey et al. | Feb 2021 | B2 |
D914878 | Shelton, IV et al. | Mar 2021 | S |
10932766 | Tesar et al. | Mar 2021 | B2 |
10932847 | Yates et al. | Mar 2021 | B2 |
10945727 | Shelton, IV et al. | Mar 2021 | B2 |
10952788 | Asher et al. | Mar 2021 | B2 |
10959727 | Hunter et al. | Mar 2021 | B2 |
10966741 | Illizaliturri-Sanchez et al. | Apr 2021 | B2 |
10966747 | Worrell et al. | Apr 2021 | B2 |
10973516 | Shelton, IV et al. | Apr 2021 | B2 |
10973517 | Wixey | Apr 2021 | B2 |
10973520 | Shelton, IV et al. | Apr 2021 | B2 |
10980536 | Weaner et al. | Apr 2021 | B2 |
10987105 | Cappola et al. | Apr 2021 | B2 |
10987123 | Weir et al. | Apr 2021 | B2 |
10987156 | Trees et al. | Apr 2021 | B2 |
10993715 | Shelton, IV et al. | May 2021 | B2 |
10993716 | Shelton, IV et al. | May 2021 | B2 |
10993763 | Batross et al. | May 2021 | B2 |
11000278 | Shelton, IV et al. | May 2021 | B2 |
11000279 | Shelton, IV et al. | May 2021 | B2 |
11020114 | Shelton, IV et al. | Jun 2021 | B2 |
11020140 | Gee et al. | Jun 2021 | B2 |
11033322 | Wiener et al. | Jun 2021 | B2 |
11039834 | Harris et al. | Jun 2021 | B2 |
11045191 | Shelton, IV et al. | Jun 2021 | B2 |
11045192 | Harris et al. | Jun 2021 | B2 |
11045275 | Boudreaux et al. | Jun 2021 | B2 |
11051840 | Shelton, IV et al. | Jul 2021 | B2 |
11051873 | Wiener et al. | Jul 2021 | B2 |
11058424 | Shelton, IV et al. | Jul 2021 | B2 |
11058447 | Houser | Jul 2021 | B2 |
11058448 | Shelton, IV et al. | Jul 2021 | B2 |
11058475 | Wiener et al. | Jul 2021 | B2 |
11064997 | Shelton, IV et al. | Jul 2021 | B2 |
11065048 | Messerly et al. | Jul 2021 | B2 |
11083455 | Shelton, IV et al. | Aug 2021 | B2 |
11083458 | Harris et al. | Aug 2021 | B2 |
11090048 | Fanelli et al. | Aug 2021 | B2 |
11090049 | Bakos et al. | Aug 2021 | B2 |
11090104 | Wiener et al. | Aug 2021 | B2 |
11096688 | Shelton, IV et al. | Aug 2021 | B2 |
11096752 | Stulen et al. | Aug 2021 | B2 |
11109866 | Shelton, IV et al. | Sep 2021 | B2 |
11129611 | Shelton, IV et al. | Sep 2021 | B2 |
11129666 | Messerly et al. | Sep 2021 | B2 |
11129669 | Stulen et al. | Sep 2021 | B2 |
11129670 | Shelton, IV et al. | Sep 2021 | B2 |
11134942 | Harris et al. | Oct 2021 | B2 |
11134978 | Shelton, IV et al. | Oct 2021 | B2 |
11141154 | Shelton, IV et al. | Oct 2021 | B2 |
11141213 | Yates et al. | Oct 2021 | B2 |
11147551 | Shelton, IV | Oct 2021 | B2 |
11147553 | Shelton, IV | Oct 2021 | B2 |
11160551 | Shelton, IV et al. | Nov 2021 | B2 |
11166716 | Shelton, IV et al. | Nov 2021 | B2 |
11172929 | Shelton, IV | Nov 2021 | B2 |
11179155 | Shelton, IV et al. | Nov 2021 | B2 |
11179173 | Price et al. | Nov 2021 | B2 |
11191539 | Overmyer et al. | Dec 2021 | B2 |
11191540 | Aronhalt et al. | Dec 2021 | B2 |
11197668 | Shelton, IV et al. | Dec 2021 | B2 |
11202670 | Worrell et al. | Dec 2021 | B2 |
11207065 | Harris et al. | Dec 2021 | B2 |
11207067 | Shelton, IV et al. | Dec 2021 | B2 |
11213293 | Worthington et al. | Jan 2022 | B2 |
11213294 | Shelton, IV et al. | Jan 2022 | B2 |
11219453 | Shelton, IV et al. | Jan 2022 | B2 |
11224426 | Shelton, IV et al. | Jan 2022 | B2 |
11224497 | Shelton, IV et al. | Jan 2022 | B2 |
11229437 | Shelton, IV et al. | Jan 2022 | B2 |
11229450 | Shelton, IV et al. | Jan 2022 | B2 |
11229471 | Shelton, IV et al. | Jan 2022 | B2 |
11229472 | Shelton, IV et al. | Jan 2022 | B2 |
11234698 | Shelton, IV et al. | Feb 2022 | B2 |
11241235 | Shelton, IV et al. | Feb 2022 | B2 |
11246592 | Shelton, IV et al. | Feb 2022 | B2 |
11246625 | Kane et al. | Feb 2022 | B2 |
11246678 | Shelton, IV et al. | Feb 2022 | B2 |
11253256 | Harris et al. | Feb 2022 | B2 |
11259803 | Shelton, IV et al. | Mar 2022 | B2 |
11259805 | Shelton, IV et al. | Mar 2022 | B2 |
11259806 | Shelton, IV et al. | Mar 2022 | B2 |
11259807 | Shelton, IV et al. | Mar 2022 | B2 |
11266405 | Shelton, IV et al. | Mar 2022 | B2 |
11266430 | Clauda et al. | Mar 2022 | B2 |
11272931 | Boudreaux et al. | Mar 2022 | B2 |
11278280 | Shelton, IV et al. | Mar 2022 | B2 |
11284890 | Nalagatla et al. | Mar 2022 | B2 |
11291440 | Harris et al. | Apr 2022 | B2 |
11291444 | Boudreaux et al. | Apr 2022 | B2 |
11291445 | Shelton, IV et al. | Apr 2022 | B2 |
11291447 | Shelton, IV et al. | Apr 2022 | B2 |
11291451 | Shelton, IV | Apr 2022 | B2 |
11298127 | Shelton, IV | Apr 2022 | B2 |
11298129 | Bakos et al. | Apr 2022 | B2 |
11298130 | Bakos et al. | Apr 2022 | B2 |
11304695 | Shelton, IV et al. | Apr 2022 | B2 |
11304696 | Shelton, IV et al. | Apr 2022 | B2 |
11304699 | Shelton, IV et al. | Apr 2022 | B2 |
11311306 | Shelton, IV et al. | Apr 2022 | B2 |
11311326 | Boudreaux | Apr 2022 | B2 |
11311342 | Parihar et al. | Apr 2022 | B2 |
D950728 | Bakos et al. | May 2022 | S |
D952144 | Boudreaux | May 2022 | S |
11317915 | Boudreaux et al. | May 2022 | B2 |
11324503 | Shelton, IV et al. | May 2022 | B2 |
11324527 | Aldridge et al. | May 2022 | B2 |
11324557 | Shelton, IV et al. | May 2022 | B2 |
11331100 | Boudreaux et al. | May 2022 | B2 |
11331101 | Harris et al. | May 2022 | B2 |
11337747 | Voegele et al. | May 2022 | B2 |
11344362 | Yates et al. | May 2022 | B2 |
11350938 | Shelton, IV et al. | Jun 2022 | B2 |
11357503 | Bakos et al. | Jun 2022 | B2 |
11361176 | Shelton, IV et al. | Jun 2022 | B2 |
11369377 | Boudreaux et al. | Jun 2022 | B2 |
11376098 | Shelton, IV et al. | Jul 2022 | B2 |
11382642 | Robertson et al. | Jul 2022 | B2 |
11389161 | Shelton, IV et al. | Jul 2022 | B2 |
11389164 | Yates et al. | Jul 2022 | B2 |
11399837 | Shelton, IV et al. | Aug 2022 | B2 |
11399855 | Boudreaux et al. | Aug 2022 | B2 |
11406382 | Shelton, IV et al. | Aug 2022 | B2 |
11406386 | Baber et al. | Aug 2022 | B2 |
11413060 | Faller et al. | Aug 2022 | B2 |
11419606 | Overmyer et al. | Aug 2022 | B2 |
11419626 | Timm et al. | Aug 2022 | B2 |
11424027 | Shelton, IV | Aug 2022 | B2 |
11426167 | Shelton, IV et al. | Aug 2022 | B2 |
11426191 | Vakharia et al. | Aug 2022 | B2 |
D964564 | Boudreaux | Sep 2022 | S |
11446029 | Shelton, IV et al. | Sep 2022 | B2 |
11452525 | Shelton, IV et al. | Sep 2022 | B2 |
11464511 | Timm et al. | Oct 2022 | B2 |
11464512 | Shelton, IV et al. | Oct 2022 | B2 |
11464601 | Shelton, IV et al. | Oct 2022 | B2 |
11471155 | Shelton, IV et al. | Oct 2022 | B2 |
11471156 | Shelton, IV et al. | Oct 2022 | B2 |
11471206 | Henderson et al. | Oct 2022 | B2 |
11471209 | Yates et al. | Oct 2022 | B2 |
11478242 | Shelton, IV et al. | Oct 2022 | B2 |
11484310 | Shelton, IV et al. | Nov 2022 | B2 |
11497547 | McKenna et al. | Nov 2022 | B2 |
11504122 | Shelton, IV et al. | Nov 2022 | B2 |
11517309 | Bakos et al. | Dec 2022 | B2 |
11529137 | Shelton, IV et al. | Dec 2022 | B2 |
11529139 | Shelton, IV et al. | Dec 2022 | B2 |
11553971 | Shelton, IV et al. | Jan 2023 | B2 |
11559304 | Boudreaux et al. | Jan 2023 | B2 |
11559307 | Shelton, IV et al. | Jan 2023 | B2 |
11559308 | Yates et al. | Jan 2023 | B2 |
11559347 | Wiener et al. | Jan 2023 | B2 |
11571210 | Shelton, IV et al. | Feb 2023 | B2 |
11576672 | Shelton, IV et al. | Feb 2023 | B2 |
11576677 | Shelton, IV et al. | Feb 2023 | B2 |
11583306 | Olson et al. | Feb 2023 | B2 |
11589865 | Shelton, IV et al. | Feb 2023 | B2 |
11589888 | Shelton, IV et al. | Feb 2023 | B2 |
11589916 | Shelton, IV et al. | Feb 2023 | B2 |
11607219 | Shelton, IV et al. | Mar 2023 | B2 |
11653920 | Shelton, IV et al. | May 2023 | B2 |
20010025173 | Ritchie et al. | Sep 2001 | A1 |
20010025183 | Shahidi | Sep 2001 | A1 |
20010025184 | Messerly | Sep 2001 | A1 |
20010031950 | Ryan | Oct 2001 | A1 |
20010039419 | Francischelli et al. | Nov 2001 | A1 |
20020002377 | Cimino | Jan 2002 | A1 |
20020002380 | Bishop | Jan 2002 | A1 |
20020019649 | Sikora et al. | Feb 2002 | A1 |
20020022836 | Goble et al. | Feb 2002 | A1 |
20020029036 | Goble et al. | Mar 2002 | A1 |
20020029055 | Bonutti | Mar 2002 | A1 |
20020032452 | Tierney et al. | Mar 2002 | A1 |
20020049551 | Friedman et al. | Apr 2002 | A1 |
20020052617 | Anis et al. | May 2002 | A1 |
20020077550 | Rabiner et al. | Jun 2002 | A1 |
20020107517 | Witt et al. | Aug 2002 | A1 |
20020123749 | Jain | Sep 2002 | A1 |
20020133152 | Strul | Sep 2002 | A1 |
20020151884 | Hoey et al. | Oct 2002 | A1 |
20020156466 | Sakurai et al. | Oct 2002 | A1 |
20020156493 | Houser et al. | Oct 2002 | A1 |
20020165577 | Witt et al. | Nov 2002 | A1 |
20020177373 | Shibata et al. | Nov 2002 | A1 |
20020177862 | Aranyi et al. | Nov 2002 | A1 |
20030009164 | Woloszko et al. | Jan 2003 | A1 |
20030014053 | Nguyen et al. | Jan 2003 | A1 |
20030014087 | Fang et al. | Jan 2003 | A1 |
20030036705 | Hare et al. | Feb 2003 | A1 |
20030040758 | Wang et al. | Feb 2003 | A1 |
20030050572 | Brautigam et al. | Mar 2003 | A1 |
20030055443 | Spotnitz | Mar 2003 | A1 |
20030073981 | Whitman et al. | Apr 2003 | A1 |
20030109778 | Rashidi | Jun 2003 | A1 |
20030109875 | Tetzlaff et al. | Jun 2003 | A1 |
20030114851 | Truckai et al. | Jun 2003 | A1 |
20030130693 | Levin et al. | Jul 2003 | A1 |
20030139741 | Goble et al. | Jul 2003 | A1 |
20030144680 | Kellogg et al. | Jul 2003 | A1 |
20030158548 | Phan et al. | Aug 2003 | A1 |
20030171747 | Kanehira et al. | Sep 2003 | A1 |
20030176778 | Messing et al. | Sep 2003 | A1 |
20030181898 | Bowers | Sep 2003 | A1 |
20030199794 | Sakurai et al. | Oct 2003 | A1 |
20030204199 | Novak et al. | Oct 2003 | A1 |
20030208186 | Moreyra | Nov 2003 | A1 |
20030212332 | Fenton et al. | Nov 2003 | A1 |
20030212363 | Shipp | Nov 2003 | A1 |
20030212392 | Fenton et al. | Nov 2003 | A1 |
20030212422 | Fenton et al. | Nov 2003 | A1 |
20030225332 | Okada et al. | Dec 2003 | A1 |
20030229344 | Dycus et al. | Dec 2003 | A1 |
20040030254 | Babaev | Feb 2004 | A1 |
20040030330 | Brassell et al. | Feb 2004 | A1 |
20040047485 | Sherrit et al. | Mar 2004 | A1 |
20040054364 | Aranyi et al. | Mar 2004 | A1 |
20040064151 | Mollenauer | Apr 2004 | A1 |
20040087943 | Dycus et al. | May 2004 | A1 |
20040092921 | Kadziauskas et al. | May 2004 | A1 |
20040092992 | Adams et al. | May 2004 | A1 |
20040094597 | Whitman et al. | May 2004 | A1 |
20040097911 | Murakami et al. | May 2004 | A1 |
20040097912 | Gonnering | May 2004 | A1 |
20040097919 | Wellman et al. | May 2004 | A1 |
20040097996 | Rabiner et al. | May 2004 | A1 |
20040116952 | Sakurai et al. | Jun 2004 | A1 |
20040122423 | Dycus et al. | Jun 2004 | A1 |
20040132383 | Langford et al. | Jul 2004 | A1 |
20040138621 | Jahns et al. | Jul 2004 | A1 |
20040142667 | Lochhead et al. | Jul 2004 | A1 |
20040143263 | Schechter et al. | Jul 2004 | A1 |
20040147934 | Kiester | Jul 2004 | A1 |
20040147945 | Fritzsch | Jul 2004 | A1 |
20040158237 | Abboud et al. | Aug 2004 | A1 |
20040167508 | Wham et al. | Aug 2004 | A1 |
20040176686 | Hare et al. | Sep 2004 | A1 |
20040176751 | Weitzner et al. | Sep 2004 | A1 |
20040181242 | Stack et al. | Sep 2004 | A1 |
20040193150 | Sharkey et al. | Sep 2004 | A1 |
20040193153 | Sartor et al. | Sep 2004 | A1 |
20040193212 | Taniguchi et al. | Sep 2004 | A1 |
20040199193 | Hayashi et al. | Oct 2004 | A1 |
20040215132 | Yoon | Oct 2004 | A1 |
20040243147 | Lipow | Dec 2004 | A1 |
20040249374 | Tetzlaff et al. | Dec 2004 | A1 |
20040260273 | Wan | Dec 2004 | A1 |
20040260300 | Gorensek et al. | Dec 2004 | A1 |
20040267311 | Viola et al. | Dec 2004 | A1 |
20050015125 | Mioduski et al. | Jan 2005 | A1 |
20050020967 | Ono | Jan 2005 | A1 |
20050021018 | Anderson et al. | Jan 2005 | A1 |
20050021065 | Yamada et al. | Jan 2005 | A1 |
20050021078 | Vleugels et al. | Jan 2005 | A1 |
20050033278 | McClurken et al. | Feb 2005 | A1 |
20050033337 | Muir et al. | Feb 2005 | A1 |
20050070800 | Takahashi | Mar 2005 | A1 |
20050080427 | Govari et al. | Apr 2005 | A1 |
20050088285 | Jei | Apr 2005 | A1 |
20050090817 | Phan | Apr 2005 | A1 |
20050096683 | Ellins et al. | May 2005 | A1 |
20050099824 | Dowling et al. | May 2005 | A1 |
20050107777 | West et al. | May 2005 | A1 |
20050131390 | Heinrich et al. | Jun 2005 | A1 |
20050143769 | White et al. | Jun 2005 | A1 |
20050149108 | Cox | Jul 2005 | A1 |
20050165429 | Douglas et al. | Jul 2005 | A1 |
20050171522 | Christopherson | Aug 2005 | A1 |
20050171533 | Latterell et al. | Aug 2005 | A1 |
20050177184 | Easley | Aug 2005 | A1 |
20050182339 | Lee et al. | Aug 2005 | A1 |
20050187576 | Whitman et al. | Aug 2005 | A1 |
20050188743 | Land | Sep 2005 | A1 |
20050192610 | Houser et al. | Sep 2005 | A1 |
20050192611 | Houser | Sep 2005 | A1 |
20050206583 | Lemelson et al. | Sep 2005 | A1 |
20050222598 | Ho et al. | Oct 2005 | A1 |
20050234484 | Houser et al. | Oct 2005 | A1 |
20050249667 | Tuszynski et al. | Nov 2005 | A1 |
20050256405 | Makin et al. | Nov 2005 | A1 |
20050261588 | Makin et al. | Nov 2005 | A1 |
20050262175 | Iino et al. | Nov 2005 | A1 |
20050267464 | Truckai et al. | Dec 2005 | A1 |
20050271807 | Iljima et al. | Dec 2005 | A1 |
20050273090 | Nieman et al. | Dec 2005 | A1 |
20050288659 | Kimura et al. | Dec 2005 | A1 |
20060025757 | Heim | Feb 2006 | A1 |
20060030797 | Zhou et al. | Feb 2006 | A1 |
20060030848 | Craig et al. | Feb 2006 | A1 |
20060058825 | Ogura et al. | Mar 2006 | A1 |
20060063130 | Hayman et al. | Mar 2006 | A1 |
20060064086 | Odom | Mar 2006 | A1 |
20060066181 | Bromfield et al. | Mar 2006 | A1 |
20060074442 | Noriega et al. | Apr 2006 | A1 |
20060079874 | Faller et al. | Apr 2006 | A1 |
20060079879 | Faller et al. | Apr 2006 | A1 |
20060095046 | Trieu et al. | May 2006 | A1 |
20060109061 | Dobson et al. | May 2006 | A1 |
20060142656 | Malackowski et al. | Jun 2006 | A1 |
20060159731 | Shoshan | Jul 2006 | A1 |
20060190034 | Nishizawa et al. | Aug 2006 | A1 |
20060206100 | Eskridge et al. | Sep 2006 | A1 |
20060206115 | Schomer et al. | Sep 2006 | A1 |
20060211943 | Beaupre | Sep 2006 | A1 |
20060217700 | Garito et al. | Sep 2006 | A1 |
20060217729 | Eskridge et al. | Sep 2006 | A1 |
20060224160 | Trieu et al. | Oct 2006 | A1 |
20060247558 | Yamada | Nov 2006 | A1 |
20060253050 | Yoshimine et al. | Nov 2006 | A1 |
20060259026 | Godara et al. | Nov 2006 | A1 |
20060259102 | Slatkine | Nov 2006 | A1 |
20060264809 | Hansmann et al. | Nov 2006 | A1 |
20060264995 | Fanton et al. | Nov 2006 | A1 |
20060265035 | Yachi et al. | Nov 2006 | A1 |
20060270916 | Skwarek et al. | Nov 2006 | A1 |
20060271030 | Francis et al. | Nov 2006 | A1 |
20060293656 | Shadduck et al. | Dec 2006 | A1 |
20070016235 | Tanaka et al. | Jan 2007 | A1 |
20070016236 | Beaupre | Jan 2007 | A1 |
20070021738 | Hasser et al. | Jan 2007 | A1 |
20070027468 | Wales et al. | Feb 2007 | A1 |
20070032704 | Gandini et al. | Feb 2007 | A1 |
20070055228 | Berg et al. | Mar 2007 | A1 |
20070056596 | Fanney et al. | Mar 2007 | A1 |
20070060935 | Schwardt et al. | Mar 2007 | A1 |
20070063618 | Bromfield | Mar 2007 | A1 |
20070066971 | Podhajsky | Mar 2007 | A1 |
20070067123 | Jungerman | Mar 2007 | A1 |
20070073185 | Nakao | Mar 2007 | A1 |
20070073341 | Smith et al. | Mar 2007 | A1 |
20070074584 | Talarico et al. | Apr 2007 | A1 |
20070106317 | Shelton et al. | May 2007 | A1 |
20070118115 | Artale et al. | May 2007 | A1 |
20070129726 | Eder et al. | Jun 2007 | A1 |
20070130771 | Ehlert et al. | Jun 2007 | A1 |
20070135803 | Belson | Jun 2007 | A1 |
20070149881 | Rabin | Jun 2007 | A1 |
20070156163 | Davison et al. | Jul 2007 | A1 |
20070166663 | Telles et al. | Jul 2007 | A1 |
20070173803 | Wham et al. | Jul 2007 | A1 |
20070173813 | Odom | Jul 2007 | A1 |
20070173872 | Neuenfeldt | Jul 2007 | A1 |
20070175955 | Shelton et al. | Aug 2007 | A1 |
20070185474 | Nahen | Aug 2007 | A1 |
20070191712 | Messerly et al. | Aug 2007 | A1 |
20070191713 | Eichmann et al. | Aug 2007 | A1 |
20070203483 | Kim et al. | Aug 2007 | A1 |
20070208336 | Kim et al. | Sep 2007 | A1 |
20070208340 | Ganz et al. | Sep 2007 | A1 |
20070219481 | Babaev | Sep 2007 | A1 |
20070232926 | Stulen et al. | Oct 2007 | A1 |
20070232928 | Wiener et al. | Oct 2007 | A1 |
20070236213 | Paden et al. | Oct 2007 | A1 |
20070239101 | Kellogg | Oct 2007 | A1 |
20070249941 | Salehi et al. | Oct 2007 | A1 |
20070260242 | Dycus et al. | Nov 2007 | A1 |
20070265560 | Soltani et al. | Nov 2007 | A1 |
20070265613 | Edelstein et al. | Nov 2007 | A1 |
20070265616 | Couture et al. | Nov 2007 | A1 |
20070265620 | Kraas et al. | Nov 2007 | A1 |
20070275348 | Lemon | Nov 2007 | A1 |
20070287933 | Phan et al. | Dec 2007 | A1 |
20070288055 | Lee | Dec 2007 | A1 |
20070299895 | Johnson et al. | Dec 2007 | A1 |
20080005213 | Holtzman | Jan 2008 | A1 |
20080013809 | Zhu et al. | Jan 2008 | A1 |
20080015473 | Shimizu | Jan 2008 | A1 |
20080015575 | Odom et al. | Jan 2008 | A1 |
20080033465 | Schmitz et al. | Feb 2008 | A1 |
20080039746 | Hissong et al. | Feb 2008 | A1 |
20080046122 | Manzo et al. | Feb 2008 | A1 |
20080051812 | Schmitz et al. | Feb 2008 | A1 |
20080058775 | Darian et al. | Mar 2008 | A1 |
20080058845 | Shimizu et al. | Mar 2008 | A1 |
20080071269 | Hilario et al. | Mar 2008 | A1 |
20080077145 | Boyden et al. | Mar 2008 | A1 |
20080082039 | Babaev | Apr 2008 | A1 |
20080082098 | Tanaka et al. | Apr 2008 | A1 |
20080097501 | Blier | Apr 2008 | A1 |
20080114355 | Whayne et al. | May 2008 | A1 |
20080114364 | Goldin et al. | May 2008 | A1 |
20080122496 | Wagner | May 2008 | A1 |
20080125768 | Tahara et al. | May 2008 | A1 |
20080147058 | Horrell et al. | Jun 2008 | A1 |
20080147062 | Truckai et al. | Jun 2008 | A1 |
20080147092 | Rogge et al. | Jun 2008 | A1 |
20080161809 | Schmitz et al. | Jul 2008 | A1 |
20080167670 | Shelton et al. | Jul 2008 | A1 |
20080171938 | Masuda et al. | Jul 2008 | A1 |
20080177268 | Daum et al. | Jul 2008 | A1 |
20080188755 | Hart | Aug 2008 | A1 |
20080200940 | Eichmann et al. | Aug 2008 | A1 |
20080208108 | Kimura | Aug 2008 | A1 |
20080208231 | Ota et al. | Aug 2008 | A1 |
20080214967 | Aranyi et al. | Sep 2008 | A1 |
20080234709 | Houser | Sep 2008 | A1 |
20080243162 | Shibata et al. | Oct 2008 | A1 |
20080255413 | Zemlok et al. | Oct 2008 | A1 |
20080275440 | Kratoska et al. | Nov 2008 | A1 |
20080281200 | Voic et al. | Nov 2008 | A1 |
20080281315 | Gines | Nov 2008 | A1 |
20080287944 | Pearson et al. | Nov 2008 | A1 |
20080287948 | Newton et al. | Nov 2008 | A1 |
20080296346 | Shelton, IV et al. | Dec 2008 | A1 |
20080300588 | Groth et al. | Dec 2008 | A1 |
20090012516 | Curtis et al. | Jan 2009 | A1 |
20090023985 | Ewers | Jan 2009 | A1 |
20090036913 | Wiener et al. | Feb 2009 | A1 |
20090043293 | Pankratov et al. | Feb 2009 | A1 |
20090048537 | Lydon et al. | Feb 2009 | A1 |
20090048589 | Takashino et al. | Feb 2009 | A1 |
20090054886 | Yachi et al. | Feb 2009 | A1 |
20090054889 | Newton et al. | Feb 2009 | A1 |
20090054894 | Yachi | Feb 2009 | A1 |
20090065565 | Cao | Mar 2009 | A1 |
20090076506 | Baker | Mar 2009 | A1 |
20090082716 | Akahoshi | Mar 2009 | A1 |
20090082766 | Unger et al. | Mar 2009 | A1 |
20090088745 | Hushka et al. | Apr 2009 | A1 |
20090088785 | Masuda | Apr 2009 | A1 |
20090090763 | Zemlok et al. | Apr 2009 | A1 |
20090101692 | Whitman et al. | Apr 2009 | A1 |
20090105750 | Price et al. | Apr 2009 | A1 |
20090112206 | Dumbauld et al. | Apr 2009 | A1 |
20090118751 | Wiener et al. | May 2009 | A1 |
20090131885 | Akahoshi | May 2009 | A1 |
20090131934 | Odom et al. | May 2009 | A1 |
20090138025 | Stahler et al. | May 2009 | A1 |
20090143678 | Keast et al. | Jun 2009 | A1 |
20090143799 | Smith et al. | Jun 2009 | A1 |
20090143800 | Deville et al. | Jun 2009 | A1 |
20090157064 | Hodel | Jun 2009 | A1 |
20090163807 | Sliwa | Jun 2009 | A1 |
20090177119 | Heidner et al. | Jul 2009 | A1 |
20090179923 | Amundson et al. | Jul 2009 | A1 |
20090182322 | D'Amelio et al. | Jul 2009 | A1 |
20090182331 | D'Amelio et al. | Jul 2009 | A1 |
20090182332 | Long et al. | Jul 2009 | A1 |
20090182333 | Eder et al. | Jul 2009 | A1 |
20090192441 | Gelbart et al. | Jul 2009 | A1 |
20090198272 | Kerver et al. | Aug 2009 | A1 |
20090204114 | Odom | Aug 2009 | A1 |
20090216157 | Yamada | Aug 2009 | A1 |
20090223033 | Houser | Sep 2009 | A1 |
20090240244 | Malis et al. | Sep 2009 | A1 |
20090248021 | McKenna | Oct 2009 | A1 |
20090248022 | Falkenstein et al. | Oct 2009 | A1 |
20090254077 | Craig | Oct 2009 | A1 |
20090254080 | Honda | Oct 2009 | A1 |
20090259149 | Tahara et al. | Oct 2009 | A1 |
20090264909 | Beaupre | Oct 2009 | A1 |
20090270771 | Takahashi | Oct 2009 | A1 |
20090270812 | Litscher et al. | Oct 2009 | A1 |
20090270853 | Yachi et al. | Oct 2009 | A1 |
20090270891 | Beaupre | Oct 2009 | A1 |
20090270899 | Carusillo et al. | Oct 2009 | A1 |
20090287205 | Ingle | Nov 2009 | A1 |
20090292283 | Odom | Nov 2009 | A1 |
20090299141 | Downey et al. | Dec 2009 | A1 |
20090306639 | Nevo et al. | Dec 2009 | A1 |
20090327715 | Smith et al. | Dec 2009 | A1 |
20100004508 | Naito et al. | Jan 2010 | A1 |
20100022825 | Yoshie | Jan 2010 | A1 |
20100030233 | Whitman et al. | Feb 2010 | A1 |
20100034605 | Huckins et al. | Feb 2010 | A1 |
20100036370 | Mirel et al. | Feb 2010 | A1 |
20100036373 | Ward | Feb 2010 | A1 |
20100042093 | Wham et al. | Feb 2010 | A9 |
20100049180 | Wells et al. | Feb 2010 | A1 |
20100057081 | Hanna | Mar 2010 | A1 |
20100057118 | Dietz et al. | Mar 2010 | A1 |
20100063437 | Nelson et al. | Mar 2010 | A1 |
20100063525 | Beaupre et al. | Mar 2010 | A1 |
20100063528 | Beaupre | Mar 2010 | A1 |
20100081863 | Hess et al. | Apr 2010 | A1 |
20100081864 | Hess et al. | Apr 2010 | A1 |
20100081883 | Murray et al. | Apr 2010 | A1 |
20100094323 | Isaacs et al. | Apr 2010 | A1 |
20100106173 | Yoshimine | Apr 2010 | A1 |
20100109480 | Forslund et al. | May 2010 | A1 |
20100145335 | Johnson et al. | Jun 2010 | A1 |
20100158307 | Kubota et al. | Jun 2010 | A1 |
20100168741 | Sanai et al. | Jul 2010 | A1 |
20100181966 | Sakakibara | Jul 2010 | A1 |
20100187283 | Crainich et al. | Jul 2010 | A1 |
20100193566 | Scheib et al. | Aug 2010 | A1 |
20100204721 | Young et al. | Aug 2010 | A1 |
20100222714 | Muir et al. | Sep 2010 | A1 |
20100222752 | Collins, Jr. et al. | Sep 2010 | A1 |
20100225209 | Goldberg et al. | Sep 2010 | A1 |
20100228249 | Mohr et al. | Sep 2010 | A1 |
20100228250 | Brogna | Sep 2010 | A1 |
20100234906 | Koh | Sep 2010 | A1 |
20100256635 | McKenna et al. | Oct 2010 | A1 |
20100274160 | Yachi et al. | Oct 2010 | A1 |
20100274278 | Fleenor et al. | Oct 2010 | A1 |
20100280368 | Can et al. | Nov 2010 | A1 |
20100298743 | Nield et al. | Nov 2010 | A1 |
20100305564 | Livneh | Dec 2010 | A1 |
20100331742 | Masuda | Dec 2010 | A1 |
20100331871 | Nield et al. | Dec 2010 | A1 |
20110004233 | Muir et al. | Jan 2011 | A1 |
20110015632 | Artale | Jan 2011 | A1 |
20110015650 | Choi et al. | Jan 2011 | A1 |
20110022032 | Zemlok et al. | Jan 2011 | A1 |
20110028964 | Edwards | Feb 2011 | A1 |
20110071523 | Dickhans | Mar 2011 | A1 |
20110082494 | Kerr et al. | Apr 2011 | A1 |
20110106141 | Nakamura | May 2011 | A1 |
20110112400 | Emery et al. | May 2011 | A1 |
20110125149 | El-Galley et al. | May 2011 | A1 |
20110125151 | Strauss et al. | May 2011 | A1 |
20110144640 | Heinrich et al. | Jun 2011 | A1 |
20110160725 | Kabaya et al. | Jun 2011 | A1 |
20110238010 | Kirschenman et al. | Sep 2011 | A1 |
20110238079 | Hannaford et al. | Sep 2011 | A1 |
20110273465 | Konishi et al. | Nov 2011 | A1 |
20110278343 | Knodel et al. | Nov 2011 | A1 |
20110279268 | Konishi et al. | Nov 2011 | A1 |
20110284014 | Cadeddu et al. | Nov 2011 | A1 |
20110290856 | Shelton, IV et al. | Dec 2011 | A1 |
20110295295 | Shelton, IV et al. | Dec 2011 | A1 |
20110306967 | Payne et al. | Dec 2011 | A1 |
20110313415 | Fernandez et al. | Dec 2011 | A1 |
20120004655 | Kim et al. | Jan 2012 | A1 |
20120016413 | Timm et al. | Jan 2012 | A1 |
20120022519 | Huang et al. | Jan 2012 | A1 |
20120022526 | Aldridge et al. | Jan 2012 | A1 |
20120022528 | White et al. | Jan 2012 | A1 |
20120022583 | Sugalski et al. | Jan 2012 | A1 |
20120041358 | Mann et al. | Feb 2012 | A1 |
20120053597 | Anvari et al. | Mar 2012 | A1 |
20120059286 | Hastings et al. | Mar 2012 | A1 |
20120059289 | Nield et al. | Mar 2012 | A1 |
20120071863 | Lee et al. | Mar 2012 | A1 |
20120078244 | Worrell et al. | Mar 2012 | A1 |
20120080344 | Shelton, IV | Apr 2012 | A1 |
20120101493 | Masuda et al. | Apr 2012 | A1 |
20120101495 | Young et al. | Apr 2012 | A1 |
20120109186 | Parrott et al. | May 2012 | A1 |
20120116222 | Sawada et al. | May 2012 | A1 |
20120116265 | Houser et al. | May 2012 | A1 |
20120116266 | Houser et al. | May 2012 | A1 |
20120116379 | Yates | May 2012 | A1 |
20120116381 | Houser et al. | May 2012 | A1 |
20120136279 | Tanaka et al. | May 2012 | A1 |
20120136347 | Brustad et al. | May 2012 | A1 |
20120136386 | Kishida et al. | May 2012 | A1 |
20120143182 | Ullrich et al. | Jun 2012 | A1 |
20120143211 | Kishi | Jun 2012 | A1 |
20120150049 | Zielinski et al. | Jun 2012 | A1 |
20120150169 | Zielinksi et al. | Jun 2012 | A1 |
20120172904 | Muir et al. | Jul 2012 | A1 |
20120191091 | Allen | Jul 2012 | A1 |
20120193396 | Zemlok et al. | Aug 2012 | A1 |
20120211542 | Racenet | Aug 2012 | A1 |
20120226266 | Ghosal et al. | Sep 2012 | A1 |
20120234893 | Schuckmann et al. | Sep 2012 | A1 |
20120253328 | Cunningham et al. | Oct 2012 | A1 |
20120253329 | Zemlok et al. | Oct 2012 | A1 |
20120265241 | Hart et al. | Oct 2012 | A1 |
20120296239 | Chernov et al. | Nov 2012 | A1 |
20120296325 | Takashino | Nov 2012 | A1 |
20120296371 | Kappus et al. | Nov 2012 | A1 |
20130023925 | Mueller | Jan 2013 | A1 |
20130071282 | Fry | Mar 2013 | A1 |
20130085510 | Stefanchik et al. | Apr 2013 | A1 |
20130103031 | Garrison | Apr 2013 | A1 |
20130123776 | Monson et al. | May 2013 | A1 |
20130158659 | Bergs et al. | Jun 2013 | A1 |
20130158660 | Bergs et al. | Jun 2013 | A1 |
20130165929 | Muir et al. | Jun 2013 | A1 |
20130190760 | Allen, IV et al. | Jul 2013 | A1 |
20130214025 | Zemlok et al. | Aug 2013 | A1 |
20130253256 | Griffith et al. | Sep 2013 | A1 |
20130253480 | Kimball et al. | Sep 2013 | A1 |
20130264369 | Whitman | Oct 2013 | A1 |
20130267874 | Marcotte et al. | Oct 2013 | A1 |
20130267943 | Hancock | Oct 2013 | A1 |
20130277410 | Fernandez et al. | Oct 2013 | A1 |
20130296843 | Boudreaux et al. | Nov 2013 | A1 |
20130321425 | Greene et al. | Dec 2013 | A1 |
20130334989 | Kataoka | Dec 2013 | A1 |
20130345701 | Allen, IV et al. | Dec 2013 | A1 |
20140001231 | Shelton, IV et al. | Jan 2014 | A1 |
20140001234 | Shelton, IV et al. | Jan 2014 | A1 |
20140005640 | Shelton, IV et al. | Jan 2014 | A1 |
20140005663 | Heard et al. | Jan 2014 | A1 |
20140005678 | Shelton, IV et al. | Jan 2014 | A1 |
20140005702 | Timm et al. | Jan 2014 | A1 |
20140005705 | Weir et al. | Jan 2014 | A1 |
20140005718 | Shelton, IV et al. | Jan 2014 | A1 |
20140014544 | Bugnard et al. | Jan 2014 | A1 |
20140077426 | Park | Mar 2014 | A1 |
20140107538 | Wiener et al. | Apr 2014 | A1 |
20140121569 | Schafer et al. | May 2014 | A1 |
20140135804 | Weisenburgh, II et al. | May 2014 | A1 |
20140163541 | Shelton, IV et al. | Jun 2014 | A1 |
20140163549 | Yates et al. | Jun 2014 | A1 |
20140180274 | Kabaya et al. | Jun 2014 | A1 |
20140180310 | Blumenkranz et al. | Jun 2014 | A1 |
20140194868 | Sanai et al. | Jul 2014 | A1 |
20140194874 | Dietz et al. | Jul 2014 | A1 |
20140194875 | Reschke et al. | Jul 2014 | A1 |
20140207124 | Aldridge et al. | Jul 2014 | A1 |
20140207135 | Winter | Jul 2014 | A1 |
20140221994 | Reschke | Aug 2014 | A1 |
20140236152 | Walberg et al. | Aug 2014 | A1 |
20140246475 | Hall et al. | Sep 2014 | A1 |
20140249557 | Koch, Jr. et al. | Sep 2014 | A1 |
20140263541 | Leimbach et al. | Sep 2014 | A1 |
20140263552 | Hall et al. | Sep 2014 | A1 |
20140276768 | Juergens et al. | Sep 2014 | A1 |
20140276794 | Batchelor et al. | Sep 2014 | A1 |
20140276797 | Batchelor et al. | Sep 2014 | A1 |
20140276798 | Batchelor et al. | Sep 2014 | A1 |
20140303605 | Boyden et al. | Oct 2014 | A1 |
20140303612 | Williams | Oct 2014 | A1 |
20140357984 | Wallace et al. | Dec 2014 | A1 |
20140373003 | Grez et al. | Dec 2014 | A1 |
20150014392 | Williams et al. | Jan 2015 | A1 |
20150025528 | Arts | Jan 2015 | A1 |
20150032150 | Ishida et al. | Jan 2015 | A1 |
20150048140 | Penna et al. | Feb 2015 | A1 |
20150066027 | Garrison et al. | Mar 2015 | A1 |
20150080876 | Worrell et al. | Mar 2015 | A1 |
20150080887 | Sobajima et al. | Mar 2015 | A1 |
20150080889 | Cunningham et al. | Mar 2015 | A1 |
20150088122 | Jensen | Mar 2015 | A1 |
20150100056 | Nakamura | Apr 2015 | A1 |
20150112335 | Boudreaux et al. | Apr 2015 | A1 |
20150119901 | Steege | Apr 2015 | A1 |
20150157356 | Gee | Jun 2015 | A1 |
20150164533 | Felder et al. | Jun 2015 | A1 |
20150164534 | Felder et al. | Jun 2015 | A1 |
20150164535 | Felder et al. | Jun 2015 | A1 |
20150164536 | Czarnecki et al. | Jun 2015 | A1 |
20150164537 | Cagle et al. | Jun 2015 | A1 |
20150230796 | Calderoni | Aug 2015 | A1 |
20150238260 | Nau, Jr. | Aug 2015 | A1 |
20150272557 | Overmyer et al. | Oct 2015 | A1 |
20150272571 | Leimbach et al. | Oct 2015 | A1 |
20150272580 | Leimbach et al. | Oct 2015 | A1 |
20150272582 | Leimbach et al. | Oct 2015 | A1 |
20150272657 | Yates et al. | Oct 2015 | A1 |
20150272659 | Boudreaux et al. | Oct 2015 | A1 |
20150282879 | Ruelas | Oct 2015 | A1 |
20150289364 | Ilkko et al. | Oct 2015 | A1 |
20150313667 | Allen, IV | Nov 2015 | A1 |
20150317899 | Dumbauld et al. | Nov 2015 | A1 |
20150351765 | Valentine et al. | Dec 2015 | A1 |
20150351857 | Vander Poorten et al. | Dec 2015 | A1 |
20150374430 | Weiler et al. | Dec 2015 | A1 |
20150374457 | Colby | Dec 2015 | A1 |
20160000437 | Giordano et al. | Jan 2016 | A1 |
20160038228 | Daniel et al. | Feb 2016 | A1 |
20160044841 | Chamberlain | Feb 2016 | A1 |
20160045248 | Unger et al. | Feb 2016 | A1 |
20160051314 | Batchelor | Feb 2016 | A1 |
20160051316 | Boudreaux | Feb 2016 | A1 |
20160066913 | Swayze et al. | Mar 2016 | A1 |
20160120601 | Boudreaux et al. | May 2016 | A1 |
20160175025 | Strobl | Jun 2016 | A1 |
20160175029 | Witt et al. | Jun 2016 | A1 |
20160206342 | Robertson et al. | Jul 2016 | A1 |
20160228171 | Boudreaux | Aug 2016 | A1 |
20160249910 | Shelton, IV et al. | Sep 2016 | A1 |
20160262786 | Madan et al. | Sep 2016 | A1 |
20160270842 | Strobl et al. | Sep 2016 | A1 |
20160296251 | Olson et al. | Oct 2016 | A1 |
20160296252 | Olson et al. | Oct 2016 | A1 |
20160296270 | Strobl et al. | Oct 2016 | A1 |
20160317216 | Hermes et al. | Nov 2016 | A1 |
20160331455 | Hancock et al. | Nov 2016 | A1 |
20160358849 | Jur et al. | Dec 2016 | A1 |
20170020614 | Jackson et al. | Jan 2017 | A1 |
20170065331 | Mayer et al. | Mar 2017 | A1 |
20170086909 | Yates et al. | Mar 2017 | A1 |
20170119426 | Akagane | May 2017 | A1 |
20170135751 | Rothweiler et al. | May 2017 | A1 |
20170164972 | Johnson et al. | Jun 2017 | A1 |
20170164997 | Johnson et al. | Jun 2017 | A1 |
20170189095 | Danziger et al. | Jul 2017 | A1 |
20170202595 | Shelton, IV | Jul 2017 | A1 |
20170209145 | Swayze et al. | Jul 2017 | A1 |
20170224332 | Hunter et al. | Aug 2017 | A1 |
20170224405 | Takashino et al. | Aug 2017 | A1 |
20170231628 | Shelton, IV et al. | Aug 2017 | A1 |
20170281186 | Shelton, IV et al. | Oct 2017 | A1 |
20170296169 | Yates et al. | Oct 2017 | A1 |
20170296177 | Harris et al. | Oct 2017 | A1 |
20170296180 | Harris et al. | Oct 2017 | A1 |
20170303954 | Ishii | Oct 2017 | A1 |
20170312018 | Trees et al. | Nov 2017 | A1 |
20170325874 | Noack et al. | Nov 2017 | A1 |
20170333073 | Faller et al. | Nov 2017 | A1 |
20170348043 | Wang et al. | Dec 2017 | A1 |
20170348044 | Wang et al. | Dec 2017 | A1 |
20170367772 | Gunn et al. | Dec 2017 | A1 |
20180014872 | Dickerson | Jan 2018 | A1 |
20180085157 | Batchelor | Mar 2018 | A1 |
20180132850 | Leimbach et al. | May 2018 | A1 |
20180168575 | Simms et al. | Jun 2018 | A1 |
20180168577 | Aronhalt et al. | Jun 2018 | A1 |
20180168579 | Aronhalt et al. | Jun 2018 | A1 |
20180168598 | Shelton, IV et al. | Jun 2018 | A1 |
20180168608 | Shelton, IV et al. | Jun 2018 | A1 |
20180168609 | Fanelli et al. | Jun 2018 | A1 |
20180168615 | Shelton, IV et al. | Jun 2018 | A1 |
20180168618 | Scott et al. | Jun 2018 | A1 |
20180168619 | Scott et al. | Jun 2018 | A1 |
20180168623 | Simms et al. | Jun 2018 | A1 |
20180168625 | Posada et al. | Jun 2018 | A1 |
20180168633 | Shelton, IV et al. | Jun 2018 | A1 |
20180168647 | Shelton, IV et al. | Jun 2018 | A1 |
20180168648 | Shelton, IV et al. | Jun 2018 | A1 |
20180168650 | Shelton, IV et al. | Jun 2018 | A1 |
20180188125 | Park et al. | Jul 2018 | A1 |
20180206904 | Felder et al. | Jul 2018 | A1 |
20180221045 | Zimmerman et al. | Aug 2018 | A1 |
20180250066 | Ding et al. | Sep 2018 | A1 |
20180271578 | Coulombe | Sep 2018 | A1 |
20180289432 | Kostrzewski et al. | Oct 2018 | A1 |
20180303493 | Chapolini | Oct 2018 | A1 |
20180325517 | Wingardner et al. | Nov 2018 | A1 |
20180333179 | Weisenburgh, II et al. | Nov 2018 | A1 |
20180353245 | Mccloud et al. | Dec 2018 | A1 |
20180368844 | Bakos et al. | Dec 2018 | A1 |
20190000459 | Shelton, IV et al. | Jan 2019 | A1 |
20190000461 | Shelton, IV et al. | Jan 2019 | A1 |
20190000475 | Shelton, IV et al. | Jan 2019 | A1 |
20190000477 | Shelton, IV et al. | Jan 2019 | A1 |
20190029746 | Dudhedia et al. | Jan 2019 | A1 |
20190038283 | Shelton, IV et al. | Feb 2019 | A1 |
20190053818 | Nelson et al. | Feb 2019 | A1 |
20190104919 | Shelton, IV et al. | Apr 2019 | A1 |
20190117293 | Kano et al. | Apr 2019 | A1 |
20190125361 | Shelton, IV et al. | May 2019 | A1 |
20190125384 | Scheib et al. | May 2019 | A1 |
20190125390 | Shelton, IV et al. | May 2019 | A1 |
20190175258 | Tsuruta | Jun 2019 | A1 |
20190183504 | Shelton, IV et al. | Jun 2019 | A1 |
20190200844 | Shelton, IV et al. | Jul 2019 | A1 |
20190200977 | Shelton, IV et al. | Jul 2019 | A1 |
20190200981 | Harris et al. | Jul 2019 | A1 |
20190200987 | Shelton, IV et al. | Jul 2019 | A1 |
20190201029 | Shelton, IV et al. | Jul 2019 | A1 |
20190201030 | Shelton, IV et al. | Jul 2019 | A1 |
20190201045 | Yates et al. | Jul 2019 | A1 |
20190201048 | Stulen et al. | Jul 2019 | A1 |
20190201104 | Shelton, IV et al. | Jul 2019 | A1 |
20190201136 | Shelton, IV et al. | Jul 2019 | A1 |
20190201594 | Shelton, IV et al. | Jul 2019 | A1 |
20190206564 | Shelton, IV et al. | Jul 2019 | A1 |
20190206569 | Shelton, IV et al. | Jul 2019 | A1 |
20190209201 | Boudreaux et al. | Jul 2019 | A1 |
20190223941 | Kitamura et al. | Jul 2019 | A1 |
20190269455 | Mensch et al. | Sep 2019 | A1 |
20190290265 | Shelton, IV et al. | Sep 2019 | A1 |
20190298353 | Shelton, IV et al. | Oct 2019 | A1 |
20190366562 | Zhang et al. | Dec 2019 | A1 |
20190388091 | Eschbach et al. | Dec 2019 | A1 |
20200054321 | Harris et al. | Feb 2020 | A1 |
20200078076 | Henderson et al. | Mar 2020 | A1 |
20200078085 | Yates et al. | Mar 2020 | A1 |
20200078609 | Messerly et al. | Mar 2020 | A1 |
20200100825 | Henderson et al. | Apr 2020 | A1 |
20200100830 | Henderson et al. | Apr 2020 | A1 |
20200113622 | Honegger | Apr 2020 | A1 |
20200129261 | Eschbach | Apr 2020 | A1 |
20200138473 | Shelton, IV et al. | May 2020 | A1 |
20200188047 | Itkowitz et al. | Jun 2020 | A1 |
20200222111 | Yates et al. | Jul 2020 | A1 |
20200222112 | Hancock et al. | Jul 2020 | A1 |
20200237434 | Scheib et al. | Jul 2020 | A1 |
20200261086 | Zeiner et al. | Aug 2020 | A1 |
20200268430 | Takei et al. | Aug 2020 | A1 |
20200268433 | Wiener et al. | Aug 2020 | A1 |
20200305870 | Shelton, IV | Oct 2020 | A1 |
20200315623 | Eisinger et al. | Oct 2020 | A1 |
20200315712 | Jasperson et al. | Oct 2020 | A1 |
20200338370 | Wiener et al. | Oct 2020 | A1 |
20200405296 | Shelton, IV et al. | Dec 2020 | A1 |
20200405302 | Shelton, IV et al. | Dec 2020 | A1 |
20200405316 | Shelton, IV et al. | Dec 2020 | A1 |
20200405410 | Shelton, IV | Dec 2020 | A1 |
20200405439 | Shelton, IV et al. | Dec 2020 | A1 |
20200410177 | Shelton, IV | Dec 2020 | A1 |
20210052313 | Shelton, IV et al. | Feb 2021 | A1 |
20210100578 | Weir et al. | Apr 2021 | A1 |
20210100579 | Shelton, IV et al. | Apr 2021 | A1 |
20210153927 | Ross et al. | May 2021 | A1 |
20210177481 | Shelton, IV et al. | Jun 2021 | A1 |
20210177494 | Houser et al. | Jun 2021 | A1 |
20210177496 | Shelton, IV et al. | Jun 2021 | A1 |
20210186492 | Shelton, IV et al. | Jun 2021 | A1 |
20210186495 | Shelton, IV et al. | Jun 2021 | A1 |
20210186497 | Shelton, IV et al. | Jun 2021 | A1 |
20210186499 | Shelton, IV et al. | Jun 2021 | A1 |
20210186501 | Shelton, IV et al. | Jun 2021 | A1 |
20210186553 | Green et al. | Jun 2021 | A1 |
20210186554 | Green et al. | Jun 2021 | A1 |
20210196263 | Shelton, IV et al. | Jul 2021 | A1 |
20210196266 | Shelton, IV et al. | Jul 2021 | A1 |
20210196267 | Shelton, IV et al. | Jul 2021 | A1 |
20210196268 | Shelton, IV et al. | Jul 2021 | A1 |
20210196269 | Shelton, IV et al. | Jul 2021 | A1 |
20210196270 | Shelton, IV et al. | Jul 2021 | A1 |
20210196271 | Shelton, IV et al. | Jul 2021 | A1 |
20210196301 | Shelton, IV et al. | Jul 2021 | A1 |
20210196302 | Shelton, IV et al. | Jul 2021 | A1 |
20210196305 | Strobl | Jul 2021 | A1 |
20210196306 | Estera et al. | Jul 2021 | A1 |
20210196307 | Shelton, IV | Jul 2021 | A1 |
20210196334 | Sarley et al. | Jul 2021 | A1 |
20210196335 | Messerly et al. | Jul 2021 | A1 |
20210196336 | Faller et al. | Jul 2021 | A1 |
20210196343 | Shelton, IV et al. | Jul 2021 | A1 |
20210196344 | Shelton, IV et al. | Jul 2021 | A1 |
20210196345 | Messerly et al. | Jul 2021 | A1 |
20210196346 | Leuck et al. | Jul 2021 | A1 |
20210196349 | Fiebig et al. | Jul 2021 | A1 |
20210196350 | Fiebig et al. | Jul 2021 | A1 |
20210196351 | Sarley et al. | Jul 2021 | A1 |
20210196352 | Messerly et al. | Jul 2021 | A1 |
20210196353 | Gee et al. | Jul 2021 | A1 |
20210196354 | Shelton, IV et al. | Jul 2021 | A1 |
20210196355 | Shelton, IV et al. | Jul 2021 | A1 |
20210196356 | Shelton, IV et al. | Jul 2021 | A1 |
20210196357 | Shelton, IV et al. | Jul 2021 | A1 |
20210196358 | Shelton, IV et al. | Jul 2021 | A1 |
20210196359 | Shelton, IV et al. | Jul 2021 | A1 |
20210196361 | Shelton, IV et al. | Jul 2021 | A1 |
20210196362 | Shelton, IV et al. | Jul 2021 | A1 |
20210196363 | Shelton, IV et al. | Jul 2021 | A1 |
20210196365 | Shelton, IV et al. | Jul 2021 | A1 |
20210196366 | Shelton, IV et al. | Jul 2021 | A1 |
20210196367 | Salguero et al. | Jul 2021 | A1 |
20210212744 | Shelton, IV et al. | Jul 2021 | A1 |
20210212754 | Olson | Jul 2021 | A1 |
20210220036 | Shelton, IV et al. | Jul 2021 | A1 |
20210236195 | Asher et al. | Aug 2021 | A1 |
20210282804 | Worrell et al. | Sep 2021 | A1 |
20210393288 | Shelton, IV et al. | Dec 2021 | A1 |
20210393314 | Wiener et al. | Dec 2021 | A1 |
20210393319 | Shelton, IV et al. | Dec 2021 | A1 |
20220039891 | Stulen et al. | Feb 2022 | A1 |
20220071655 | Price et al. | Mar 2022 | A1 |
20220167982 | Shelton, IV et al. | Jun 2022 | A1 |
20220168005 | Aldridge et al. | Jun 2022 | A1 |
20220168039 | Worrell et al. | Jun 2022 | A1 |
20220226014 | Clauda, IV et al. | Jul 2022 | A1 |
20220304736 | Boudreaux | Sep 2022 | A1 |
20220313297 | Aldridge et al. | Oct 2022 | A1 |
20220346863 | Yates et al. | Nov 2022 | A1 |
20220387067 | Faller et al. | Dec 2022 | A1 |
20220406452 | Shelton, IV | Dec 2022 | A1 |
20230038162 | Timm et al. | Feb 2023 | A1 |
20230048996 | Vakharia et al. | Feb 2023 | A1 |
20230270486 | Wiener et al. | Aug 2023 | A1 |
20230277205 | Olson et al. | Sep 2023 | A1 |
20230372743 | Wiener et al. | Nov 2023 | A1 |
20230380880 | Wiener et al. | Nov 2023 | A1 |
20230397909 | Shelton, IV et al. | Dec 2023 | A1 |
Number | Date | Country |
---|---|---|
2535467 | Apr 1993 | CA |
2460047 | Nov 2001 | CN |
1634601 | Jul 2005 | CN |
1775323 | May 2006 | CN |
1922563 | Feb 2007 | CN |
2868227 | Feb 2007 | CN |
201029899 | Mar 2008 | CN |
101474081 | Jul 2009 | CN |
101516285 | Aug 2009 | CN |
101522112 | Sep 2009 | CN |
102100582 | Jun 2011 | CN |
102149312 | Aug 2011 | CN |
202027624 | Nov 2011 | CN |
102792181 | Nov 2012 | CN |
103281982 | Sep 2013 | CN |
103379853 | Oct 2013 | CN |
203468630 | Mar 2014 | CN |
104001276 | Aug 2014 | CN |
104013444 | Sep 2014 | CN |
104434298 | Mar 2015 | CN |
107374752 | Nov 2017 | CN |
3904558 | Aug 1990 | DE |
9210327 | Nov 1992 | DE |
4300307 | Jul 1994 | DE |
29623113 | Oct 1997 | DE |
20004812 | Sep 2000 | DE |
20021619 | Mar 2001 | DE |
10042606 | Aug 2001 | DE |
10201569 | Jul 2003 | DE |
102012109037 | Apr 2014 | DE |
0171967 | Feb 1986 | EP |
0336742 | Oct 1989 | EP |
0136855 | Nov 1989 | EP |
0468194 | Jan 1992 | EP |
0705571 | Apr 1996 | EP |
1698289 | Sep 2006 | EP |
1862133 | Dec 2007 | EP |
1972264 | Sep 2008 | EP |
2060238 | May 2009 | EP |
1747761 | Oct 2009 | EP |
2131760 | Dec 2009 | EP |
1214913 | Jul 2010 | EP |
1946708 | Jun 2011 | EP |
1767164 | Jan 2013 | EP |
2578172 | Apr 2013 | EP |
2668922 | Dec 2013 | EP |
2076195 | Dec 2015 | EP |
2510891 | Jun 2016 | EP |
3476302 | May 2019 | EP |
3476331 | May 2019 | EP |
3694298 | Aug 2020 | EP |
2032221 | Apr 1980 | GB |
2317566 | Apr 1998 | GB |
S50100891 | Aug 1975 | JP |
S5968513 | May 1984 | JP |
S59141938 | Aug 1984 | JP |
S62221343 | Sep 1987 | JP |
S62227343 | Oct 1987 | JP |
S62292153 | Dec 1987 | JP |
S62292154 | Dec 1987 | JP |
S63109386 | May 1988 | JP |
S63315049 | Dec 1988 | JP |
H01151452 | Jun 1989 | JP |
H01198540 | Aug 1989 | JP |
H0271510 | May 1990 | JP |
H02286149 | Nov 1990 | JP |
H02292193 | Dec 1990 | JP |
H0337061 | Feb 1991 | JP |
H0425707 | Feb 1992 | JP |
H0464351 | Feb 1992 | JP |
H0430508 | Mar 1992 | JP |
H04152942 | May 1992 | JP |
H 0541716 | Feb 1993 | JP |
H0576482 | Mar 1993 | JP |
H0595955 | Apr 1993 | JP |
H05115490 | May 1993 | JP |
H0670938 | Mar 1994 | JP |
H06104503 | Apr 1994 | JP |
H0824266 | Jan 1996 | JP |
H08229050 | Sep 1996 | JP |
H08275951 | Oct 1996 | JP |
H08299351 | Nov 1996 | JP |
H08336545 | Dec 1996 | JP |
H09130655 | May 1997 | JP |
H09135553 | May 1997 | JP |
H09140722 | Jun 1997 | JP |
H105237 | Jan 1998 | JP |
10127654 | May 1998 | JP |
H10295700 | Nov 1998 | JP |
H11128238 | May 1999 | JP |
H11169381 | Jun 1999 | JP |
2000210299 | Aug 2000 | JP |
2000271142 | Oct 2000 | JP |
2000271145 | Oct 2000 | JP |
2000287987 | Oct 2000 | JP |
2001029353 | Feb 2001 | JP |
2002059380 | Feb 2002 | JP |
2002186901 | Jul 2002 | JP |
2002263579 | Sep 2002 | JP |
2002330977 | Nov 2002 | JP |
2003000612 | Jan 2003 | JP |
2003010201 | Jan 2003 | JP |
2003116870 | Apr 2003 | JP |
2003126104 | May 2003 | JP |
2003126110 | May 2003 | JP |
2003153919 | May 2003 | JP |
2003339730 | Dec 2003 | JP |
2004129871 | Apr 2004 | JP |
2004147701 | May 2004 | JP |
2005003496 | Jan 2005 | JP |
2005027026 | Jan 2005 | JP |
2005074088 | Mar 2005 | JP |
2005337119 | Dec 2005 | JP |
2006068396 | Mar 2006 | JP |
2006081664 | Mar 2006 | JP |
2006114072 | Apr 2006 | JP |
2006217716 | Aug 2006 | JP |
2006288431 | Oct 2006 | JP |
2007037568 | Feb 2007 | JP |
200801876 | Jan 2008 | JP |
2008017876 | Jan 2008 | JP |
200833644 | Feb 2008 | JP |
2008188160 | Aug 2008 | JP |
D1339835 | Aug 2008 | JP |
2010009686 | Jan 2010 | JP |
2010121865 | Jun 2010 | JP |
2012071186 | Apr 2012 | JP |
2012223582 | Nov 2012 | JP |
2012235658 | Nov 2012 | JP |
2013126430 | Jun 2013 | JP |
100789356 | Dec 2007 | KR |
101298237 | Aug 2013 | KR |
2154437 | Aug 2000 | RU |
22035 | Mar 2002 | RU |
2201169 | Mar 2003 | RU |
2405603 | Dec 2010 | RU |
2013119977 | Nov 2014 | RU |
850068 | Jul 1981 | SU |
WO-8103272 | Nov 1981 | WO |
WO-9308757 | May 1993 | WO |
WO-9314708 | Aug 1993 | WO |
WO-9421183 | Sep 1994 | WO |
WO-9424949 | Nov 1994 | WO |
WO-9639086 | Dec 1996 | WO |
WO-9712557 | Apr 1997 | WO |
WO-9800069 | Jan 1998 | WO |
WO-9840015 | Sep 1998 | WO |
WO-9920213 | Apr 1999 | WO |
WO-9923960 | May 1999 | WO |
WO-0024330 | May 2000 | WO |
WO-0064358 | Nov 2000 | WO |
WO-0128444 | Apr 2001 | WO |
WO-0167970 | Sep 2001 | WO |
WO-0172251 | Oct 2001 | WO |
WO-0195810 | Dec 2001 | WO |
WO-02080793 | Oct 2002 | WO |
WO-03095028 | Nov 2003 | WO |
WO-2004037095 | May 2004 | WO |
WO-2004078051 | Sep 2004 | WO |
WO-2004098426 | Nov 2004 | WO |
WO-2006091494 | Aug 2006 | WO |
WO-2007008710 | Jan 2007 | WO |
WO-2008118709 | Oct 2008 | WO |
WO-2008130793 | Oct 2008 | WO |
WO-2010027109 | Mar 2010 | WO |
WO-2010104755 | Sep 2010 | WO |
WO-2011008672 | Jan 2011 | WO |
WO-2011044343 | Apr 2011 | WO |
WO-2011052939 | May 2011 | WO |
WO-2011060031 | May 2011 | WO |
WO-2011092464 | Aug 2011 | WO |
WO-2012044606 | Apr 2012 | WO |
WO-2012061722 | May 2012 | WO |
WO-2012088535 | Jun 2012 | WO |
WO-2012150567 | Nov 2012 | WO |
WO-2016130844 | Aug 2016 | WO |
WO-2019130090 | Jul 2019 | WO |
WO-2019130113 | Jul 2019 | WO |
Entry |
---|
Covidien Brochure, [Value Analysis Brief], LigaSure Advance™ Pistol Grip, dated Rev. Apr. 2010 (7 pages). |
Wright, et al., “Time-Temperature Equivalence of Heat-Induced Changes in Cells and Proteins,” Feb. 1998. ASME Journal of Biomechanical Engineering, vol. 120, pp. 22-26. |
Covidien Brochure, LigaSure Impact™ Instrument LF4318, dated Feb. 2013 (3 pages). |
Covidien Brochure, LigaSure Atlas™ Hand Switching Instruments, dated Dec. 2008 (2 pages). |
Covidien Brochure, The LigaSure™ 5 mm Blunt Tip Sealer/Divider Family, dated Apr. 2013 (2 pages). |
Jang, J. et al. “Neuro-fuzzy and Soft Computing.” Prentice Hall, 1997, pp. 13-89, 199-293, 335- 393, 453-496, 535-549. |
Sullivan, “Optimal Choice for Number of Strands in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 14, No. 2, Mar. 1999, pp. 283-291. |
Weir, C.E., “Rate of shrinkage of tendon collagen—heat, entropy and free energy of activation of the shrinkage of untreated tendon. Effect of acid salt, pickle, and tannage on the activation of tendon collagen.” Journal of the American Leather Chemists Association, 44, pp. 108-140 (1949). |
Wall et al., “Thermal modification of collagen,” J Shoulder Elbow Surg, No. 8, pp. 339-344 (Jul./Aug. 1999). |
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal Free Shrinkage,” Transactions of the ASME, vol. 119, pp. 372-378 (Nov. 1997). |
Chen et al., “Phenomenological Evolution Equations for Heat-Induced Shrinkage of a Collagenous Tissue,” IEEE Transactions on Biomedical Engineering, vol. 45, No. 10, pp. 1234-1240 (Oct. 1998). |
Harris et al., “Kinetics of Thermal Damage to a Collagenous Membrane Under Biaxial Isotonic Loading,” IEEE Transactions on Biomedical Engineering, vol. 51, No. 2, pp. 371-379 (Feb. 2004). |
Harris et al., “Altered Mechanical Behavior of Epicardium Due to Isothermal Heating Under Biaxial Isotonic Loads,” Journal of Biomechanical Engineering, vol. 125, pp. 381-388 (Jun. 2003). |
Lee et al., “A multi-sample denaturation temperature tester for collagenous biomaterials,” Med. Eng. Phy., vol. 17, No. 2, pp. 115-121 (Mar. 1995). |
Moran et al., “Thermally Induced Shrinkage of Joint Capsule,” Clinical Orthopaedics and Related Research, No. 281, pp. 248-255 (Dec. 2000). |
Wells et al., “Altered Mechanical Behavior of Epicardium Under Isothermal Biaxial Loading,” Transactions of the ASME, Journal of Biomedical Engineering, vol. 126, pp. 492-497 (Aug. 2004). |
Gibson, “Magnetic Refrigerator Successfully Tested,” U.S. Department of Energy Research News, accessed online on Aug. 6, 2010 at http://www.eurekalert.org/features/doe/2001-11/dl-mrs062802.php (Nov. 1, 2001). |
Humphrey, J.D., “Continuum Thermomechanics and the Clinical Treatment of Disease and Injury,” Appl. Mech. Rev., vol. 56, No. 2 pp. 231-260 (Mar. 2003). |
National Semiconductors Temperature Sensor Handbook—http://www.national.com/appinfo/tempsensors/files/temphb.pdf; accessed online: Apr. 1, 2011. |
Hayashi et al., “The Effect of Thermal Heating on the Length and Histologic Properties of the Glenohumeral Joint Capsule,” American Journal of Sports Medicine, vol. 25, Issue 1, 11 pages (Jan. 1997), URL: http://www.mdconsult.com/das/article/body/156183648-2/jorg=journal&source=MI&sp=1 . . . , accessed Aug. 25, 2009. |
Douglas, S.C. “Introduction to Adaptive Filter”. Digital Signal Processing Handbook. Ed. Vijay K. Madisetti and Douglas B. Williams. Boca Raton: CRC Press LLC, 1999. |
Chen et al., “Heat-induced changes in the mechanics of a collagenous tissue: pseudoelastic behavior at 37° C,” Journal of Biomechanics, 31, pp. 211-216 (1998). |
Technology Overview, printed from www.harmonicscalpel.com, Internet site, website accessed on Jun. 13, 2007, (3 pages). |
Sherrit et al., “Novel Horn Designs for Ultrasonic/Sonic Cleaning Welding, Soldering, Cutting and Drilling,” Proc. SPIE Smart Structures Conference, vol. 4701, Paper No. 34, San Diego, CA, pp. 353-360, Mar. 2002. |
AST Products, Inc., “Principles of Video Contact Angle Analysis,” 20 pages, (2006). |
Lim et al., “A Review of Mechanism Used in Laparoscopic Surgical Instruments,” Mechanism and Machine Theory, vol. 38, pp. 1133-1147, (2003). |
Huston et al., “Magnetic and Magnetostrictive Properties of Cube Textured Nickel for Magnetostrictive Transducer Applications,” IEEE Transactions on Magnetics, vol. 9(4), pp. 636-640 (Dec. 1973). |
Incropera et al., Fundamentals of Heat and Mass Transfer, Wiley, New York (1990). (Book—not attached). |
F. A. Duck, “Optical Properties of Tissue Including Ultraviolet and Infrared Radiation,” pp. 43-71 in Physical Properties of Tissue (1990). |
http://www.apicalinstr.com/generators.htm. |
http://www.dotmed.com/listing/electrosurical-unit/ethicon/ultracision-g110-/1466724. |
http:/www.ethicon.com/gb-en/healthcare-professionals/products/energy-devices/capital//ge . . . |
http://www.medicalexpo.com/medical-manufacturer/electrosurgical-generator-6951.html. |
http://www.megadyne.com/es_generator.php. |
http://www.valleylab.com/product/es/generators/index.html. |
Graff, K.F., “Elastic Wave Propagation in a Curved Sonic Transmission Line,” IEEE Transactions on Sonics and Ultrasonics, SU-17(1), 1-6 (1970). |
Makarov, S. N., Ochmann, M., Desinger, K., “The longitudinal vibration response of a curved fiber used for laser ultrasound surgical therapy,” Journal of the Acoustical Society of America 102, 1191-1199 (1997). |
Walsh, S. J., White, R. G., “Vibrational Power Transmission in Curved Beams,” Journal of Sound and Vibration, 233(3), 455-488 (2000). |
Covidien 501(k) Summary Sonicision, dated Feb. 24, 2011 (7 pages). |
Morley, L. S. D., “Elastic Waves in a Naturally Curved Rod,” Quarterly Journal of Mechanics and Applied Mathematics, 14: 155-172 (1961). |
Gooch et al., “Recommended Infection-Control Practices for Dentistry, 1993,” Published: May 28, 1993; [retrieved on Aug. 23, 2008]. Retrieved from the internet: URL: http//wonder.cdc.gov/wonder/prevguid/p0000191/p0000191.asp (15 pages). |
Sullivan, “Cost-Constrained Selection of Strand Diameter and Number in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 16, No. 2, Mar. 2001, pp. 281-288. |
Orr et al., “Overview of Bioheat Transfer,” pp. 367-384 in Optical-Thermal Response of Laser-Irradiated Tissue, A. J. Welch and M. J. C. van Gemert, eds., Plenum, New York (1995). |
Fowler, K.R., “A Programmable, Arbitrary Waveform Electrosurgical Device,” IEEE Engineering in Medicine and Biology Society 10th Annual International Conference, pp. 1324, 1325 (1988). |
Lacourse, J.R.; Vogt, M.C.; Miller, W.T., III; Selikowitz, S.M., “Spectral Analysis Interpretation of Electrosurgical Generator Nerve and Muscle Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, pp. 505-509, Jul. 1988. |
Campbell et al., “Thermal Imaging in Surgery,” p. 19-3, in Medical Infrared Imaging, N. A. Diakides and J. D. Bronzino, Eds. (2008). |
Gerhard, Glen C., “Surgical Electrotechnology: Quo Vadis?,” IEEE Transactions on Biomedical Engineering, vol. BME-31, No. 12, pp. 787-792, Dec. 1984. |
http://www.4-traders.com/JOHNSON-JOHNSON-4832/news/Johnson-Johnson-Ethicon-E . . . |
Henriques. F.C., “Studies in thermal injury V. The predictability and the significance of thermally induced rate processes leading to irreversible epidermal injury.” Archives of Pathology, 434, pp. 489-502 (1947). |
Arnoczky et al., “Thermal Modification of Conective Tissues: Basic Science Considerations and Clinical Implications,” J. Am Acad Orthop Surg, vol. 8, No. 5, pp. 305-313 (Sep./Oct. 2000). |
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal, Isotonic Shrinkage,” Transactions of the ASME, vol. 120, pp. 382-388 (Jun. 1998). |
Kurt Gieck & Reiner Gieck, Engineering Formulas § Z.7 (7th ed. 1997). |
https://www.kjmagnetics.com/fieldcalculator.asp, retrieved Jul. 11, 2016, backdated to Nov. 11, 2011 via https://web.archive.org/web/20111116164447/http://www.kjmagnetics.com/fieldcalculator.asp. |
Leonard I. Malis, M.D., “The Value of Irrigation During Bipolar Coagulation,” 1989. |
Covidien Brochure, The LigaSure Precise™ Instrument, dated Mar. 2011 (2 pages). |
Glaser and Subak-Sharpe, Integrated Circuit Engineering, Addison-Wesley Publishing, Reading, MA (1979). (book—not attached). |
Erbe Electrosurgery VIO® 200 S, (2012), p. 7, 12 pages, accessed Mar. 31, 2014 at http://www.erbe-med. com/erbe/media/Marketing materialien/85140170 ERBE EN VIO 200 S D027541. |
Hörmann et al., “Reversible and irreversible denaturation of collagen fibers.” Biochemistry, 10, pp. 932-937 (1971). |
Dean, D.A., “Electrical Impedance Spectroscopy Study of Biological Tissues,” J. Electrostat, 66(3-4), Mar. 2008, pp. 165-177. Accessed Apr. 10, 2018: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597841/. |
Moraleda et al., A Temperature Sensor Based on a Polymer Optical Fiber Macro-Bend, Sensors 2013, 13, 13076-13089, doi: 10.3390/s131013076, ISSN 1424-8220. |
IEEE Std 802.3-2012 (Revision of IEEE Std 802.3-2008, published Dec. 28, 2012. |
“ATM-MPLS Network Interworking Version 2.0, af-aic-0178.001” ATM Standard, The ATM Forum Technical Committee, published Aug. 2003. |
Missinne, et al. “Stretchable Optical Waveguides,” vol. 22, No. 4, Feb. 18, 2014, pp. 4168-4179 (12 pages). |
Number | Date | Country | |
---|---|---|---|
20210196364 A1 | Jul 2021 | US |
Number | Date | Country | |
---|---|---|---|
62955299 | Dec 2019 | US |